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SUMMARY 
The existence of sub-populations of T cells, distinguished by their 
maturity, membrane characteristics and functions, has been established, 
and an introduction to T cell heterogeneity is provided in Chapter I. 
T cell proliferation is an early event in many immune responses. It 
is reasonable to assume that any mechanism which regulates the iriagni-
tude of T cell proliferation may affect the overall outcome of the 
immune response, in terms of the types of effector cells produced. 
In these studiei the antigen oxazolone (a potent stimulator of T cell 
proliferation) is used to discover possible factors that may regulate 
the proliferative response. 
In Chapter II information is presented about the antigen oxazolone 
and the cellular events that occur after its cutaneous application. The 
experiments reported in this chapter show that T cells can transfer 
adoptively the DNA synthetic response to oxazolone into irradiated 
recipients (measured by uptake of 125 IUdR) and this syatom was used to 
investigate the kinetics of the response. Mature T cells produced cell 
for cell a greater response than do thymooytes. However, regardless of 
the source of T cells, a characteristic pattern of response was revealed 
where peak DNA synthesis occurring on days 3, 4 or 5 could not be elevated 
by increasing the dose of cells. Thus a hoeostatio mechanism appears 
to regulate the magnitude of the T cell response. Experiments failed 
to implicate any sub-population of T cells in regulating the response, 
and the possible existence of other mechanisms is diacussed. 
(ix) 
In chapter III the production of antibodies to oxazolone of classes 
jri, ?G, cTA, and sub-classes KG1, YG2a and G2b in the sera of 
mice given one or two applications of oxazolone was investigated. 
The possibility that T cell proliferation may be regulated by antibody 
production was investigated by studying the effect of passively 
administered hyperimiliune serum on the proliferative response • It was 
found to have no demonstrable effect. 
Antigen-mediated recruitment of circulating cells is recognised as being 
an early event in the initiation of an immune r'espoiw e and an account 
of cell traffic is given in the Introduction to Chapter IV and V. 
The relationship between cell proliferation and cell recruitment 
was studied and the possibility that the regulation of T cell prolifer-
ation way be mediated by altering cell traffic was investigated in 
Chapters IV and V. In Chapter IV a new technique for investigating 
cell localisation is described, using 75 8e-LaelenomethiOflifle ( 
75Sem) 
a -emittiflg isotope, as a radioactive marker for lymphocytes. 
The  technique is evaluated within the context of the problems associated 
with using radioactive isotopes as markers for lymphocytes. The 
advantages of 788em are the high levels of incorporation that can be 
achieved and the low levels of in vivo reutilisation and absence of 
any adverse effects on lymphocyte iinmunocompetence. 
The studies in Chapter V revealed that cutaneous application of oxazolone 
produces an accumulation of labelled celia in the regional lymph nodes 
24-48 hours after application, with a conconimitant decrease in the 
recruitment of cells in the contra].ateral nodes • Cell traffic to 
draining and contralateral nodes returned to normal after 4 to 5 days. 
(x) 
The magnitude of cell recruitment was independent of DNA synthesis 
occurring concurrentlY in the stimulated node. Thus the factors that 
regulate the proliferation of T cells did not appear to involve or be 
mediated via an alteration in cell recruitment. These results are 
discuSsed in terms of current concepts concerning the mechanisms that 




GENERAL INTRODUCTION AND INTRODUCTION TO T (ILLS 
General introduction 
The adult rninmalian immune system depends on interactions between two 
interdependent components, the circulating immunological tissues, blood and 
lymph, and the fixed immunological organs, the spleen and lymph nodes, 
bone-marrow and thymus. The blood and lymph contain antigen, imniuno-
competent cells and their precursors, and antibody • The immunological 
viability of this circulating component is dependent on replenishment 
by the bone-marrow and thymue, and filtration through the spleen and 
lymph nodes • These structures are ret icular meshworks which physically 
and biologically filter and change the composition of the fluids passing 
through them. They sequester antigen and immunocompetent cells, provide 
sites f or their interaction, provide a suitable environment for the 
consequent proliferation and differentiation of activated lymphocytes, 
and allow the release of the end products able to effect an immune 
response. 
Tirinalian blood and lymph contain a variety of leucocy tea; lymphocytes 
and their precursors, monocytes, granulocytes and platelets. These 
all play a role in defenie mechanisms, but the essential unit responsible 
for specific immunity is the lymphocyte. The outstanding feature of 
the lymphocyte that distinguishes it from non-specific defence 
mechanisms is its ability to recognise specific antigenic structures, 
to become senaitised and produce a heightened secondary response to 
2. 
that antigen. 
Lymphocytes are a heterogencous population with regard to their membrane 
characteristics, distribution and function. The ultimate origin of 
lymphocytes are the haemopoetic stem celia, that i*, cells able to 
differentiate into spec iaiised blood cells and with the capacity for 
extensive self-renewal (Lajtha, 1966; Barnes & Loutit, 1967a; 
Caffrey-Tyler & Everett, 1966). The first haemopoetic stem cells of 
avian and rnRntmalian embryos are found in the yolk sac (Moore & Owen, 
1967a) and later in the foetal ms*nmalian liver (Moore & Metcalf, 1970) 
and in the adult bone-marrow (Barnes & Loutit, 1967a, 1967b). Cells 
from these organs are seeded via the blood and their differentiation to 
more mature cells is directed along certain pathways by the inductive 
influence of the particular environment in which the cells lodge 
(Moore & Owen, 1967a, 1967b; Metcalf & Moore, 1971). The inductive 
influence is provided by the 'primary lymphoid organs' (Miller, 1966) 
which consist of the thymus gland in mnmmfLl5 and birds and the bursa 
of Fabricius in avian species. 
Classically, the vertebrate immune response was described as being of 
two types, characteriaed by the production of either humoral antibody 
or the production of cell-mediated immunity. This dichotomy can be 
reconciled in terms of differential contribution by cells which 
differentiate in the thymus or T cells and cells which differentiate 
in the absence of the thymue or B cells (Roitt e 1 ,1969) T cells are 
responsible for initiating cell-mediated immunity and B cells are 
responsible for the major prcduótion of antibody .. 	The majority of 
Z. 
izanune responses require the participation of both T and B cells. 
The major portion of these studiea is concerned with the hinetics and 
regulation of the T cell proliferative response to the antigen oxazolime. 
T 00118 are a heterogeneous population and their ttaturat ion and various 
functions are described below. 
Introduction to T cells 
1. P!aturation of T coils 
(a) The Thyp 
The th3fimxs  is the organ with the highest rate of production of lympho-
cytes which takes place almost entirely in the thymic cortex, the 
cedullary lymphoid cells exhibit little or no titotio activity 
(2etcalf, 1964). In several studios tritiated thymidine was injected 
into the thymus and after one pulae, many large and ccdiuin aized 
lymphocytes were labelled, but only a tow amall lymphocytes were 
labelled • 	(tIetcaif, 1966; 1etca1f & Wiadroski, 1966; Borum, 1968). 
These results, suggesting that large lymphocytes differentiate to 
produce small thyEocytes accords with the codel of cortical lympho-. 
poiesis proposed for the rat thymus by 9ainte-rario and Leblond (1965). 
Differentiation of large thymooytea to sml1 thyrnocyten is accompanied 
by 2ovezent of cells from the cortex to the neduM (Boruin, 1960; 
Veiasman, 1973). The total cortical population appears to be replaced 
every 3-4 days (etca1f & Wiadrowski 1966; 1rotcalf, 1966). As the 
aize of the adult thymus remaina relatively constant, this rapid renewal 
4, 
muet be balanced by an equally rapid loss through either cell death or 
migration. 
There is good evidence to show that celia migrate from the adult 
thyinus to the peripheral lymphoid tiaeu. Indirect evidence was 
provided by experiments where thymectoaiaed mice were restored to 
iinmunocompetence by giving theni chromosomally marked thymus graft.. 
Celia of thymic origin were found in peripheral lymph node tissue 
(Miller, 1962; Miller & Oaoba, 1963; Jia fs- et 	11964;' 
Davies et al., l966 Leuchars et al., 1964) • More direct evidence was 
provided by labelling thymocytes in situ with the tritiated precursors 
of DNA and ENA, and following the subsequent appearance of labelled 
cells in the spleen and lymph nodes of guinea-pigs (Nossal, 1964) and 
rats (Weisaman 1967). There appears to be some homeostatic ineohanisra 
which regulates the rate of outflow of thymocytes from the thymue. 
For example, Metcalf (1966) grafted mice with 12-48 thymue grafts, 
injected tritiated thymidine and found the same percentage of labelled 
cells in peripheral lymph nodes as found in normal mice given only 
intrathyinic thymidine. There is evidence f or a population of cells 
that under normal conditions never leavathe thymus (Elliot, 1973). 
There is very little eridence of cell death in the thymus, but it is  
thought that some proliferating cells die (Metcalf, 1966). The 
function of the intense lymphopoieeie within the thymus could be to 
allow diversification of cells with regard to their antigen receptors, 
possibly accompanied by deetruction'of self-reactive cells (Burnet 
1962). 
6 . 
The origin of cells within the thymus is undoubtedly etrinsio. 
Experiments have been performed using chicken chimeras'irepopu1ated 
with different cell populations which can be chromosouially distinguished 
by the male ZZ or female ZW chromoaomes. Thus chicken embryos were 
parabiosod at the yolk sac stage and found to have a hiIZ level of 
thymic chimerism, and thymic grafts developing on cborioallantois became 
populated by host cells (L1oore & Owen, 196?c)0 Thymic rudinonts from 
chick and mouse embryos of various ages were removed and their ability 
to become lymphoid wss tested , vitro, the results suggested that 
stem cells enter the chick thymus at about day 11 (Owen & Ritter, 1969). 
none-marrow cells, distinguished by the mouse chromosøme mar1er T6T6 
were found to ropopulate the thymus of lethally irradiated syngenoic 
recipients (Ford & I4cklem, 1963) and the shielded thymue of part-body 
irradiated mico (1'ord et al., 1963), 
Cells within the thymus differentiate and 'mature' to form thynocytea 
charactorisod by their immunocompetonce and ability to migrate to the 
peripheral lymphoid tissuo. The production of mature thyznocytos is 
accompanied by rearrangement of surface components distinguished using 
011oantisera, and can be conveniently doacribcd as occuring in two 
stages; 
The maturation of cells which have recently migrated to the 
thymus to immature thymocytea. 
The maturation of immatara thymocyteci to mature thymocytea. 
6. 
Development of inmiRture thymocytes 
)iurine stem cells from foetal yolk sac migrate into the rudimental 
thymus atabout 11 days of gestation (Owen & Ritter, 1969). At this 
stage they have no theta antigen or thyinus - leukaemia (TL) antigen 
but by 18 days the majority are killed by anti-theta serum and 61% by 
anti-TL serum (Owen & Raff, 1970). This change is accompanied by 
cellular proliferation and the cells differentiate to small lymphocytes 
(Owen & Raff, 1970). The experiments were performed by culturing 
14 day thymic rudiments in isolation on chick chorioallantoie, thua 
eliminating the possibility that new cells carrying theta and TL antigen 
were entering the thymic rudiment • Therefore foetal cells acquire 
theta Land TL antigen in the thymua • There is circumstantial evidence 
indicating that bone-marrow cells also develop these antigenic 
characteristics. Bone-marrow cells do not carry theta (Reif & Allen, 
1964; Aoki et al., 1969) or TL antigen (Aoki et al., 1969), they have 
however been shown to become TL positive under thymic influence. Thus 
thymic grafts of C57B1/6 strain (TL negative) were implanted under the 
kidney capsule of thymectomised (A X C57B]J6) F 1 hosts (TL positive). 
The grafts were repopulated by host cells which were TL negative on 
day 11, but after 4 days in the thymua they became TL positive 
(Schlesinger & Harwitz, 1968). The possibility that TL positive cells 
were entering the graft between days 11-18 was not excluded. 
Development of mature thymocytes 
A population of thymocytes migrates to the peripheral lymphoid tissue 
where it eventually exhibits immunocompetence and the properties of 
secondary lymphoid tisøue and T cells. Such properties include the 
7. 
ability to recirculate and certain alloantigenic surface character-
istics. Lymph node cells have littl• theta, no TL, but hsavy repres-
entation of H2 antigen (Reif & Allen, 1964; Aoki etal., 1969). This 
contraeta to the high levels of theta and TL found in the majority of 
thyluocyt... Thymocytes were injected into lethally irradiated syngenaic 
hosts, the apleena were harvested and were found to have alloantigen 
representation identical to that found in lymph nodes (Rat f & Owen, 1970; 
Rat f, 1971). Thymocytee of A strain mice (TL positive) were shown to 
lose their TL antigen in the periphery (Lance et al., 1970). It is 
theoretically conceivable that thymocytes acquire these properties while 
in the periphery, but exper izments suggest that at least some are acquired 
within the thyinus. For example, it has been shown that thymocytes in 
the thymus of a TL positive strain, lose their TL antigen while in the 
thymus and gain immunocompetence, by experiments that concentrated the 
cells able to perform graft versus host activity from TL positive 
thymuses by use of anti-TL sera (Leckband, 1970,1971). The possibility 
that mature T cells able to mediate a graft versus host response were 
entering the thymus was excluded by Ritter (1971) who showed development 
of graft versus host activity in embryonic thymue cultured in diffusion 
chanibera. 
Another method of isolating an intrathymic cell population which displays 
immunocompotence is to administer cortisone acetate (2mg/mouse) 2 days 
before harvesting the thymus (Cohen et al., 1970). About 95% of the 
thymocytes are destroyed (Cohen et al., 1970), the surviving cells are 
found in the medulla (Iøchidate & Metcalf, 1963; Warner, 1964) and are 
TL negative (Schlesinger & Golaki, 1967). The cortisone resistant 
S . 
meduliary thymocytea produce graft vs hoot responses (Blomgren & 
Anderceon, 1969; Cohen et al., 1970; Blomgren & Andersøon, 1970), 
respond to allo9onoic cells in vitro (1omgren & 8vednyr, 1971; 
nosier & Cantor, 1971), to RR in vitro (Blongren & Svediiyr, 1971) and 
cooperate with bone-marrow celia to produce bumoral responses to ahcop 
erythrocytea, bovine serum albumin, ovalbumins and NIP (Andorsoon & 
Blomgren, 1970). These results are substantiated by V7arner's study 
(1964) which demonstrated that immunocompetence of the chicken thymus 
resided solely in the medulla. As thymic cortical cells divide they 
appear to move into the medulla (Borum, 1968) and cortisone resistant 
thymocytes arise from cortisone sensitive cortical cells (Weisaman, 1973). 
There is evidence linking cortisone resistant thynzocytes with circul-
sting cells and peripheral T cells. 	51Cr labolled cortisone resistant 
thymocytes migrate to lymph nodes in hiior numbers than thymocytes 
(Elomgren & Anderason, 1972; Lance ot ml., 1970), cortisone resistant 
celle are TL negative and TL negative coils behave as recirculating 
cells (Raff, 1971). The "cell volume distribution" of cortisone 
resistant thymocytes is similar to that of a normal lymph nodo 
population (B]omgren & Anderseon, 1969). 
Cortisone resistant thymocytes thus represent a population of thymocytes 
that have acquired some maturity, they are not however identical to 
either lymph node T cells or spleen cells • 1iesulto suggest that 
cortis3ie resistant thymocytos are a heterogeneous population and that 
some require 4 or 5 days in the periphery bafore showing lymph node T 
cell kinetics to hiatoconpatibility antigens (Flosier & Cantor, 1971; 
Cantor & nosier, 1972). This may explain why cortisone resistant 
9. 
thymocytes do not synergise with thymocytea to produce eplenomegaliy as 
do lymph node cells, and why spleen cells, when injected into F 1 
recipients produce a peak mortality of the recipients 31 days after 
injection, 4 days earlier than do cortisone resistant thycocytes 
(Tigelanr & Asofaky, 1973). Tigelaar and Asofaky (1973) suggested 
the existence of a cortisone sensitive iaunocoriipetent thymocyte to 
explain the latter observation. This is supported by the fact that 
although cortisone resistant thymocytes account for 55 of total 
thytuocytes, cell for cell they are only six times more active in T.-B 
cell collaboration (Andersson & Blomgren, 1970) and ten times more 
active in graft vs host responses (Blongren & Anderseon, 1969; 
Tigellar &Asofsky, 1973). The existence of cortisone sensitive 
circulating T cells is also iip1ied by: the fact that short lived 
peripheral T cells are more susceptible to cortisone than long-lived 
periphoral ? coils (I1il1er & Cole, 1967 Esteban, 1988). Thus while 
providing a useful tool to concentrate i!nnunocompotent thymus cells, 
cortisone may not ref loct any physiological division of thyinocytea and 
may indoed exclude a mature T cell population and be heterogeneous with 
regard to the maturity of the thyznocytes it does represent. 
(b) The peripheral lyinphoid tissue and circulating cells 
The peripheral lyriphoid tissue consists of circulating immunocopetent 
lymphocytes able to lodge in lymphoid tissue such as the spleen and 
lymph nodes and respond specifically to antigen by the production of 
humoral antibody or the effectors of cell-mediated iimrnmitye 
10. 
The life-span of about 90% of circulating cells in the rat has been 
calculated as being 2-3 months (Little 	al., 1962; Everett and 
Tyler-Caffrey, 1967). Lymphocytes circulate from the blood through 
the lymph nodea, through the lymphat ice and via the thoracic duct back 
to the blood (Gowane & Knight, 1964). The route taken by small 
lymphocytes from the blood to the lymph nodes is through or between the 
endothelial cells of the post-capillary venules. Electron microscope 
studies have shown these cells apparently passing through the cytoplaam 
of the endothelial cells (Marchesi & Gowana, 1964), although more recent 
evidence suggests the lymphocytes may move between the cells (Schoefi, 
1972; Claeason et aX., 1971). Lymphocytes are tthought to leave the 
nodes primarily through the efferent lymphatic channels (Hall & Mprria, 
1964; Gowane & Knight, 1964). The route of cell migration through 
the spleen is not definitely established. Cells migrate from the 
blood to the periarteriolar sheaths, by passing through gaps in the 
lining of the endothelial walls of the marginal sinus (Gold-Schneider & 
McGregor, 1968a) and probably exit via the splenic vein. 
The majority of thoracic duct cells are T cells, for about 85% of thoracic 
duct cells are sensitive to anti-theta serum (Raff, 1969; Raff & Wortis, 
1970; Miller & Sprent, 1971,a treatment which in the presence of 
complement specifically lysea T cells (Raft & Wortis, 1970; 
Schlesinger & Yron, 1970). The majority of thoracic duct celia migrate 
to the paracortex of lymph nodes, the interfoilicular areas of Peyer'a 
ptches and the periarteriolar sheaths of the spleen. These areas 
have been termed IT dependent' areas (Parrott et al., 1966). The - 
thoracic duct also contains B cells (Ellis, 1969; Howard, 1972a, 1972b; 
11. 
Mandel gt al., 1973; Sprout, 1973; Sprent and Basten, 1973) B cells 
migrate preferentially to the T independent areas of lymph node and spleen 
(Parrott & de Sousa, 1971; Howard etal., 1972). 
There is a fairly large body of evidence to suggest that circulating 
T cells are not derived directly from the thymus, but indirectly, 
probably as a result of maturation of newly formed T cells in the 
periphery. Maturation could be driven by a thymic hormonal factor 
(Stutman at al., 1969) or by antigen (Cantor, 1971). These poasibil-  
ities are not mutually exclusive. Miller and Mitchell (1969) found that 
thyinus cells given to lethally irradiated mice produced, in response to 
sheep red cells, large pyronophilic cells which gave rise to a progeny 
of smaller lymphocytes . - These behaved as recirculating lymphocytes when 
injected into normal recipients. Similarly, Sprout & Miller (1971, 
1972b) injected thymus cells labelled with tritiated thymidine into F 1 
recipients. These thymocytes proliferated in response to alloantigena 
and 4.8 days later labelled cells appeared in the thoracic duct • These 
cells were specifically cytotoxic as shown by their ability to reject 
grafts in vivo, and lyse tumour cells In vitro (Sprout & Miller, 1911, 
1972c). 
Recirculating cells are essential to maintain the integrity of the Immune 
system. There are two bodies of evidence to support this contention; 
a) part of the immunodeficiency caused by neonatal thymectomy can be 
attributed to the concomitant decrease in circulating cells • Neonatal 
12. 
thymectomy is associated with a depression in the ability of anini1s to 
undertake a cellular immune response such as homograft rejection or 
delayed hypersensitivity (Arnasonetal., 1962; Miller, 1961) and 
also with a depression in some huinoral responses (reviewed in Miller & 
Osoba, 1967). The conconnnitant decrease in the number of circulating 
cells was discovered by measuring the number of lymphocytes that could 
be mobilised within 48 hours of draining the thoracic duct of normal 
and neonatally thymectomised mice. In this way it was found that 
8.6 x 10 cells were produced from a normal mouse compared to 2-3 x 106 
cells from a thymectoznieed animal (Miller & Mitchell, 1967; Agnew, 1967). 
This evidence is corroborated by ' qrihowing that the spleen and lymphoid 
tissues of rats which have undergone chronic thoracic duct drainage 
are identical to the spleen and lymphoid tissue of rats which have 
undergone neonatal thymectomy (Goldechneider & McGregor, 1968a). 
T'yinectomiaed mice can be restored to iununocompetence by the intra-
venous injection of thoracic duct cells (Agnew, 1967; Miller 
1967a; Sprent & Miller, 1971) and cells from neonatally thy*nectomised 
mice do not reaotre imniunocompetence (Agnew, 1967). 
b) The functional capacity of the lyniphoid compartment of lymph nodes 
and spleen has been shown to depend substantially on the entry of cells 
from the pool of recirculating lymphocytes, rather than on the cells 
resident within the node. Hall and Morris (1964) showed that 2,000 R 
irradiation did not impair the haemolyein response of the locally 
irradiated sheep popli teal lymph node • The node must therefore have 
responded by the recruitment of recirculating cells • Local heavy 
irradiation of the spleen has also been shown not to dinige the 
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haemolysin response (van den Broek, 1971; Sim(i9 & Petrovi, 1976). 
The elegant experiments of Ford and Gowana (1967) demonstrated that 
the baemolysin response of a spleen, isolated and perfused in vitro, 
was proportional to the number of cells circulating through the spleen. 
Their results suggested the existence of a compartment of lymphocytes 
within the spleen representing perhaps 20 of the spleen population 
which is critical for the immune response and is dependent on replenish-
ment by the blood. 
It is possible to postulate why a recirculating source of immunocompetent 
cells is more efficient than a sessile population. For example, 
selective theories of immunity suggest that only a small proportion of 
lymphocytes are able to react to a particular antigen. Cell traffic 
would thus allow a much larger number of eligible cells to be made 
available for induction allowing antigertic selection from the whole pool 
of recirculating cells, rather than only those present in a certain 
location (Ford and Gowans, 1907). It is also possible that cells 
moving through a lymph node or spleen may facilitate contact between 
antigen and imiaunocompetent cells • The raechanism of cell recruitment 
during an immune response is discuaaed in Chapter IV14nd V. 
2. Functions of T cells 
(a) Humoral antibody production 
Neonatal thyinectomy is associated with defects in the ability to 
undertake certain antibody responses (Lililer & Osoba, 1967) such as 
those to heterologous erythrocytea and heterologous proteins. The 
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IgG phase is core severely depleted than the I! (rililer et al., 19671?; 
Taylor & Wortis, 1968). There are some antigens that when a&iinistered 
to T cell deprived anicals elicit as gcod a response as in noraal 
cmiza1s • These ant iezis appear not to reqiire the presence of the 
thyte for an optzzal reoponso and are terrned T iepoz1ent. A ccicon 
characteristic of T indapondent antico in that otructwrally thoy are 
conpsed of repeating identical units, oipioo of ouch antierio Ore 3111 
roaococca1 polyt3accharide (uEathrey at al., 1964; Ibviard at al., 1971), 
endotod.n iron E. coil (&11or 8 F.lichaol, 1971; 1ridoroscn Blogz'on 
1971), polyvinyipyrroliclofle (Andoreson & 31oigron, 1971) 9 and polyaoried 
flgo1lin from8almoneila adelaide (eLdaiu & Bacton, 1971). 
Evidonce sugsting syaery between T cello and B colla in the 
productionof antibody to 7 dopondeiat antiono arose from the reou1t 
of novoral types of exoriment; 
I. Irradiated or thymectoniodd and irradiated nico whoa roconotituted 
with ui2tures of thynus cello tnd unrrow cello produced more antibody 
ainct sheep erythrocyten than could be accounted for by the oum of the 
activities alone (reviewed by C1aon & Chayeron, 1969). 
ii. Davies etal. (1066, 1967) uoed mico which had been adult 
tbjcoctomieed, lethally irradiated bouoarrow reconstituted and given 
thyzua crafts with o1iht1r different imuno8enicity to the bone rrow 
donors. Thirty days actor thyraus Grafting, tho mice wr inuniosd 
with ohoop orythrocytes and their oploens transferred into irradiated 
rocipionts previously icnuniscd ainst either the thys or tho b©nO- 
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arroti donors. The recipients imiuni8ed against the thycus donor 
produced a baecolysin response, while those which had been immunised 
atint the bone-marrow donors produced no antibody. These resuith 
intirated that the antibody producing cells were bone-rnarrow derived 
but did not exclude the possibility that B cells had been 'processed' 
by the thycus during the 30 days between thymus grating and ictiunis-
at ion. 
iii. It was found that spleen cells and sheep erytbrocytes when 
injected into irradiated recipients produced antibody forming cells 
in the spleen detected as 'boemolytic foci'. Thymus cells alone 
produced no foci, 10 thoracic duct celia gave 8 haemolytio foci, 
bone-marrow cells alone gave no foci, but a combination of 10 thoracio 
duct cells and 10 
7
bone-marrow cells, althoui having no effect on the 
number of foci, increased the number of antibody forming cells per 
ocua. Unequivocal evidence that the antibody was derived from, bone-
marrow cells and not thyriius cells was obtained by reconstitution of 
thymectomised mice with somi-ailogenoic thyraocytea of thoracic duct 
coilø and identification using alloantisora (reviewed by Miller & 
L2itobeil, 1969 and LLiller, 1972). 
It is established that T cells are essential to allow B cells to 
produce antibody against certain antigens, A three cell interaction 
is probably the minimum number of cel4 type, involved in the production 
of antibody, a ince zuacrophages are evidently necessary to either present 
antigen to B cells or perhaps process it into an ivnnunogenioforn 
(reviewed by Fe1dmnin& Noseal, 1973) • Another aspect of the role of 
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T cells in antibody production is that the helper T cell reco6nisee 
the 'carrier specificity' of the iatigenic molecule and allows and 
augzents the B cell, response which is directed against the bapten 
(1Iitchieon, 1971; Iiiller, 1972). 
(b) Cel1-iediated igiziunity 
Ioonatal1y thymectoised mice are severely depleted in their obility to 
reject allogeneic skin grafts or tucours, to give delayed hypersensitiv-
ity responses to tuberculin (ArnØsoneta1,ii962jiillor & Osoba, 1967) and 
to give contact sensitisation responses to low molecular weight 
chemicals such asoxazolone (Parrott & do $ouaa, 1969; Parrott 
1970). The exact role of the T cell in these phenomena can be 
considered as an initial antigen specific proliferative response, 
followed by the activity of effoctor cells which were poasibly produced 
by the initial proliferation. 
The proLiforative response of T coils to antigen wao first ehovin by the 
use of thymectomised, irradiated bone-narrow reconstituted mice which 
were implanted with a chromosomally marked thymus graft. Cells of 
thymic origin were found in the peripheral lymphoid tissue and were 
observed to proliferate in response to sheep erythrocytes (Leuchars, 
etal., 1966; Davies etal., 1966) and a skin homograft (Davies 
1966). Thymocytes and thoracic duct lymphocytes when injected into 
irradiated recipients proliferate in response to a variety of antigenic 
stimuli. Proliferation has been measured by the incorporation of 
tritiated thymidine (prcnt & tiiller, 1971, 1972a) and 	)X-iodinated 
deoyuridine (Corshon & Hencin, 1971) and by counting uitotic indices 
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in chromosome chimer Ic mice (Davies et al., 1966). Thus thymocytea 
proliferate in response to hiatocompatibility antigens (Sprent & 
L2Iller, 1971, 1972a; Gershon & Liebhaber, 1972), sheep erythrocytes 
(Gershon & Bencin, 1971; jfrixger & Gershon, 1972; Davies et al., 1969a; 
Carter etal., 1969), ferritin, polymerised flagellin, keyh1e limpet 
haeocyanin, Brucella abortus (Kruger & Gershon, 1972), and Salmonella 
fjgeiljn (Davies et al,, 1970). In descending order the magnitude of 
the proliferative response to various antigens was found to be as 
follows; oxazolone, sheep red cells, bovine gamma glubulin, bovine 
serum albumin, almoneUa flagellin (Carter et al •, 1969). Thus the 
extent of T cell proliferation varies in response to different antigens. 
The Immunological significance of T cell mitotic activity is not clearly 
established. For example, whether proliferation represents a 
iaturationa1 procedure necessary to produce effector cells, or whether 
it represents simply amplification of effector cells or whether mitotic 
activity is necessary to produce 'helper T cells' is unknown. The 
products of T cell proliferation have one or more of a variety of 
characteristics; 
They show helper activity towards the antigen that initiated their 
proliferation. 
They may show an increased ability to proliferate in response 
to further contact with the original antigen. 
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They have the property of diapedesie and can thUs invade skin 
grafts or areas where a contact sensitising agent has been administered 
(Koeter et al., 1971; Asherson etal., 1973a). 
They have the ability to recirculate (Sprent & Miller, 1972b; 
Miller & Mitchell, 1970). 
They pssess cytotoxic properties; cytotoxic properties include 
the mechanisms whereby allografts are specifically rejected in vivo 
(Sprent & Miller, 1972c), specific oytotoxicity against "'-Cr labelled 
inastocytoma cells in vitro (Sprent & Miller, 19720) and non-specific 
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cytotoxicity against 	Cr labelled mastocytoma cells (Ashereon 
1973a). The rejection of allografte involves other leucocyte types 
such as inacrophagee and granulocytes, the release of soluble mediating 
factors such as migration-inhibitionfactor (MIF), chemotactic factors 
and transfer factor (Waksinnn & Colley, 1971). Much of the histological 
appearance of delayed hypersensitivity is mediated by pharmacological 
substances released from cells other than T cells (Turk, 1967a). 
The question whether different T cell populations mediate these various 
functions, or whether the same T cell can perform a variety of functions 
depending on its environment and mode of stimulation is unresolved. 
(c) 	Regulation of the immune response by T cells 
There is compelling evidence to suggest that T cells, or a population 
of T cells, play a role in regulating the magnitude and quality of the 
immune response. Two known features of T cells suggest that they may 
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include guitabie celia for such a function. 
B cells require the cooperation of T celia in order to produce 
antibody to the majority of antigens. The helper function of T cells 
is carrier specific (Mitchiaon, 1971). The existence of a system 
which necessitates the recognition of two antigenic epitopes by different 
call populations in order to induce an immune response, provides a sensitive 
mechanism of regulation. 
Unresponsiveness is both more easily induced by low and high dcaes 
of antigen, and in more prolonged in Tcells than B cells (Taylor, 
1969; Chi1ler., 1971). 
These two properties suggest that unresponsiveness in the immune system 
is in most instances mediated at the T cell level. Allison etal. (1971) 
suggested that T cell unresponsiveness to self antigens prevents 
potentially self reactive B cells from responding to self-antigens, and 
any mechanism that overrides the necessity for T cells, such as virus 
infections, may lead to a breakdown in the control system and result in 
autoimmunity. Recent experimental evidence suggests the existence of 
T cell sub-populations that can either augment or suppress the immune 
response. The responses affected are both humoral and cell-mediated. 
The evidence is as follows: 
I. ExamDles of T cells augmenting the immune response 
a) The helper T cell which is csrrier specific and cooperates with 
B cells to enable them to produce antibody (reviewed in Transplantation 
Reviewe, 1969). 
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b) Synergistic interactions between T cells mediating graft vs host 
responses have been documented. T cells found in the thymus and spleen 
synergise with T cells found in the lymph node, blood and thoraoio duet 
to produce responses greater than can be accounted for by the sum of the 
responses (Raff & Cantor, 1971; Cantor, 1972a; Cantor & Asofeky, 1972). 
In these experiments the graft vs host response was measured by 
splenomegslly or mortality assays. Other experiments have measured 
the synthesis of DNA by cells which are participating in a graft vs 
host reøponee and it has been concluded that there are synergistic 
interactions taking place (Liebbaber t al. ,1972; 	Gershon & 
Liebbaber, 1972). 
ii. Examples of T cells suppreasig the immune response 
There is evidence that T cells suppress the formation of allotypic 
antibody (Rerzenberg et al., 1973), antibody to T independent antigens 
(Baker et al., 1970b), homocytotropic antibody (Okumura & Tada, 1971a, 
1971b) and antibody directed agninst self antigens (Allison et al., 1971). 
Reports from Gerehon and his co-workers suggest synergistic 
responses between T cells mediating a graft vs host response and 
negative or suppressive interactions were also suggested (Liebhaber 
at al., 1972; Gershon & Liebhaber, 1972; Gershon & Liebbaber, 1974). 
Gerahon (1974) suggeate that T cells can respond to signals of the 
iramtme response and reply by either enhancing the response or suppressing 
it, thus returning the response to some optimal level. The possible 
existence of eubpopulations of T cells, or regulatory T cells is 
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pertinent to the subject of this thesis and the evidence outlined in 
ib), iia), and iib) above is described in more detail in Chapter II. 
Aims of the present studies 
T cell proliferation precedes many inunune responses • The functiona of 
the products of proliferation may be three-fold; 
To mediate T cell cytotoxicity, as occurs in the rejection 
of allografta or in response to contact sensitising agents. 
To collaborate with antibody producing cells. 
To produce memory cells for both the cytotoxic and humoral 
responses. 
it Ltepparent that the overall outcome of the immune response, that is 
the proportion of cells able to collaborate with B cells, able to be 
cytotoxic or able to give a memory response, may depend on the magnitude 
of, and cell interactions during, the initial phase of cellular prolif- 
erat ion. 
Evidence in the literature suggests the existence of sub-populations of - 
T cells, some of which may have a regulatory role. The aims of the 
present studies were to investigate the proliferative response of T 
cells to discover; 
a) whether T cell aubpopulationa demonstrate the evidence for T cell 
interactions and whether these interactions could contribute to regulating 
the magnitude of the response. (Chapter II) 
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antibody is produced in the majority of iune reponsoa, the 
possible role of B cells and their products in regulating T cell 
proliferation was inve8tiated (Chapter III). 
Antigon-inedated recruitment of circulating cells is recognised 
as being an early event in the initiation of the iiiuno response 
(Ford & Gowans, 1967). The relationship between cell proliferation 
and cell recruitment was studied and the possibility that any regulatory 
role exertod by T cells was mediated by altering cell traffic wa 
invostitntod (Chaptos W &v). 
23. 
CRWFER II 
STUDIES ON THE T CELL PROLIFERATIVE RESPONSE 
INTRODUCT ION 
The antigen chosen to investigate the kinetics of T cell, proliferation 
was 2-ethoxy-methylene-4-phenyl oxazolone (oxazolone). Oxazolone was 
first introduced by Gell, Rarrington and Rivera (1946) and has been 
shown to be a potent contact seneitising agent (Oort & Turk, 1965) 
and cause T cell proliferation (Parrott & de Sousa, 1966; Davies 
1969b,; Carter etal., 19 9). The system used to measure cell prolif-
eration was to irradiate mice (900 R) and repopulate them with variou* 
doses of lymphocytes obtained from different lymphoid organs. The 
animals were given oxazolone and cell proliferation was measured 3, 4 
and 5 days later by incorporation of 126 I-labelled iodinated deoxy-
uridine. 
The kinetics of the proliferative response were investigated with a 
view to obtaining some information about: 
the presence of T cell sub-populations, 
evidence for T cell interactions, that may contribute to 
regulating the response. 
A review of the relevant literature, presenting information about the 
antigen and T cell sub-populations is provided. 
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REVIEW OF THE LITERATURE 
1. Contact sensitisation 
(a) The cntien 
Application to the skin of any of a large number of low molecular weight 
chemical substances can aenaitise mice, such that the application to the 
akin of the same substance about a week later produces an inflammatory 
response with all the features of delayed hypersensitivity. (An account 
of the histological features associated with delayed hypersensitivity is 
found in Turk, 1967). 
landateiner showed contact aensitisation in guinea-pigs to various 
chioro- and nitro-substituted benzenes (Landateinar & Jacobs, 1935). 
Io suggested that simple compounds become antigenic by combination with 
body protein, a view propounded as early as 1907 by Wolff-Eisner 
(referred to by Eiaen & Belinan, 1953). The importance of chemical 
combination with protein became evident from several experiments. For 
example, there is a correlation between the ability of simple compounds 
to combine with aniline and their ability to sensitise guinea-pio 
(Landcteiner & Jacobs, 1936). Alao, orythrocyte etroma conjugated with 
dinitrofluorobonzene (DNFB) or picryl chloride elicits contact nsiti-. 
ation when injected with Freund's adjuvant intraperitoneally in guinea-
pigs (Landateiner & Chase, 1941). It was found that 2, 4-dinitrochloro-
benzene and similar compounds react with lysine amino groups of epidermal 
proteins and that 2, 4-dinitrophenyl sulphonyl chloride and 2, 4-nitro-
phenyl thiocyanate combine with the deulphjde bonds of cystine (Eisen & 
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13e1nn, 1953). Using DNCB labelled with 4C and applying it to the 
skin, it was found that about 20% was excreted in the urine, 70-80% 
was disseminated in non-cutaneous structures, and the 5 remaining in 
the akin was exclusively localised in the. epidermis (Eiaen & Tabachink, 
1958). 
Benacerraf and Gell (1959a) discovered that the apecifioity of the 
cellular delayed response was different from that of the antibody response 
to proteins conjugated with picryl chloride and oxazolone. Thus they 
detected delayed hypersensitivity against the protein carrier and anti-
bodies against the hapten. In an attempt to define the 'cartier' 
produced by painting the chemical directly on the akin, Benaceraf & 
Gall (1959b, 1961) immunised guinea-pigs with picryl-protein conjugates 
of heterologoua and homologous proteins or pure picryl chloride and 
challenged with intradermal conjugates or by contact • Inimunisation 
against the heterologous conggatea produced good delayed hypersensitivity 
against another conjugate, mwth better than the reaction to contact. 
Conversely, animals given picryl chloride by contact, gave better contact 
responses than responses to intra-dermal inject ions, and intra-dermal 
injections of homologous proteins decreased the differ uces • The 
authors concluded that the picryl group combined in vivo with a fibrous 
semi-soluble protein or with a cell membrane. Thus the in vivo conjugate 
involves a much broader based group than only the picryl moiety. 
The structure of oxazolone is such that it may combine with the free 
amino Uroups of proteins. It does not apparently produce as much 
macroscopic inflammation as picryl chloride. On. the baaia of the work 
26. 
of Benacerraf and Gell it seems reasonable to suppose that the antigenic 
moiety recognised by the ce]li which msdiate the delayed response to 
oxazolone consists of oxazolone plus self-protein or altered self-protein. 
If this supposition is correct, it would possibly be expected that a 
large proportion of lymphocytes might recognise the altered self-protein, 
as 18 the case where about 7% of circulating lymphocytes respond to 
transplantation antigens (Ford & Atkins, 1972). It is known that 
lymphocytes proliferate in response to antigen, if the degree of 
proliferation is accepted as a reflection of the number of antigen 
reactive cells (a highly speculative proposition) then oxazolone is 
recognised by a larger number of lymphocytes. (able to proliferate) 
than are sheep red blood cells, bovine ganmiA globulin or bovine serum 
albumin (Carter et al., 1960. 
(b) Sensitisation 
The initial cellular response in the lymph node draining the site of 
application of a homograft or contact sensitising agent are very 
similar (Scothorne & McGregor, 1955; Parrott, 1967). Both responses 
consist of cellular proliferation, mainly confined to days 4-6 after 
sensitisation, in the paracortex and may be initiated by entry of 
sensitised circulating lymphocytes or antigen. The relative importance 
of sensitisat ion of lymphocytes in the periphery or in the lymph node 
is unresolved. 
An intact at ferent lymphatic system, draining the site of eensitisatiou, 
is essential for primary rejection of homograft skin (Frey & Werke, 1957; 
Tiiert etal., 1965; Barker & Billingbaa, 1968). Saricr and 
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Billlngham, (1968) demonstrated that the efferent limb of the response 
is independent of the lymphatics, thus the afferent lymphatics are 
necessary for sensitisation. This isapparently not so for kidney 
grafts which can be rejected with only a vascular connection to the body 
méetà&.,i955; Lavender et al., 1968; 8trober & Gowans, 1968). 
This has to be reconciled with the observation that certain vascularised 
cites, such as the cheek pouch of the hamster, enjoy exemption from cell-
mediated rejective processes (3i11inam r 	I.196o)Po9 ibly different 
organs require different environments to produce sensitisation. Thus 
blood may normally be a poor vehicle because the putative agent is 
diluted, but the kidney with a large area of blood contact may negate 
this disadvantage. On the other hand, skin aenaitisation may tako 
place in the parenchyina which requires a rich lymphatic drainage to 
contact the local node. 
That lymphocytes become sensitised in the periphery was postulated by 
Medawar (1958) and supported by Brent and Hodavar (1967), on the basis 
that peripheral blood lymphocytes participate in cell-mediated immunity. 
It is difficult to conduct a definitive experiment because the circul-
ating lymphocyte is essential to effect the response as well as 
possibly initiate it. Similarly the possibility that the antigen or 
cell debris found in the afferent lymph draining a homograft (I!all, 
1967) or medullary sinuses of nodes draining the site of contact 
senaitisation (ci'eSousa & Parrott, 1969) has initiated central lymphocyte 
senaitisation cannot be precluded. deS6usa'& Pairbtt• (1969) 
investigated the histology of the akin and lymph nodes during the 
initial response to oxazolone in normal and thymectomised mice. T 
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dependent lymphocytes were found after 2-4 hours in the skin, but the 
absence of these colic in the thymectomised mice was not necessarily 
the cause of their failure to respond. Macrophages containing melanin 
were found in cortico-medullary junctions in both treated groups, 
suggesting that akin components had reached the node. It is intereating 
that germinal centres and plasma cells were present in nodee of thymec-
tomised animals and increased with multiple applications of oxazolone. 
The possibility that antigen reaches the draining node combined with 
soluble proteins in afferent lymph is suggested by the findings of Hall 
and Smith (1971), who painted sheep with isotopically labelled dini- 
trot luorobenzene. They failed to find isotope associated with cell 
debris in the at ferent lymph but did find it attached to soluble 
proteins. 
(c) The histological response 
The response to oxazolone includes two major events: 
The cellular proliferation which occurs in the draining lymph 
nodes. This is assessed by the appearance of pyroninophilic 
blast cells or by the incorporation of 125-I-iodinated 
deoxyuridine (Oort & Turk, 1965; Pritchard & Micklem, 1972). 
The cutaneous response after challenge. This is measured 
usually 7 days after aensitisation, by challenging the ear and 
measuring the increase in its thickness 2-48 hours later. 
The nature of these events and their probable interdependence is 
described below. Oort and Turk (1965) performed histological and 
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autoradiographical studies on sections of auricular lymph nodes 2-6 
days after the ears of guinea-pigs had been painted with oxazolone. 
These studies revealed two important points: 
(1) The proliferation of pyroninophilic blast cells was mainly 
confined to the paracortica]. zone (that is, the deep cortex) 
and reached a peak 4 days after atiinulat ion. At this time 
the paracortex had expanded to occupy one third of the lymph 
node area in histological sections. 
(ii) A transformation was observed of large 3H-thymidine labelled 
pyroninophilic cells to small labelled lymphocytes between days 
4-6. Cells of the plasma cell series were found in the medulla 
on days 5 and 6. 
The histological response to oxazolone appeared similar to the increaae 
in 'tertiary cortical nodules' found in rabbit lymph nodes 4 days after 
application of a homograft (Scothorne & rlcGregor, 19$), to the day 4 
pyroninophilic cells found in imprints from stimulated lymph nodes 
(Turk & Stone, 1963) and to the effects of various carcinogens on the 
draining lymph nodes of mice (Fjelde & Turk, 1968). Subsequent 
experiments have verified that the peak appearance of pyroninophilic 
blast cells iflresponse to oxazolone in mice, occurs 4 days after 
oxazolone (Parrott & do Sousa, 1966; de Sousa & Parrott, 1969) but 
the peak blast cell response to allografta appears to occur 6-8 days 
after grafting (Turk, 190Th,; Parrott, 1967; Micklem & Brown, 1967). 
Scothorne and icGregor (1955) postulated that the large dividing cells are 
important in mediating graft rejection, although no blast cells were 
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found at the site of the graft. This paradox was to a certain extent 
clarified by the dernonetrat ion by Gowane (1962) that large pyrono-
ninophilic blast cells could transform into small lymphocytes, and this 
actually occurred in the response to oxazolone (Oort & Turk, 1965). 
That cellular proliferation in the paracortex is dependent on the 
presence of a thymus was clearly established by evidence of two types; 
first that this area was depleted in neonatally thymectomised (Parrott 
sal., 1966; Parrott, 1967; de Sousa & Parrott, 1969) and nWnu mice 
(de Sousa et al., 1969), and secondly that radiolabe].led thymocytes 
home specifically to these areas (Parrott et &1,, 1966; Parrott & 
do Sousa, 1971;) and a thyiuua graft restored the depleted paracortical 
areas in MVM mice (do Sousa & Pritchard, 1974). 
On the basis that the major initial response to oxazolone in the 
draining lymph nodes occurs in the paracortex, and that cellular 
proliferation in this area is T dependent, it can be inferred that the 
cells which respond at this time to oxazolone are T dependent. This 
hypothesis has been confirmed by comparing the histology of lymph 
nodes from normal and neonatally thymectomiaed mice that had been 
painted with oxazolone. Mice which had been thymectomised lacked a 
proliferative response in the paracortex (Parrott & de Sousa, 1966; 
Parrott, 1967; de Sousa & Parrott, 1969) although the histology of 
the germinal follicles and medullary area were the same as in normal 
mice and in mice etimulated with pneumoccal polysacoharide S III 
(de Sousa & Parrott, 1969) • The T dependence of the initial 
prollfcrativc rozponso was -Inc confIrmed Independently by other 
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workers • Mice which had undergone adult tbymectomy, lethal irradiat ion 
and bone-marrow reconstitution were found not to produce a proliferative 
response to oxazolone measured by counting the number of mitotic cells. 
Dividing cells were found however in the presence of a thymus graft, and 
were of thymic origin (Davies et al., 196 	Athymic nu/nu mice 
produced no proliferative response to oxazolone as assessed by the 
incorporation of 125 	mated deo)yiwiiine (Pritchard & Micklem, 
1972). 
The ability to present the delayed response is also thymus dependent. 
This is illustrated by the findings that no delayed response was 
detected in neonatally thymectomised mice (de Sousa & Parrott, 1969), 
adult thymectomised irradiated mice (Parrott et al., 1970), and athymic 
M/au mice (Pritchard & Micklem, 1072). 
The cell interactions and pharmacological agents that produce the 
inflmnmation and erythemia of adelayed hypersensitivity response are 
largely unknown. During this process a variety of leuoocytea 
infiltrate the affected area, including cells of the inonocyte, 
polymorph and lymphocyte series. It has been postulated that the 
pyroninophilic blast cells found in nodes draining the site of 
application of oxazolone 4 days after oxazolone treatment are the same 
cells or the precursors of the cells that: 
show non-specific cytotoxicity in delayed responses and move 
to sites of inflammation (Asherlon at al., 1973b) 
migrate to bone-marrow, where they proliferate and provide a 
source of sonsitised cells to respond to future antigen (Aheron 
& Zeinbala, l073 ). 
32. 
Delayed hypersensitivity to oxazolone (Ashereon & Ptak, 1968) can be 
passively transferred by lymph node celia 3-4 days after antigen, by 
spleen cells 4-5 days after oxazolone, and by peritoneal exudate and 
bone-marrow cells 7 and 10 days after cutaneous aensitisation (Ptalc & 
Asherson, 1969; Asherson & Zembala, 1973). The ability of lymphoid 
tissue to transfer delayed hypersensitivity rapidly declines with time 
using lymph node and spleen cells but persisted with bone-marrow. 
Both the macrophage and lymphocyte components of peritoneal exudate 
cells were able to transfer delayed hypersensitivity (Ashereon & 
Zembala, 1970) • Passive transfer was fc*ind to be antigen specific 
and sensitive to anti-theta and complement, and is therefore T 
dependent (Zembala & Asherson, 1973). The resistance of transfer by 
peritoneal exudate cells to anti-theta treatment was thought to be due 
to the presence of theta resistant macrophages. 
Indirect evidence that pyroninophilic blast cells produced by oxazolone 
move non-specifically to sites of inflmmtion has been produced. 
51 -Cr-labelled lymph node cells from immuniaed donors were injected 
into syngeneic recipients and homed to inflamed ears in significantly 
higher amounts than unimmunised lymph node cells (Asherson & Aliwood, 
1972) • These migratory cells were sensitive to anti-theta and 
complement (Ashereon et a].., 1973a) and were only produced by IT 
dependent' antigens (Asheraon & Aliwood, 1972). At least some of 
these cells were blast cells, for a higher proportion of 125 
iododeoxyuridine labelled (in vitro and j. vivo) cells arrived at areas 
of inflAmmation than did celia labelled with 51 (Asherson et al., 
19?3a), and they did not include macrophages (Ashex-son et al., 1973a). 
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Proliferation of blast cells in the draining lymph node appears to be 
associated with the appearance of migratory cells, for mice made 
tolerant to picryl chloride did not develop lymphocytes that homed to 
inflamed areas (Aghereon & Allwood, 1972) and neither did they give a 
DNA synthetic response to picryl chloride (Asherson & Barnes, 1973). 
As yet there is no direct evidence that blast cells leave the lymph node 
in intact mice. Evidence from other sources suggest that this is 
possible. There was an increase in the number of immunoblasts in the 
thoracio duct lymph of rats 4 days after administration of dinitro-
chlorobenzene (Delorme etal., 1969), 4 days after the injection of F 1 
recipients with parental cells (Sprent & Miller, 1972) and 7 days after 
bacterial infection with t±steria (Koster &tal., 1971; McGregor etal., 
1971). Cytotoxicity may be a property to be expected from blast cells 
about to migrate to inflamed regions, and indeed pyroninophilic cells 
produced,xazo1one stimulation were shown to be non-specifically 
cytotoxic, reaching their peak in cytotoxicity 4 days after ox*zolone 
(Asherson et al, 19730. Blast cells in the thoracic duct which were 
produced in response to transplantation antigens were found to be 
specifically cytotoxic (Sprent & Miller, 1972c). Thoracic duct blast 
cells produced in response to Listeria when injected into syngeneic 
recipients protected them from Listeria infection (Koster 
1971; McGregor et al. 1971). The suggestion that some blast cells 
move to sites of inflammation is given credence by the findings that 
some blast cells do not recirculate (Delorme etal., 1969; Sprent & 
Miller, 1972b; McGregor etal., 1971) and may acquire the ability 
to eztravaaate into inflamed tissues (Koster atal., 1971; 
34. 
RosentreichetaL,1971). Other types of cells also appear in sites of 
inflammation and the majority appear to be non-specific and of a 
series other than the small lymphocyte (McClusky et al., 1963; 
Najarian & Feldman, 1963; Luberoff & Wakaman, 1968a, 1968b; Spector & 
Willoughby, 1968). 
2. Sub-populations of T cells and their role in regulating the immune 
response 
The varied funct ions of effector cells which are produced as a result 
of the activation of]r cells by antigen, may reflect different cell 
populations. In that instance the question arises whether the sub-
populations were present before antigen activation, or only after as 
a direct conaeqwnce of antigen activation. The different functions 
of effector cells may however denote the presence of one multi-effector 
cell population, the responses of which depend on either the micro-
environment or perhaps the form in which the antigen is presented to it. 
Most of the experiments that indicate the existence of T cell aub-
populations cannot distinguish between the effects of primary T cell 
sub-populations and populations of activated T cells. 
The existence of functional heterogeneity among the T cell population 
implies the existence of a system that may qualitatively and quantit-
atively regulate the T cell and perhaps B cell response. Hetero-
geneity has been detected in situations where there is a positive 
interaction between T cells, thus boosting the response and negative 
interactions, thus suppressing the response. 
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(a) Evidence for positive interactions between T cells 
Lymphoid tissues differ in their ability to mediate Craft VS host 
responses measured by the production of splenovzegully. The 
descending order of reactivity of tissues are peripheral blood 
lymphocytes (PEL), lymph node cells, spleen cells and thymocytes (Cantor 
& Asofaky, 1970 ; Tigelaar & Asofaky, 1072). The addition of an 
exceedingly siiàll number of relatively active cells (such as PBL) to 
inactive cells (thymocytes) produced a response greater than could be 
predicted from the sum of their activities (Cantor & Asofeky, 1976; 
Tigelaar & Asofaky, 1972). Both cell types must be allogeneic to the 
host (Cantor & Asofeky, 1970.) and both are depleted by neonatal 
thymectomy (Cantor & Asof sky, 1972) or by anti-theta serum and 
complement (Cantor, 19720 indicating the T dependence of these celia. 
Evidence that the two cell typos differ in their properties stems from 
the differential offoctø of anti-thymecyte serum (ATS). Thus the 
Wzaft vs hoot activity of the spleen was severely damaged by ATS but 
was rostorod with small numbers of PEL, and the amplifying ability of 
PEL was lost more rapidly than their ability to respond independently 
(Cantor & Aaofeky, 1972) • Therefore two types of T cell differing in 
their properties and distribution may be distinguished, (1) the 
amplifier celle which are found in blood (Cantor & Asofsky, 1972), 
lymph nodes (Cantor & Asofeky, 19700, and thoracic duct (Cantor, 1971), 
and which are sensitive to anti-lymphocytic sera (Cantor & Asofaky,  
1072), and (ii) the precursor cells which are found mainly in the 
spleen and thymus and which are resistant to ALS. 
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This bimodal distribution of T cells is supported by investigations 
into the properties of celia which foru rosettes with sheep red cells 
(SBC). A population of immune and background rosette forming cells 
to SBC have been shown to be sensitive to anti-theta and complezaent 
(Greaves & Moller, 1970; Bach etal., 1970) and thus were assumed to be 
T dependent (TRFC). Background TRFC to SBC which are found in the 
spleen and thymus are sensitive to anti-theta and cornplement and 
azothioprine (Bach & Dardenne, 1972), and appear to have only one iminuno-
globulin light chain on their surface (Greaves & Rogg, 1971). They 
are eliminated by adult thymectoniy in less than six days but only 
after more than 48 hours by ALS treatment (Bach & Dardenne, 1973). In 
contrast, background TRFC to SBC which are found in lymph nodes and 
peripheral blood are only moderately sensitive to azothidprine (Bach & 
Dardenne, 1973) and have both light and heavy chains on their surface 
(Greaves, quoted by Castor, 1972c). They are unaffected by adult 
thymectoiny but disappear after 6 hours of ALS treatment in vivo (Bach 
& Dardenne, 1973). After innnuniaation the spleen TRFC resemble background 
lymph node TRFC, being less sensitive to anti-theta serum and azothioprine 
(Bach & Dardenne, 1973). 
Therefore it appears possible to distinguish two types of T cell. 
There is a population found predominantly in the spleen and thymus 
which is sensitive to adult thymectomy and thus dependent on the 
thyiuua, but insensitive to ALS and therefore sessile. After immunis-
ation these cells appear to resemble those found in the lymph nodes 
and blood, that is not dependent on the adult thyinus, therefore 
possibly 1ong1±ved, but sena1tve to AT$ and therefore circulating 
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cells • These two cell types have been termed Ti and T2 (Cantor, I 
19I20. Cantor further postulated (1972a, i972)that Ti and T2 belong 
to the sane cell lineage, that T2 is a core mature form of Ti and that 
Ti is driven to T2 by antigen. He suggested that T2 cells are respon-
sible for the T lymphocyte coz3ponent of both the prinary and secondary 
responses and that the only response of Ti is to becoce T2. The 
relation between Ti and T2 is purely speculative, but there is evidence 
to suggest that when thymus cells are injected into either syngenelo 
recipients with antigen (Tiiller & Llitchell, 1969) or into semi-
allogeneic recipients (Sprent & IIiller, 1972b 1972c; 1971) they 
proliferate and after 4-6 days are able to circulate. There is 
further evidence to suggest a dissociation of T cell behaviour in 
cell mediated responses • It was shown that different cell populations 
had differing abilities to produce graft vs host responses, depending 
on whether it was measured by the mixed lymphocyte response, splenomegally 
or mortality assays. Thus it is conceivable that different T cell 
subpopulations are the main effectors In these assays (Tigelaar &. 
Asofeky, 1972; Lorse et al., 1974). 
(b) Evidence for the existence of suppressor T cells 
The evidence for the existence of suppressor T coils is not conclusive, 
especially where the target is postulated as another T cell population. 
There is however accumulating impressive evidence for the existence of 
a T cell population that suppresses antibody formation. By inforence 
the possibility of T-T interactions cannot be excluded. 
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Experiments have suggested the possibility of feedback inhibition by T 
cells on certain types of antibody production such as the production of 
antibody to T independent antigens and homocytotropic antibody. 
Animals which were depleted of T cells by either neonatal thymectoray 
or treatment with ant i-lymphocytic sera or a combirtion of both 
produced an .Ll.enhanced antibody response to keyhole limpet haeiiocyanin 
(Humphrey et al., 1964; Baui:i et al., 1969; Kerbal & Eidinger, 1071), 
PVP (Kerbal & Eidinger, 1971) and pneunococcal polyeaccharide 8111 
(Thirnphreyetal., 1964; Baker etal., 1970a). 	In the majority of 
these responses an increase in ftt was observed but in some instances 
G increased (Kerbal & Eldinger, 1971; Baum et al., 1969). 	It is 
therefore unlikely that thymectoniy and treatment with anti-lyzapocytic 
aera produced their effects by removing the bG that would normally 
inhibit ri (Uhr ;& 7M6IIer,1968). Evidence that X E production may be 
regulated by suppressor cells arises from experiments which ahowed 
that passive cutaneous anaphylaxis to dinitrophenyl (DNP)-Aacaris was 
enhanced in magnitude and duration in splenectonised and thymectomised 
rats (Okumura & Thda, 1971a). Voreover, the enhancement was prevented 
by the transfer of thymocytes from hyperimznune donors. Suppression 
by thymocytea was antigen specific and found not to be due to passive 
antibody. Haemagglutinatjon titres of both total and UE-resistant 
antibody, were normal. 
Adoptive transfer of thymocytes has been shown to suppress, non-
specifically, various ntibody responses. For example, lethally 
irradiated nice were allowed to respond to horse red cells after they 
had been reconstituted with bone-marrow and normal spleen cells. The 
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addition hoever of cortisone resistant thymocytee or primed thymocytee 
to the reconstituting cell inocula inhibited restoration of the 
response (Eidinger & Progs, 1972). Similarly, the injection of 
thymocytes into irradiated recipients (700R) which had been re-
constituted with bone-marrow did not elevate their response to 
Eichericbia coli atigen and in some instances the IM response was 
depressed (Lthiler & Michael, 1971 ). Thymocytes suppressed the 
ability of bone-marrow cells to produce antigen reactive cells to 
polyzuerised flagellin (Möller & Michael, 1971b). The existence at 
suppressor cells in the spleen was suggested by the findings that 
spleen cells which had been activated by concanav1inA when added with 
sheep erythrocytes to spleen cells in yitro, suppressed the XM and 
G *esponse to the antigen (Rich & Pierce, 1973). 
Some types of immunological unresponsiveness have been explained by 
the presence of inhibitory T cells. Suggestion, that T cells which 
have been intensely stimulated by antigen can become inhibitory and 
non-specifically suppress the ability of standby cells to respond to a 
different antigen within 1-10 days of the first would account for some 
instances of 'antigenic competition' (Adler, 194; Radovich & Talmage, 
1967). For example, mice which had been depleted of their T cells 
by neonatal thymectomy and irradiation, gave a normal response to horee 
erythrocytea four days after they had been injected with sheep 
erythrocytes (a procedure that in intact mice would abrogate the 
response to horse erythrocytes). Moreover, the simultaneous 
administration of 6 x 10 thymocytes with the sheep erythrocytes 
inhibited the antibody response to horse red cells, and 6 x 10 
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thymocytes restored antigenic competition more efficiently than 
1.5 x 10 thymocytea (Gerahon & Kondo, 1971i)? A similar phenomenon 
was reported to occur in vitro (Sjiberg & Britton, 1972). Sjoberg and 
Britton (1972) also demonstrated that cells from mice which had been 
immunised with Escherichia coli (a T independent antigen) could not 
produce antigenic competition although the response to Escherichia coli 
could be suppressed by cells from mice which had been immunised with 
sheep erythrocytes. This corroborates the suggestion that an antigen, 
in order to be able to initiate antigenic competition, needs to stimulate 
T cells. 
Convincing evidence that B cells can be specifically inhibited from 
producing antibody arises from the phenomenon of 'allotypic suppression'. 
Mice (SJL X Balb/c) which had been bred from female Balb/c that had 
been immunised against the paternal allotype antibody (IgIb) did not 
produce IgIb and it was suggested that its production is actively 
suppressed (Jacobson & Herzenberg, 1972 Jacobson et al. 1972). 
Cells from these mice were found to suppress IgIb production in semi-
lethally irradiated mice, and the suppressor cell found in the spleen, 
thymua, lymph node and bone-marrow was found to be a T cell (Herzenberg 
et al., 1973). 
It has been suggested that in certain instances tolerance is actively 
maintained by thymocytea or peripheral T cells. Gershon IKcido (1970) 
showed that the presence of thyuiocytes was essential to maintain the 
tolerant state of T dependent B cells. Spleena from mice which had 
been irradiated, reconstituted with bone-marrow cells and given a 
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tolerising regime of sheep erythrocytea and thymocytes were found able 
to transfer adoptive tolerance specifically to sheep cells, but only 
when thymocytee were used in the tolerising regime (Gershon 	1971b). 
The active nature of the suppress ion was strengthened by the evidence 
of )icCullagh (1970) who showed that tolerance In rats could not be 
broken by the injection of syngeneic thoracic duct celia. 
Adoptive transfer of tolerance has also been achieved using peripheral 
lymphoid tissue. Low zone tolerance to bovine serum albumin (BaA) was 
transferred by spleen cells into normal mice (Terman et al., 197). 
Inhibitory antibody produced by tolerant cells was implicated in the 
specific tolerant state which was produced by the transfer of lymph 
node cells from mice unresponsive to picryl chloride to normal mice 
(Aeherson et al., 1971). Similarly spleen cells from mice which had 
been made tolerant to BSA, when injected into normal mice transferred 
spec if IC tolerance (Crowle & Ru, 1969). Both of these responses measured 
delayed hypersensitivity. Lymph node cells can normally restore the 
response to picryl chloride when injected into irradiated mice which 
have been previously made unresponsive to picryl chloride, but when. 
mixed with tolerant lymph node cells they were unable to do so 
(Aaheron at al, 1971). 
Allison et al. (1971) suggested that suppressor T cells may play an 
important role in regulating the immune response and preventing the 
onset of autoiamiune disease. They suggested that T cells could 
perform this function by two mechanisms: 
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By being unresponsive to self-antigens, and thus not cooperating 
with B cells that have receptors for self-antigens. 
By exerting a specific feedback control on autoantibody 
formation. 
Evidence for the second mechanism arises from experiments using NZB mice 
which normally develop symptoms of autoimmune diseases at about four 
months of age. Allison et al. (1971) suggest that this in due to a 
lack of suppressor T cells, for the transfer of young thymocytes to 
old mice prevented the onset of Coomb's positiveness, and this effect 
was abrogated by ALS treatment. 
There is therefore a body of evidence accruing which suggests that T 
cells can suppress antibody formation. The mechanism of this 
suppression, whether by cell to cell contact or by production of some 
factor has not been elucidated • The importance of macrophages in the 
immune response and in particular the suggestion that in the absence of 
macrophages, or when the macrophage surface is saturated with 
IgT-antigen complexes, T cells become tolerogenic for B cells (Feldman, 
1973) may contribute to the understanding of the mechanisms involved in 
T cell-mediated suppression. 
The existence of a population of T cells that can inhibit antibody 
formation has to be reconciled with the knowledge that there is a 
population of T cells that help B cells produce antibody. The 36 
response is sometimes more suppressed than the 6M response, and this 
may suggest that the cooperative T cell is the target for suppression. 
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It has however been suggested that if B cells are directly suppressed 
by T celia then 'helper' function may simply represent suppression of 
the suppressor celia (Allison et al., 1971; Droege, 1973). 
The evidence in favour of the existence of T cell sub-populations that 
eynergise in graft vs host responses (Cantor, 1972a,, 1972c)has been 
described. Experimental observations by R.K. Gershon and his colleagues 
suggest that there may be bidirectional effects of interaction between 
parental and F cells during a graft vi host response, producing synergy 
in some responses and suppression in others (Liebbaber et al., 1972; 
Gerahon stat,, 1972). Gerahon suggests that the kinetics of the 
response by thymocytea to histocompatibility antigens implicates the 
presence of suppressor T cells (Gerahon & Liebhaber, 1972). He 
postulates a regulatory role for these interactions, because high 
responder parental thymocytes are suppressed by the presence of F 1 
cells and low responder parental cell, are boosted by F1 cells 
(Gershon 6t . a 1. 1974) 	 One of the difficulties of interpreting 
these results is that figures tend to be very Variable, and differences 
are often small • This does not mean that the differences are not 
significant, but any definite opinion must await the advent of more 
data. 
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MATERIALS AND METHODS 
JLice 
Three to four month old male mice of the inbred strain cm/H were used 
in the majority of experiments. Six to ten week old mice were used 
as thymocyte donors. 
Irradiation 
Mice were placed in polystyrene boxes and exposed to lethal x-irradiat ion 
(900R) from a Westinghouse machine under the following conditions; 
230kV; 15mA; 0.5mm Cu and 1.0mm Al filtration; dose-rate 66R/minute. 
Preparations of cell suspensions 
Thymusos and lymph nodes were gently homogenised in ground glass tubes 
and the homogenate filtered through steel mesh. All cell suapensiona 
were prepared in Banks Balanced Salt Solution (Banks 855, Oxoid) 
p11 7.4  with sodium bicarbonate and kept at 0-40C. Suspensions were 
washed three times and their viability assessed using Nigrosin 
(B.D.R.) immediately prior to the cells being injected into the tail 
vein in 0.4 mls of Banks 885. 
peripheral blood lymphocytes 
Mice were bled from the retroorbital plexus into heparinised tubes. 
The blood was washed three times in Banks BSS and the volume adjusted 
to the required lymphocyte concentration in 0.4  mis • In some experi-
ments the erythrocy tea were removed with Plasmagel (Laboratoire Roger 
Bellon, Neuilly). 5 mlø of blood were mixed with 2 mla of PJamagel, 
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mid and tilted to an angle of about 45°C and incubated for an hour 
at 370C. During this period the tube containing the mixture was 
slowly turned upright. The red cells sedimented and the supernatant 
containing white cells was removed. In experiment 5, where the 
results are shown in table I t. 3, tho blood was injected in 0 • 4 ml doses 
without prior treatment. 
ortieone treatment 
The treatment recomnended by Blomgren and Andereson (1969) was used. 
2.5  vig of ifydrocortisone Acetate (Boots, Nottinghs, England) were 
injected intraperitoneally into six to ten week old nice and they 
were killed two days later. 
Anti-theta treatment 
Preparation of anti-theta serum 
Anti-theta serum was raised in AICR mice by the method of Reif and 
Allen (1966). Three to four month old female AKR mice were given 
four weekly injections of 10 CM tbymus cells with 2 x 10 pertuaeiS 
oraniame in 0.2 mis of saline intraperitoneally. Ten days after 
the last injection the mice were bled from the retroorbital plexus 
and the blood was allowed to clot. The serum was removed and non-
specific cytotoxicity was absorbed by CM spleen cells. 
Testing of anti-theta serum 
0.1 ml of anti-theta serum, of various dilutions from 1:2 to 1:256 
was added to 0.08 mis of rabbit comp1eaent and 0.1 ml of Hanks B SO 
containing 106 nucleated cells from bone-marrow, thymus, spleen or 
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lymph nodes • The cells and anti-theta/complement mixture were mixed 
and incubated for 48 minutes at 37°C. Viability was assessed using 
nigrosin. The lowest dilution found to give optimum killing of 
thymocytee was chosen to be used routinely. 
c) Use of anti-theta serum 
Anti-theta serum was added to 1 ml of Banks BS8 containing 5 x 10 6 
lymphocytes to make a final concentration of 1:8. They were incubated 
for 40 minutes at 370C with occasional shaking. Guinea-pig or rabbit 
complement which had been freshly absorbed with mouse red blood cells 
was added to make a final concentration of 1:5. and incubation was 
continued for a further 20 minutes. The cells were waahed three times 
in Banks BBS and viability was assessed with nigrosin. Control 
suspensions were incubated under the same conditions using normal AKR 
serum and complement. 
Thyinectomies 
Thymectomies were performed on mice when they were four weeks old. 
The technique was demonstrated to me by Helen Pritchard. The mice 
were examined post-mortem for the presence of thymic remnants. 
Ant iaena 
a) Oxazolone 
2-ethoxy-methylene-4-phenyl-OxaZolOne (British Drug Houses) was 
dissolved in absolute alcohol at 600C at 10% w/v. Two methods of 
application were used: 
4'?. 
0.05mls (5mg) visa applied using a pipette to a shaved area 
approxiLiately 2 x 1 cm on the left side of the thorax. 
Control mice were shaved and received hot ethanol only. 
0.05mls (5mg) was applied to the left bind foot pad of an 
annesthetised (Nembutal 51DH ) mouse and the foot was 
iLiobilised by binding it with Plaster of Paris Iandage 
("Gypsona", T .J. Smith and I'epbow Ltd., England). Control 
mice were anuesthetised and given hot alcohol and their feet 
bound with Gypsona bandage. 
Ferritin 
0.1mg of Ferritin (Koch-Light Labs., Bucks) in 0.05 mis of saline was 
injected subcutaneously into right foot-pads. Control mice received 
saline only. 
Polyvinylpyrrolidone (PVP) 
PVP, m.wt. 340,000 was kindly provided by Henry Claiiien. 2 LB13 were 
injected in 0.06  ml of saline subcutaneously into the right fore-foot 
pads. 
rieaeurement of DNA synthesis 
DMA synthesis was measured by incorporation of 126 I-labelled 6-iodo-
2 1 -dooxyuridine ( 126 1-UdR) (fladiochemiccil Q.ntre, Amershae) after the 
method of Hughes ot al. (1034) modified by Pritchard and Micklem (1072). 
Liice received s * 10 8 moles of FUdR (Roche Products Ltd.) in 0.2 ola 
of saline intra-peritoneally followed one hour later by 1 pCi of 
125 1-Uc1R, adjusted to a specific activity of 5 mCi/mg, by the sage route. 
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Iiice were killed two hours later, their lymph nodes excised and fixed 
in formal-ethanol (4' forinalln in VAb ethanol). Unincorporated label 
was reaoved by several changes of 701  ethanol over a period of 5-7 days, 
until the washings contained no more than twice background counts 
(Elkina, 1970). 
Axillary and brachial nodes from one side of the animal were counted 
together in an Auto-Packard Gamma counter. The injected dose was 
also counted. The organs were counted for 5 minutes, background 
subtracted, and the counts per minute were adjusted to the counts 
that would have been obtained from an injected dose of 106  cpm. The 
calculation was as follows: 
counts in organ (opiu) x 10 uptake = 	injected dose (cpm) 
It can be seen that the terms 'cpi' cancel out, and the 125 1-UdR uptake 
is therefore the log10 of the proportion of the injected dose that was 
incorporated. 
Statistical analysis 
The statistical significance of differences between results was aseea8ed 
using the Student's T Test. 
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RESULTS 
1. The response of normal mice to different doses of oxazolonS 
These responses were measured 3 days after the adininistrat ion of the 
antigen. 
The effect of painting different doses of oxazolone on the flank. 
pig. 11.1: Table 11.1. 
The results recorded in Fig. 11.1 show that the lymph nodes which 
received the gratest stimulation, measured by the uptake of 128 1-UdR, 
were the regional axillary and brachial nodes • A range of oxnzolone 
doses from 2.1 mg to 10 ag produced no differences in the amount of 
1251-UdR incorporated by the draining nodes. Doses of antigen above 
3 mg did however stimulate the contralatexal axillary and brachial 
nodes and increased the amount of 1251..UdR incorporated by the inguinal 
and popliteal lymph nodei • There are no data reporting the effect 
of alcohol on DNA synthesi, within the inguinal and popliteal nodes. 
it in notable that the administration of o3azolons on the left flank 
stimulated DNA synthesis by the ,pleen.TabiieiiLLi 1 shows that increasing 
the dose of oxazolone, especially between 1.40 mg decreasSd the ratio 
of 1251-UdR which was incorporated in the draining/contralateral 
axllary and brachial lymph nodes • It did not however decrease the 
ratio of label which was incorporated in the draining/contralateral 
ingui*1 and popliteal nodes, where the ratio was consistently unity. 
The effect of painting different doses of oxazolone on the hind 
foot pad. Fig. 11.2: Table 11.2. 
The results shown in Fig. 11.2 demonstrate that the lymph nodes which 
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received the greatest amount of stimulation by oxazolone were those 
nearest the point of application, the inguinal and popliteal lymph nodes. 
In contrast, in the axillary and brachial nodes there was no indication 
of a proliferative response specific to oxazolone below 1 mg of antigen 
and possibly there was no response to doses of 1-10 ing. There was no 
dose dependent increase in the amount of proliferation found in any 
of the lymph nodes, and Table 11.2 shows that there was no dose-dependent 
change in the ratio of 125 1-UdR uptake between the draining and contra 
lateral nodes. The variability of these results is noticeable compared 
to the results reported in Table 11.1. The spleen sppears to remain 
hardly stimulated when the foot-pad is painted. The results in Table 
11.2 show that the inguinal nodes gave consistently more proliferation 
in the draining than the contra lateral nodes, down to 0.3  mg. of 
oxazolone. The ratio of the amount of 
125I-UdR incorporated between 
the draining and contralateral axillary nodes was unity except for the 
dose of 1 mg where the ratio was 3.04 ± 1.67. 
2. Timing of the experimental procedures. Fig. 11.3 
The experiments which were to be utilised in this series of studies 
(Chapter I) involved lethally irradiating (900R) mice, repopulating 
them with different doses of various cell suspensions, and sensitising 
them with 5 mg of oxazolone. Pilot atudies (A.C. Payne, pers. comm.) 
in this laboratory indicated that there could be an advantage to delaying 
the application of oxazolone until one day post irradiation and repopulation. 
This suggestion was formally tested. Three groups of mice were subjected 
to lethal irradiation, were injected with three doses of thymocytes, 
106, 5 x 106  and 5 x 10 and were painted with oxazolone according to 
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the following schedule: 
Group A: were irradiated, three hours later they wore 
repopulated 
and 24 hours after repopulat ion they were painted with 
oxazolone. 
Group B: were irradiated, three hours later they were repopulated 
and three hours aftor ropopulation they were given oxa2.OlOnO. 
Group C: were irradiated, three hours later they were painted 
with 
oxazolone and three hours after antigen they vmro injected 
with thynocytes. 
All responses were measured by estimating the amount of 125  I-DdE 
incorporated by the draining lymph ricdee 4 days after the application 
of oxazolone. The results in Fig. 11.3 show that lymph nodes from 
animals in Group A produced s ignificantly higher proliferative responses 
than those from Group B, at all thyuiocyto doses. There wore no 
differences between the responses of nodes from mice in Groups A and B 
to alcohol. Animals from Group A also incorporated more 
125IUdE in 
their draining lymph nodes than did mice from Group C, when injected 
with lO and 5 x lO thymocytca. 
3. Coil transfer experiments domonstrati pjho response of 
lymphocytes from different anatomical regions to oxazolone 
In these experiments, nice were lethally irradiated (900R), ropopulatod 
on the saze day and sensitised with 5 mg of oxazolone on the left flan1 
one day later • D)& synthesis was rneasured in the axillary and brachial 





(1) The response of low doses of thymocy tea in lymph nodes of 
irradiated mice: Fig. 11.4. 
The proliferative response of 3.6 x 10, 1.2 x 106  and 3.6 x 
thymocytes were measured 4 days after oxazolone. The amount of 51-UdR 
incorporated in the lymph nodes of the irradiated recipients increased 
concomitantly with the number of thymocytes which had been iven. The 
smallest number of thymocytee (3.6 x 10 5) were sufficient to produce a 
response significantly greater than the controls response to alcohol 
(P 0.01-0.005). The varioue thymocyte inocula did not proliferate 
in response to alcohol to a significant degree. 
(ii) The resDonae of high doses of thyinocytea in lymph nodes of 
irradiated mice: M. 11.5. 
Although this was a different experiment to that performed using low 
doses of thymocytes (as described above), the results are corrected to 
a standard injected dose and are therefore, to a certain extent, 
comparable between experiments. The proliferative response of 5 x 10 7 
cells to oxazolone was probably greater than that of 3 x 106  cells 
(Fig. 11.4), but thereafter increasing the number of thymocytes that 
were injected was quite ineffective in increasing the amount of 125 
incorporated by lymph nodes • There are no groups that were given 
alcohol, and these results may overestimate the response to oxazolone 
because some of the incorporated isotope could be due to non-specific 
stimuli. The proliferative response of thymocytes to oxazolone thus 
plateaus at about 5 x 10 cells. 
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The response of thymocytes in spleene of irradiated mice. 
Fig. 11.6: Fig. II.?. 
Spleene were obtained from the mice which were used in experiments (i) 
and (ii) described above.. 
There was no significant proliferation of 3.6 x 10, 1.2 x 10 6  or 
3 x 106 thymocytes in the spleene of Irradiated recipients. There were 
no groups of animals which had received the higher doses of thyrnocytes 
and alcohol, and in the absence of this control it is not possible to 
conclude that thymocytes were responding to oxazolone • The level of 
incorporation was below that fc*ind in lymph nodes. 
The response of thymocytes 3, 4 and 5 days after the administration 
of oxazolone. Fig. 11.8. 
The results obtained from experiments (1) and (ii) suggested that 
5 x 10 thymocytes give a maximum response to oxazolone that cannot be 
superseded by higher numbers of thymocytea. It is conceivable however 
that a high dose of cells gives a maximum response at an earlier time 
than a low dose. Thus the conclusion drawn from experiments (i) and 
(ii) must be verified by measuring the response of different thymocyte 
doses 3, 4 and 5 days after oxazolone. The response of 3 x 1O 5 , 
3 x 10 6 , 10 7  and 7 x 10 
7
thymocy tee was measured. Lymph nodes from 
animals which had beth injected with 10 or 3 x 108  showed no 
differences in the amount of 251-UdR incorporated, on any of the 
days tested. On day 3, the response from 3 x 106  thyniocytes was 
significantly greater than that from 3 x 10 cells • The response 
from 7 x 10 cells was greater than all other doees. On day 4, the 
mice which had been injected with 7 x 10 cells gave a similar response 
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to those that had been injected with 10 celia. Similarly, on day 5 
those mice which had been inoculated with 7 x 107 gave a similar 
response to those inoculated with 10 cells and there was no 
significant dif2erence between the response of animals Injected with 
3 x 106 thymocyte and 7 x lO thymocytes (P 0.15-0.10), The response 
from animals which had been injected with the lowest number of thymocytea 
3 x 10 was consistently the lowest response. 
These results demonstrated that: 
High numbers of thymocytes, when injected into irradiated 
recipients gave their maximum proliferative response to oxazolone 
earlier than low numbers of thymocytes. 
There was no difference in the maximum amount of 125 1-UdR 
incorporated by lymph nodes of animala which had been injected with 
7 x 10 thyviocytes and those injected with 3 x 106  thyiuocytes. Thus 
within a certain dose range, a twenty-fold increase in cell number does 
not produce any increase in proliferation. 
The maximum amount (;f 251-um incorporated by the lymph nodes 
of animals which had been injected with 7 x 10 cells was significantly 
below the amount incorporated by unirradiatad animals. 
b) Cortisone resistant thymocytea. Fij. 11.2 
Thymuses were removed from Dice 2 days after they had received 421 .3 mg 
of cortisone acetate. They were much reduced in size and cell coufltø 
showed that they contained 5-10% the number of cells found in thyrnuses 
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from untreated mice. 
The proliferative responses of lymph nodes from irradiated mice which 
had been injected with 106  normal and 106  cortiaone resistant thymocytes 
were compared 3, 4 and 5 days after the adminietration of oxazolone. 
Mice which had been irradiated, injected with thymocytes and painted 
with alcohol were killed on day 4. The results in Fig. 11.9 show 
that the lymph nodes from mice which had been injected with normal 
thymocytes produced a steady increase in the amount of 
125
I-UdR 
incorporated between days 3 and 5 0 in contrast to the lymph nodes 
from mice which had been injected with cortisone. resistant thymocytes, 
these showed similar amounts of isotope incorporation on days 4 and 5. 
The amount of proliferation from cortisone resistant thymocytea was 
significantly greater on each day than that produced by normal thymocytea 
(day 3, P 0.025-0.0125; day 4, P 0.0025-0.0005; day 5, P 0.0125). 
The differences in reactivity between the thyniocyte populations is 
illustrated by the observation that on day 3 the response from normal 
thymocytea was hardly greater than the control value (P 0.05) while 
the response from cortisone resistant thymocytes was significant 
(P 0.05-0.025). 
The following two experiments, (c) and (d) were done in collaboration 
with N. Anderson and E.S. Micklein. 
c) Lymph node lymphocytes, Fig. 11.10. 
Lymphocytes which were obtained from the pooled axillary, brachial 
and inguinal nodes were injected into irradiated recipients in doses 
56, 
ranging from 103 - 8.8 x 166 cells/mouse. The minimum number which 
was found necessary to allow the lymph nodes of the recpiefltB to 
produce a significant proliferative response to oxazolone, 4 days 
after its administration, was 3 x 10 4;  the response increased in 
magnitude concomitant with the cell increments, particularly within 
the dose range, io 5- 106 . The greatest response was given by mice 
which had been injected with the greates number of lymphocytes, that 
is 8.8 x 106 cells. The response produced by 8.8 x 10 6  cells was 
significantly lower than that produced by unirradiated mice 
(P = 0.025 - 0.0125). 
d) Peripheral blood lymphocytes. Fig. 11.11 
Fig. 11.11 incorporates the results from two experiments which involved 
measuring the incorporation of 125 1-UdR by lymph nodes of irradiated 
mice which had been injected with peripheral blood lymphocytes. 
In one experiment, blood lymphocytes were injected in doses ranging 
from 5.3 x 10 3 - 1.8 x 10 
6 cells/mouse, and the response to oxazolone 
was measured 4 days after oxazolone. In the second experiment the 
number of cells which were injected varied from 35 x 10 - 8 x 106/ 
mouse and the blood was passed through plasrnagèl to remove red blood 
cells • The response of animals which had been injected with 
35 x 10 5 - 8 x 10 
6 cells was measured 4 days after oxazolone and the 
response of animals which had been injected with 3 x 10 cells and 106 
cells was assayed on day 5 as well as on day 4. The lowest number of 
lymphocytes which were found capable of transferring a response to 
4 oxazolone was 5.3 x 10 •cells. The magnitude of the response increased 
as the number of transferred cells was increased and the greatest increase 
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occurred within the range 5.3 x 104 to 3 x 106  cells. Thereafter the 
response possibly tended to plateau between 3 x 10 
6 
 and 8 x 10 
6
cells. 
The response of mice which had been injected with 8 x 106  cells was 
significantly below the proliferative response of unirradiated mice, 
4 days after oxazolone. Animale which had been injected with 3 x 10 
and 106  lymphocytes produced a considerable increase in their uptake 
of 25I-UdR between days 4 and 5. The amount of label incorporated 
by lymph nodes of mice which had been injected with 106cella was within 
the range of response produced by unirradiated animals 5 days after 
oxazolone. 
4. Experiment to investigate the effect of thyznocytes and cortisone 
resistant thymocytes on the response of lymph node cells to 
oxazolone. Fig. 11.12 
Mice were irradiated and given injections of various lymphocyte types, 
or mixtures of lymphocyte types according to the following schedule; 
No. and type of lymphocytes 
Cortisone 
Group 	Lymph nod• lymphocytes 	Thymocytes 	resistant 
thymocytes 
A 	 3x105 	 - 	 - 
B 	 - 	 io6 	 - 
C 	 - 	 - 	 la5 
D 	 3x105 
	
106 
E 	 3x105 	 - 	 10 
The above groups were duplicated and hail were painted with oxazolone 
and half with alcohol • The animals were injected with 251-UdR 4 days 
after the administration of oxazolone or alcohol and the amount of 
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isotope incorporated in their lymph nodes a.jiueasured. A dose of 
3 x 10 lymphocytes was chosen because, as carbe seen from Fig. II. 10, 
any change in the responsiveness of cells at this dose should result in 
a detectable enhancing or depressing effect. Animals which had been 
injected with 3 x 10 lymphocytes gave a significant proliferative 
response to oxazolone. The responses produced from mice which had 
been Injected with 10 6  thymocytea or 10 cortisone resistant thymocytes 
was not above that produced by the aloohol controls; this was unexpected. 
The magnitude of the response that was transferred by a mixture of 
3 x 108 lymph node lymphocytes and 106  thymocytee was equivalent to that 
transferred by 3 x 10 lymphocytes alone. Similarly, mice which had 
hggy 4r,IrpiI with a rnixtum of 3 x 10 lvnanhocvtes and 10 cortisone 
resistant thyrnocytea produced the same amount of 25 I-UdR incorporation 
as did mice which had been injected with lymphocytes alone. 
5. The proliferative response of lymphocytes from animals previously 
immunised with oxazo]one 
Animals were irradiated and given injection., of lymphocytes from donors 
which had received either 10 mg of oxazolone or 0.1 ml of alcohol on 
shaved areas of both sides of the flank 14 days previously. In order 
to ascertain the T cell component of these lymphocyte populations, 
and whether they participate in the 'secondary' proliferative response 
to oxazolone, some mice were injected with cell suspensione which had 
been treated with anti-theta serum and rabbit complement. Cell 
euap*nsions which were not treated with anti-theta serum were incubated 
with normal mouse AKR serum and rabbit complement. 
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The anti-theta serum produced a cytotoxic index on normal lymphocytes 
of about 28% and on lymphocytes from imrnunised mice of about 66%. 
Irradiated recipients received injections of either 3 x 10 normal 
lymphocytes, 3 x 10 normal lymphocytes which had survived anti-theta 
treatment, 3 x 6 10 lymphocytes from donors which had been iimnunised 
to oxazolono or 3 x 10 lymphocytes from immunised donors after treat-
mont with anti-theta serum. The mice received either oxazolone or 
alcohol one day after the cell suspensions, and were injected with 
5I-UdR 4 days later. The lymph nodes from mice which had been 
injected with cells from immunised donors, incorporated significantly 
more 125 UØ (2.9 ± 0.05) than the lymph nodes from mice which had 
received normal cells (2.4 ± 0.08). The ability of normal lymphocytes 
to transfer the proliferative response was depressed after treatment 
with anti-theta serum, although the response was greater than that 
achieved by the alcohol controls. The elevation of the, proliferative 
response produced in irradiated recipients by the transfer of cells 
from immunised donors was partially abrogated when the transferred cells 
were incubated with anti-theta serum, although it remained significantly 
above the response produced by a similarly treated group of animals which 
had received alcohol • It is interesting that the response was also 
significantly higher than the response transferred by anti-theta serum 
treated normal lymphocytes. 
6. The effect of adult thyinectomy on the ability of lymph node 
and peripheral blood lymphocytes to transfer the proliferative 
response to oxazolone. Table 11.3 
The results from two experiments are shown in Table 11.3. Mice were 
thymectomised when they were 4 weeks old and were used to donate lymph 
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node and blood celia 6 months later in experiment I and eight months 
later in experiment II. The controls consisted of mice of the same 
age that had not been thymectoraised and young (10 week old) mice. 
In experiment I, irradiated recipients received injections of one of 
the following cell suspensions: 
(1) peripheral blood cells or lymph node cells from thymectomised 
donors. 
peripheral blood or lymph node cells from 7 month old donors. 
peripheral blood or lymph node cells from 10 week olcIdonors. 
The mice were painted with oxazolone or alcohol the following day and 
injected with 1251-UdR 3 and 4 days after the administration of the 
antigen. Post-mortem examination of thymectomised donors revealed the 
presence of one thymus lobe in one of the eight thymectomised donors. 
The lymph nodes from this mouse were not used In the experiment but 
the blood unfortunately was. The results show that recipients of 
2.18 x 106  peripheral blood lymphocytes from thymectomised donora gave 
a response on day 3 that was, cell for cell, significantly below that 
produced by recipients of 2.72 x 106  peripheral blood lymphocytes from 
normal donors of the same age. Comparison of the response of the 
recipients of cel]s from thymectomised donore with that of the recipients 
of peripheral blood lymphocytes from young mice which were painted with 
alcohol demonstrates that peripheral blood lymphocytes failed to 
transfer a response to oxazolone, on day 3 • On day 4 however, the 
recipients of cells from thymectomised mice produced a response to 
oxazolone ainificantly above the alcohol control (P 0.05 - 0.025). 
The response would not appear to be Inferior to that produced by 
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peripheral blood lymphocytes from normal 7 month old donors. Similarly,  
mice which had received lymph node cells from thymectomised or normal 
7-month old donors showed little difference in their ability to respond 
to oxazolone, 4 days after oxazolone. A comparison of the abilities 
of lymph node cells from normal and thymectomised donors to transfer 
the 3 day response to oxazolone cannot be made because the results 
pertaining to the response of lymph node cells from normal 7-month old 
donors are not available. 
There was no significant difference between the responsiveness of lymph 
node cells from young mice and from 7-month old mice (P 0.01). 
In experiment I I mice were irradiated and given injections of one of 
the following: 
(1) 0.5 x 10 lymph node lymphocytes from thymectomised donors. 
(ii) 0.5 x 106  lymph node cells from normal donors of the same age 
as the thymectomised donors. 
iii o.s x 106  lymph node cells from 10 week old donors. 
The mice were painted with oxazolorie or alcohol the following day and 
injected with 1251-UdR 4 days after administration of the antigen. 
Post-mortem examination of the thymectomised donors revealed no traces 
of thymus. The results demonstrate that there was no difference in 
the ability of lymph node lymphocytes from 9 month old thymectomised 
and 9 month old normal donors to transfer a 4 day proliferative response 
to oxazolorte (2.5 ± 0.038 compared to 2.47 ± 0.05). The responses which 
were transferred were significantly higher than those transferred by the 
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same number of lymphocytes from 10 weekold mice (P 0.025). If the 
r•aponse of the cells from the young mice (2.33 ± 0.05) is compared 
to the lymph node dose response curve in Fig. 11.10 (compiled using 
3 month old mice), it can be seen that the response is below that 
which would be predicted from Fig. 11.10, that is a value of about 
2.6. Thus, possibly the young mice which were used in experiment II 
were producing an abnormally low response. 
7. The proliferative response of thymocytes to ferritin and PVP. 
Figs. 11.14 and 11.15. 
Irradiated recipients received injections of i0 6 , 	3 x 107 and 108 
thymocytea and on the same day they were injected in the left fore foot 
pad with either ferritin or PVP. Control groups of irradiated mice 
received the same schedule of injections of thymocytes and were given 
saline subcutaneously in the fore foot pad. 	5I-UdR was injected 
3, 4 or 5 days later and the incorporation in the draining lymph nodes 
was estimated. The incorporation of 
125
I-UdR in response to ferritin 
is shown in Fig. 11.14. Mice which had been injected with either 10 6 
or 10 thymocytes failed to produce a DNA synthetic response on days 3, 
4 or 5. On day 5, although the response of mice which had received 
high doses of thymocytea, that is 10 8  and 3 x 10 
7 thymocytes was 
significantly above the response of the saline controls, the response 
of 3 x 107 cells (2.24 ± 0.08) was only equivalent to that of 3 x 10 
thymocytes responding to oxazolone (Fig. 11.8). 
The proliferation of thymocytes in response to stimulation by PVP is 
shown in Fig. 11.15. Mice which had been injected with 3 x 107 cells 
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failed to respond on days 3, 4 or 5.mice which had been injected with 
108  thymocytea produced a proliferative response on day 5 of 2.26 ± 0.14, 
a value significantly above the saline control which had received 108 
thyraocytea (P 0.01). The results on day 4 are difficult to interpret 
due to the high levels of proliferation achred by animals which 
received injections of saline. These results are notably variable 
compared with the results obtained using oxazolone. 
Fig. 11.1 
5I-UdR incorporation by various lymph nodes and the spleen of mice, 3 
days after receiving different doses of oxazolone or alcohol administered 
on the left flank. 
Recipients of oxazolone; incorporation by the draining U and contralateral 
o axillary and brachial lymph nodes; draining A and contralateral 
inguinal nodes; draining • and contralateral 0 popliteal nodes; • spleen. 
Recipients of alcohol; incorporation by the axillary and brachial nodes y 
(shaded area) and spleen <C> (shaded area). 
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Pig. 11.9 
incorporation by lymph nodes of irradiated recipients of 
106 cortisone resistant thymocytes or 10 6  thyuzocytea • 3, 4 and 5 days 
after receiving ozo1one or alcohol. 
The response in irradiated recipients of 106  cortisone resistant 
thymocytes and ozolcne A , of 106  cortisone resistant thymocytea 
6 	 '6 and alcohol , of 10 thymocytes and oxazolone • , of 10 thyiao- 
cytea and alcohol K> , of saline  and oxazolone• , of saline and 
alcohol 0 ; in normal recipients of oxazolone • 
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Fig. 11.11 
' IUdR incorporation by lymph nodes of irradiated recipients 
of differsnt doses of peripheral blood lymphooyta • 4 and 5 
days after receiving oxazolone or alcohol. 
Exp.l: The response in irradiated recipients of peripheral 
blood lymphocytes (PBL) and oxazolone • , of PBL and 
alochol 0, of saline and oxazolone A • of saline and 
alcohol V; in normal recipients of oxazolone • or 
alcohol 0 , 4 days after oxazolone. 
Exp.2: The response in irradiated recipients of PBL and oxazolone 
A , of PBL and alcohol L # of saline and oxazolone V , of 
saline and alcohol V ; of normal recipients of oxazolone • 
or alcohol C> 4 days after oxazolane. 
The response in irradiated recipients of PBL and oxazo]one 
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Fig. 11.12 
incorporation by lymph nodes of irradiated recipients 
of lymph node lymphocytes A thymocytes 3, cortisone resistant 
thymocyteS C O lymph node lymphocytes and thyrnocytea A + B, 
lymph node lymphocytes and cortisone resistant thymocytoc A + C 
in reaponsa to oxazolone (shaded) or alcohol (unshaded) 4 days 
after antLen adainistration. 













251UdR incorporation by lymph nodes of irradiated recipients 
treated 
of anti-theta/immunised lymph node cells A. inununised lymph 
node cells treated with normal ARR serum B, anti-theta treated 
normal lymph node cells C. normal lymph node cells treated with 
normal AIR serum D, in response to oxazolone (shaded) or 
alcohol (unshaded), 4 days after ant icen administration. The 
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Fig. 11.14 
125 IUdR incorporation by lymph nodes of irradiated recipients of 
different doses of thymocytes 3, 4 and 5 days after receiving 
0.1mg of Ferrit4n or 0.05 mis of saline, injected s.c. into the 
right fore foot pad. 
The response of irradiated reoipienta of 10 6 thymocytes A , 
thyinocytes • , 3 x 10 thyznocytee • and 10 thymocytes U 
to Ferritin. The response of irradiated recipient8 of 10 
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Fig. 11.15  
120IUdR incorporation by lymph nodes of irradiated recipients of 
different doses of thymocytes, 3, 4 and 5 days after receiving 
2igm of PvP or 0.05 mis of saline, injected s.c. into the right 
fore foot pad. 
The response of irradiated recipients of 3 x 10 thymocytea • 
and 208  thymocytea • to P1'. The response of irradiated 
6 	 8 recipients of 10  thymocytea 	or io thymocytes El to saline. 
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 IUdR incorporated between the draining and contralateral lymph 
nodes in mice, 3 days after receiving different doses of o,zolone, which 
was painted on the left flank. 
Lymph nodes 
Oxazolone 
dose (rag) 	Axillary and 	Inguinal 	Popliteal brachial 
10 	 2.71 1.66 0.76 
5.24 0.75 0.14 
2.70 1.41 1.70 
2.47 0.66 0.80 
mean+SD 	3.28±1.30 	1.24±0.49 	1.10±0.44 
12.05 	 0.82 0.83 
8.38 1.11 1.21 
10.32 	 1.57 0.86 
0.79 1.17 
mean +80 	10.25+1.84 	1 .07 ± 0 . 36 	1.02±0.20 
0.3 	 18.67 0.52 0.88 
8.74 1.28 2.72 
11.96 0.72 1.84 
22.38 0.88 1.00 
mean + SD 	15.44 ± 6.20 0.85 ± 032 1.76 ± 0.73 
0.1 	 14.89 CO.69 L3.60 
9.61 0.91 1.14 
9.11 0.93 1.77 
38.03 2.04 1.00 
17.91+13.66 1.15 ± 0.61 1.37±1.20 
TABLE 11.2 
Ratio of 
125  IUdR incorporated between the draining and contralateral 
lymph nodes of mice, 3 days after receiving different doaes of oxazolone, 
which was painted on the left hind foot pad. 
Lymph nodes 
Oxazolone 
dose (mg) 	Axillary and Inguinal Popliteal 
• 	 brachial 
10 	 0.98 2.20 3.15 
1.60 	. 4.52 4.46 
1.23 . 2.63 .4.98 
1.51 5.46 
mean+8D 	1.27+0.31 	. 2.72±1.29 	4.52+0.995 
4,86 	 3,72 	 4.63 
1.43 10.09 1.97 
4.05 	 4.25 	 6.85 
1.82 10.17 5.52 
mean SD 	3.04 ± 1.67 	7.06 ± 3.58 	4.74 ± 2.06 
0.3 	 1.13 	 12.23 	 1.41 
1.09 3.99 3.02 
• 	 0.99 	 2.87 	 2.56 
0.79 3.90 3.78 
mean + SD 	1.01 -4. 0.15 	5.75 ± 4.35 	2.69 ± 0.80 
061 	 1150 	 1.48 	 2.54 
• 	. 1.30 4.57 22.33 
• 1.34 	 4(30 	 3.40 
1.93 9.92 1.09 
mean +SD 	1.52+0.29 	5.06±3.53 	.7.34±10.04 
TABLE 11.3 
1 IUdR incorporation by lymph nodes of irradiated recipients of lymph 
node lymphocytes or peripheral blood lymphocytes from normal or adult-
thymectomised mice, in response to ozolone or alcohol, 3 and 4 days after 
antigen administration. 
Days after oxazolone • Mean 
Exp. Donor Cell type, Oxazolone 
	 125IUdR ± SE 
Day3 	No. 	Day4 	No. 
mice mice 
TbX 2.18, PBL + 1.85 ± 0.04 5 2.39 ± 0.06 5 
1.0, UiC + 2.0940.05 5 2.59±0.16 5 
N 2.72 9 PBL + 2.34 ± 0.06 5 2.66 ± 0.08 5 
• 	7m 1.0, LNC + - * 2.74 ± 0.104 3 
N 2.22, PBL + 2.47 ± 0.04 4 2.88 ± 0.05 5 
2.5m 1.0, WC + 2.28 ± 0.05 4 2.91 + 0.06 5 
2.22, P81. - 1.88 ± 0.14 4 2.09 ± 0.15 8 
1.0, LNC - 1.79±0.06 8 2.10±0.11 8 
11 	mx 0.5, im + : - - 2450±0.038 6 
Om 0.6, INC - - 1.62 ± 0.09 8 
N 0.8, LNC + - 2.47±0.03 6 
Om 0.8, LNC - 	- - 1.321 0.14 6 
N 0.8, uc + - - 2.33±0.05 8 
2.5rii 0.8, LNC - - 1.78 ± 0.12 6 
Nocelle + - - 1.84±0.147 6 
Nocella - - - 1.50±0.08 6 
mx = Thymectcini.ed at four weeks of age 
N = not thymectoinised 	 PBL = Peripheral Blood Lymphocyte 
?m = 7 months old 	 L1C = Lymph Node Cells 
= 9 months old 
2.5m = 2.5 months old 
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DISCUSSION 
1 	Evaluation of the technique used to estimate cellular pro1iferatio 
Incorporation of 125 1-labelled 5-lodo-2 '-Deoxyuridine ( 25 I-UdR) to 
measure DNA synthesis and hence provide an estimate of cell prolifera-. 
tion has been shown to be a sensitive and reproducible technique by 
various workers in this laboratory. The chemical and biological 
properties of 
126
I-UdR and the factors affecting its incorporation 
into DNA as a thymidine analogue were described by Pru9soff (1963). 
It is incorporated into DNA and provides a stable label, that is, it 
is not removed from intact DNA in living cells (Commerford, 1966). The 
utiliaation of 5I-UdR by various tissues of mice has been compared to 
the utilisation of tritiatdd thymidine (Fox & Pnissóff,, 1965; 
Feinendegen et Al., 1966; Detblefaen, 1970). Differences in the 
rate of incorporation, cataboliam and reutilisation were detected 
between these two compounds. The main advantage of 25I-UdR is 
that reutilisation is reported to be negligible or non-existent 
(Hughes etal., 1964; Commerford, 1968; Feinendigen etal., 1966) or 
restricted to about 6% for the whole body (Rofer et al., 1969a; 
Hofer et al., 1969b; Dethlefsen, 1970). The other advantage, a 
practical one, is the relative ease of treating and counting tissues 
labelled with 25I-UdR. Due to the low energy of P particles, tissues 
which have been labelled with tritiated thymidine have to be homo-
genised or solubilised to disperse the cells, and mixed with 
scintillant before counting. Also, aflowances have to be made for 
colour quenching which may occur when using blood or spleen. 	26I-UdR 
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however is a gemma emitter and can be counted with no prior tissue 
preparation. The disadvantage of 125_ 
	
is its potential toxicity 
(Jaffe & Pruasoff, 1960; Dubba & Kit, 1964; Uorris & Cramer, 1966), 
the toxic effects can however be avoided by using 1251.-UdR of high 
enough specific activity (Feinendegen et 	, 1966; Fox & Lajtha, 
1967). There is evidence that the iodine formed catabolically from 
I-UdR is probably not incorporated into proteins (Hughes 
1964; Fox & Pruagoff,1965). The technique which has been utilised 
in the present studies was first described by Hughes et al. (1964) 
who found that fluorodeoxyuridine (FUdR) by preventing the cellular 
synthesis of thymidine, greatly increased the incorporation of 
I-UdR. 
1251 	has been used to estimate the amount of cellular loss from 
tumoura (Dethlefsen, 1971), the proliferation of haemopoietic tissues 
(Bennet et al., 1968), the proliferation during a graft vs host response 
(Elkins, 1970; Gershon & Liebhaber, 1872; Gerahon et al., 1972; 
Gerehon et al., 1974):; 	spleen and lymph node proliferation to 
bovine serum albumin and human serum albumin (Makela & Mitehison, 
1965b), proliferation of spleen and lymph node cells in vivo to picryl 
chloride (Asherson & Barnes, 1973), proliferation of thyniocytes to 
sheep erythrocytes (Gershon & Renoin, 1971; Kruger & Gerahon, 1972), and 
to a variety of antigens (Kruger & Gershon, 1972). Pritchard and 
Micklem (1972) investigated the ability of athymic nu/nu mice to 
respond to oxazolone and compared the results obtained by measuring 
the response with 125 1-UdR and measuring the change in weight between 
stimulated and unatimulated nodes. They found the method which used 
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126 I-UdR produced results that were more consistent and probably more 
accurate than those obtained by weight measurements. When interpreting 
results that have involved the use of 1251-UdR it should be noted that 
not all DNA synthesis may be associated withceu division Olarrie, 1973). 
2. Parameters of the experimental system 
Normal mice produce a high proliferative response to oxazolone as 
measured by the incorporation of 25I-UdR (Pritchard & Micklem, 1972). 
In order to investigate the ability of various types of lymphocytes to 
respond to oxazolone it was evident that a system that involved transfer 
of cell populations into irradiated recipients was necessary. The 
peak proliferation of T cells to oxazolone was shown to occur 3-5 days 
after the administration of the antigen (Davies et al., l969b),thua 
in the present studies responses were measured either on day 4, or on 
days 3, 4 and S. 
Experiments 1 and 2 were performed to discover the optimal dose of 
oxazolone to administer, the area of application and the timing of the 
irradiation relative to the timing of the administration of antigen. 
The results which are'ehown in Figs. 11.1 and 11.2 indicate that doses 
of oxazolone from 0.1 mg to 10 mg produce no difference in the amount 
of DNA synthesiaed during the response of the draining lymph nodes or 
spleen. Possibly all antigens have an optimal dose where increasing 
the dose no longer results in a concomitant increase in the response. 
rflela and Mitchison (1965b) found this to be the case using bovine 
serum albumin and indeed discovered that high doses suppressed the 
response. Oxazolone appears to stimulate primarily those lymph nodes 
nearest the site of its application..; An interesting feature of the 
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response is shown in Table 11.1  where increasing the amount of oxazolone 
administered to the flank increased the DNA synthetic response in the 
distant nodes. Possible explanations for this phenomenon are that 
the distant nodes receive their stimulation either by excess oxazolone 
which has been transported internally or externally or by excess 
circulating sensitised lymphocytes. The question of central or 
peripheral sensitisation by skin grafts and contact sensitising agents 
remains unresolved. When oxazolone was painted on to the foot pad and 
subsequently covered, there was not such a pronounced effect of the 
increase in dose stimulating the distant nodes. This tends to imply 
that oxazolone was spread externally between the animals that were 
painted on the flank. The mice were not caged individually and 
contact between them would be probable. Experiments by Hall and 
Smith (1971) suggested that antigen from the site of contact 
sensitisation can be carried combined with soluble proteins in the 
afferent lymph, and pass through the draining lymph nodes, avoiding 
phagocytosia, into the efferent lymph and circulation. This might 
explain the effects of flank stimulation, but the same phenomenon did 
not occur when the foot pad was stimulated. Possibly the vascular 
or lymphatic connections between the inguinal and popliteal lymph nodes 
of the left and right sides are not direct enough to promote this effect. 
The experiments in Chapter II required a system that would allow the 
maximum proliferative response, while at the same time rninimising 
background proliferation. The results which were obtained by stimul-
ating animals on the foot pad were variable, the ratios of stimulated 
to contralateral nodes were not as great as those which were produced 
by painting the thorax. It was therefore decided to routinely paint 
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the shaved area of the thorax and administer excess oxazolone, that 
is 5 mg. 
Pilot experiments by A .C. Payne had indicated that administering 
oxazolone the day after irradiation and repopulation produced higher 
and more consistent results than performing all the procedures on one 
day. The results in Fig. 11.3 confirm this to be the case. 	It 
should be noted that there were no groups of mice which had been 
irradiated, repopulated and painted with alcohol and experience of 
this technique indicates that high responses can occasionally be due 
to non-specific proliferation. However, the fact that the same 
thyinocyte suspension was used for all groups and the preliminary studies 
of A.C. Payne suggest that these results ehow a real advantage in 
delaying oxazolone administration for one day. Experiments have shown 
that lymphocytes which have been injected intravenously become 
entangled in the fine capillary network of the lung during the firet 
2 hours, and possibly longer after their injection (Hall etal., 1972). 
Oxazolone behaves similarly to many antigens (Ford, 1968; Zatz & Lance, 
1971; Frost & Lance, 19740and causes circulating cells to become 
'trapped' or retarded within the stimulated lymph node or spleen (as 
reported in Chapter IV) within 24 hours of antigen administration. 
It seems plausible that if for several hours cells are trapped in the 
lungw, the response in the lymph nodea may be delayed. 
3. Kinetics of the T cell proliferative response to oxazolone 
Experiments 3a, 3b, 3c and 3d were designed to investigate whether 
any factors regulate the magnitude of the proliferative response of T 
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cells to oxazolone and the nature of these factors. 
If there were no control mechanisms which regulated the proliferative 
response of a lyiaphocyte population, increasing the number of potentially 
reactive cells would lead to a proportional increase in the response. 
T cells are a heterogeneous population with regard to maturity, membrane 
properties and possibly functions. In order to ascertain the possible 
role of different T cell populations in the proliferative response to 
oxazolone, the kinetics of various doses of lymphocytes from different 
anatomical compartments were investigated. 
a) Thymocytes 
The results which are shown in Figs. 11.3-8 show that thymocytes, when 
injected into irradiated recipients, synthesise DNA in response to 
oxazolorie. The irradiated recipients which had not been repopulated 
demonstrated that the DNA synthesis was due to injected thymocytes 
and the mice which had been given alcohol and thymocytea showed that 
the response was induced by oxazolone. The kinetics of the response 
are very similar to those given by thymocytea in response to hiato-
compatibility antigens (Sprent & Lliller, 1971; Gershon & Liebhaber, 
1972) and sheep erythrocytes (Gerehon & Hencin, 1971). 
Within a certain range of doses, increasing the number of cells did not 
increase the magnitude of the proliferative response. A maximum res-
ponse was reached with 5 x 107 thyuiocytes (Fig. 11.5 and 11.8). This 
figure accords well with the results which were obtained from a similar 
experiment which investigated the proliferative response of CSA 
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thymocytes which had been injected into lethally irradiated (CiA x C5IB1) 
F1 mice (Sprent & rilier, 1972a). The response was measured in the 
spleen by the uptake of tritiated thymidine. It was found that numbers 
of thymocytes between 106  6 x 107 produced a linear increase in the 
response but it reached a plateau after 6 x 10 7 coils. 
It is conceivable that although doses of thymocytes above 5 x 107 produce 
no greater response than lower doses on day 4, they may produco a 
greater response at a different tiao. Thus the response of 3 , 10 9  
3 x 10 6 , 10 
7 
 and 7 x 10 
7
thynocytes wore measured at 3, 4 and 5 days 
after the application of ozolono. The results (Fig. 11.8) showed 
that: 
(1) the high dose of thymocytes produced their peak DNA synthetic 
response a day earlier than the lower doses. 
the DNA synthetic response of the high dose of thymocytos 
platoaued a day earlier than the lower doses, and possibly 
decreased thereafter. 
low doses of cells showed a lag phase before responding 
demonstrably. 
within a certain dose range, a twenty-.fold increase in cell 
number did not produce any increase in proliferation. 
The experimental system which was used by Gershon and Liobhaber (1972) 
to investigate the kinetics of the thymocyto response to hiatocompatibility 
antigens was similar to this syctem. They injected C3N thymocytes into 
lethally irradiated (C3H x DiA 2) F1 recipients and measured the 
125 
incorporation of 	I-UdR in the spleen and lymph nodes 1-5 days later. 
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The results showed features in common with those of the present studies. 
For example, they found that 4.5 x 107 thymocytes produced their peak 
DNA synthetic response on day 3, and the response declined on day 5, in 
contrast to 1.5 x 10 
7 thymocytes which did not respond on day 3, but the 
amount of DNA synthesised increased between days 4 and 5. Gerahon 
and Bencin (1971) found that increasing the thymocyte dose from 
5 x 106  to 5 x 107 did not elevate the proliferative response to sheep 
erythrocytea. 
The present studies, combined with the dose response studies described 
above (Gershon & Liebhaber, 1972; Gerahon & Hencin, 1971) show that 
increasing the thyinocyte dose by a multiple does not increase the 
amountóf DNA which is synthesised by the cells in response to antigen 
by the same multiple. Moreover, within a certain dose range, increasing 
the number of thyInocytes does not increase DNA synthesis at all. 
This observation implies the existence of a mechanism that regulates 
the magnitude of the proliferative response. Possible mechanisms 
are as follows: 
Exhaustion of antigen; this is unlikely because more than enough 
antigen (5 mg) is present to produce the maximum response in 
normal animals. 
Exhaustion of some product necessary for DNA synthesis; this is 
unlikely in view of the fact that normal animals can support more 
DNA synthesis than that produced by the highest number of 
thymocytea, it may be possible however that irradiation depresses 
the concentration of nucleotides available. 
Negative feedback which inhibits T cells, produced by antibody or 
other B cell products; this may be a control mechanism which 
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operates in normal mice, but it seems unlikely it would operate 
in the irradiated thymocyte-repopulated animal. Nevertheless 
there could be radioresistant B cells that may exert an inhibitory 
effect. 
(iv) Migration of DNA synthesising cells from the lymph nodes; there 
is evidence that blast cells migrate from lymph nodes. For 
example Ashergon et al (1973*) have suggested that blast cells 
migrate from lymph nodes 4 days after oxazolone, and showed that 
cells which have recently incorporated 125 1-UdR migrated to areas 
of inflammation. Evidence that implies that thymocytes could 
be migrating in the present experiments stems from the findings 
of Sprent & Miller (1972a) that blast cells appear in the thoracic 
duct lymph of mice which had been given allogeneic thymus cells 
4-5 days previously. It is thus possible that blast cells, which 
were produced as a result of thymocytes responding to oxazolone 
may be leaving the draining node 4 and 5 days after the 
application of antigen. However, on the assumption that the same 
proportion of blast cells leave the nodes from animals which were 
injected with low numbers of thymocytes as leave the nodes of 
animals containing relatively high numbers of thymocytes, this 
does not readily explain why the response plateaus, a phenomenon 
only observed with high doses of cells. To consider cell 
migration a plausible explanation, it is necessary to assume or 
postulate that migration can occur only after a certain number of 
cells have proliferated or have been produced. 
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(v) Thymocytes are a heterogeneous population of cells, and it has 
been suggested that they may contain a population with 
suppressor activities (chiller etal., 1971; Elliot, 1073). 
The kinetics of the thymocyte proliferative response to histo-
compatibility antigens was explained by the suppressor 
activities of certain populations (Cershon & Liebhaber, 1072). 
b) Uature T cells 
The majority of thymocytes are immature (Bloingren & Andereson, 1069) 
and the possibility that a suppressive effect is mediated by immature 
cells that normally perhaps never leave the thynius was investigated. 
Thus the dose response kinetics of cortisone resistant thyinocytes, 
lymph node lymphocytes and peripheral blood lymphocytes were 
investigated. 
The responses of these cell suspensions were measured only in the 
lymph nodes. The results in Figs. 11.6 and 11.7 indicate that very 
little proliferation occurs in the spleen, in a transfer situation, 
It is conceivable that the splenic response is delayed due to the 
accumulation and teiiporary trapping of injected cells within the 
stimulated lymph nodes • Agherson and Barnes (1973) found that the 
spleen in normal mice produced three peaks of DNA synthesis in response 
to picryl chloride, on days 2, 8 and S. They suggested the day 5 
result was due to cells which had migrated from the lymph nodes. It 
may therofore be possible that if irradiated recipients could be 
maintained long enough, a response would be detected in the spleen. 
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i) Cortisone resistant thymocytes 
The DNA synthetic response of lyr3ph nodes from mice which had been 
irradiated and repopu]ated with 10 6  thymocytes or cortisone resistant 
thymocytes was compared, (Fig. 11.9) 3, 4 and 5 days after the 
application of oxazolone. It can be seen that the kinetics and 
megnitude of DNA synthesis produced by 10 6 cortisone resistant 
thymocytes is similar to that produced by 10 thymocytes (Fig. 11.3). 
These results suggest that cortisone resistant thyn2ocytes are, cell for 
cell, about ten times as active as norr1al thycocytes in responding to 
oxazo lone. 
It is to be expected that cortisone resistant thyxaocytes represent a 
large proportion of the thymocytes which proliferate in response to 
oxazolone. They account for a large proportion of irnnunocompetent 
cells in the thymus (reviewed by Claman, 1972). Cortisone resistant 
thymocytes were found to be ten times as effective as thymocytes in 
producing splenomegally (Blomgren & Anderson, 1969) and thirty timee 
as effective as thyrnocytes in the in vitro.response to PHA and allogeneic 
cells (Blomgren E Cvedmyr, 1971). The kinetics of the response to 
oxazolone, presented in these studies, is similar to those found by 
Blomgren and Svedaiyr (1971). 	It is interesting that the acount of 
which was incorporated by mice which had received 106 cortisone 
resistant thymocytes, and were giving a 5 day response to oxazolone 
(2.6 ± 0.09) was similar to the amount incorporated by mice which had 
received 10 thynocytes (2.75 ± 0.1). These figures represent 
approximately the peak performance achieved by thymocytes in these 
series of experiments, that is when 7 x 10 thymocytes produced a 
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uptake of 2.98 + 0.08. Thus it appears that the proliferative 
response fails to increase, or declines when a certain amount of 
proliferation has occurred. Sprent and Miller (1972a) found the 
proliferative response of thymocytes and cortisone resistant thymocytea 
in allogeneic recipients levelled off after similar amounts of 
3H-thytnidine had been incorporated. 
ii) Lymph node and peripheral blood cells 
The response of various numbers of lymph node and peripheral blood 
lymphocytes to oxazolone were examined to ascertain whether these 
cell types also produce a plateau of responsiveness at high doses. 
The response of mice which had received lymph node cells (Fig. 11.10) ' 
increased in an injected dose range of 3 x 10 - 106 cells, but 
thereafter the response levelled off. Peripheral blood lymphocytes 
showed (Fig. 11.11) a dose dependent increase between S x 10 
4
and 
3 x 10 
6 
 cells, but the response which was produced by 10 7 cells was no 
greater than to 3 x 106  cells. Thus a prima facie interpretation of 
these observations is that there is a levelling of f of the response 
at high doses. However a factor which limits the interpretation of 
these results Is that the DNA synthetic response was only measured on 
day 4. As can be seen from Fig. 11.11, where the response of animals 
which had been Injected with 3 x 10 and 106  cells was measured on 
days 4 and 5, there was an increase in the amount of DNA synthesises 
between days 4 and 5. 
A possible reference point with which to compare these results, Is the 
125 
amount of 	I-UdR which was incorporated by normal unirradiated mice 
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4 days after oxazolone. The peak response of the mice which had 
received the largest numbers of thymocytea was significantly less than 
normal. Animals which received cortisone resistant thymocytea and 
peripheral blood cells did however attain the normal level. Previous 
experiments by N. Anderson and H.S. Micklem (per.. comm.) which 
utilised lymph node lymphocytea in dose response experiments, indicated 
that animals which have been repopulated with these cells may produce 
a proliferative response to oxazolone as great as the normal response. 
The response of lymph node cells may however include proliferating B 
cells • Davies et al.(1969b , )utilized thymectomised mice which had been 
injected with bone-marrow cells and 3 x 107 thymocytea. Fifty days 
later they were painted with oxazolone. it was found that on day 4 
of the response, over 75% of dividing cells in the draining nodes were 
of thymic origin. 
It would be difficult to conclude on the basis of the present studies 
that there is any real difference in the kinetics of the proliferative 
responses of lymph node cells, peripheral blood lymphocytes, cortisone 
resistant thymocytes or thymocytes. These results do not provide 
evidence for the existence of qualitatively different T cell populations 
that either suppress or enhance other T cells in their proliferative 
response to oxazolone. A possible and perhaps simple interpretation 
of these results would be that: 
(1) the amount of 1251-UdR which in incorporated reflects the number 
of responsive cells which are present. 
(ii) a mechanism operates which prevents further synthesis of DNA 
when a certain number of cells have divided. 
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The drawback of those experiments is that responses were measured on 
only one or three days. Exploring the system over a longer time 
period may well reveal patterns of responsiveness that distinguish 
these cell populations qualitatively as well as quantitatively. For 
example, Sprent and Miller (1972a) investigated the pattern of the 
proliferative response of thymocytes, cortisone resistant thymocytes 
and thoracic duct cells in the spleens of irradiated allogeneic 
recipients over 10 days and concluded that the cell suspensions 
contained qualitatively different cell populations. 
A possible interpretation of the difference between the profile of 
the thymocyte response to oxazolone and that of the other cell 
suspensions may be simply that 95% of a thymocyte cell suspension 
are immature, non-responsive cells • There is evidence however to 
suggest that the thymus has suppressive effects in some circumstances 
(as described in Chapter II) and the possibility that some of the 
'non-responsive' cells may be suppressing the response should be 
considered for two reasons: 
The peak response of the highest number of thymocytea is well 
below the level of proliferation which was achieved by unirradiated 
mice. This is not true of cortisone resistant thymocytes or 
peripheral blood cells. 
The plateau part of the thyntocyte response which is shown in 
Fig. 11.5 is a more convincing plateau than those found using 
other cell types. 
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The results from Experiments 3a, 3b, 30 and 3d suggest the existence 
of a homeostatic mechanism which controls the amount of cell division 
which occurs in response to oxazolone. What bearing do these results 
have on the response in normal mice and its regulation? They show the 
peak DNA synthetic response of lymphocytes in the transfer situation 
to occur 4 days after oxazolone, that is one day later than the peak 
response in normal mice (Pritchard & Micklem, 1972). This may be due 
to the time taken for injected cells to localise. The normal mouse 
has been found to show intense paracortical hyperplasia one day after 
oxazolone, this reaches a maximum on days 3 and 4, and thereafter 
declines (Oort & Turk, 1968; Parrott & do Sousa, 1966). The early 
phase of proliferation is mainly T cells. The B cells produce their 
maximum proliferation on days 8 and 6 (Davies et al., 1969b). Thus 
T cells proliferate to oxazolone in irradiated and normal mice with 
maximum activity on days 3 and 4, and thereafter activity declines. 
This pattern of T cell proliferation may be characteristic for contact 
aensitisation and allograft responses. For example, animals which 
were painted with picryl chloride produced a maximum DNA synthetic 
response in their draining lymph nodes on day 3, and the response 
declines on day 5, as measured in vivo (Asberson & Barnes, 1973) and 
in vitro (Barnes, 1973). Thymocytee also showed a similar pattern 
of mitosia when undergoing a graft vs host response (Gershon & 
Liebhaber, 1972) Sprent & Miller, 1972c). Whether this pattern of 
mitotic activity is characteristic of all T cells and induced by all 
T cell antigens is unknown. In mice which had been neonatally 
thymectomised, irradiated, bone-marrow reconstituted and given a thymue 
graft, lymph node cells of thymic origin were ahown to proliferate to 
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a variety of antigens (Carter et al., 1969 ) 	The response 6o 
oxazolone showed kinetics similar to the present findings. The 
response to sheep erythrocytes peaked sharply on day 3 and fell 
between days 3 and 4. The response to bovine gamma globulin pealed 
on day 4 and fell on day 5 • The response to bovine serum albumin rose 
gradually between days 3 to 6, and the response was not followed there-
after. It has been suggested (Gerahon & Liebbaber, 1972; Gerahon, 
1974) that the kinetics of the T cell response to histocompatibility 
antigens in irradiated recipients is produced by interactions between 
T cell populations of a suppressive nature, and that moreover, 
interactions of this type operate in the normal animals and serve to 
regulate the response. 
4. Experiment to investigate the existence of suppressive or 
potentiating interactions between T cells • affecting the 
response to oxazolone 
There is evidence that in certain circumstances thymocytea, cortisone 
resistant thymocytea and thymocytea from immunised recipients 
('educated thymocytee') can either potentiate or depress the prolifer-
ation of other T cells. Thus Cantor (1972b)found that 5 x 10 lymph 
node cells and 5 x 106 thymus cells gave a graft vs host response 
greater than could be accounted for by the sum of the responses measured 
by splenomegally. On the other hand, Gerabon et al. (1972) showed that 
1 x 107 T cells from mice which had been imniuniaed to sheep erythrocytee, 
when mixed with 1 7 thymocytes and transferred into an irradiated 
recipient, depressed the response to sheep red cells to a level below 
that attained by educated T cells independently. 
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If synergistic and suppressive response between T cell populations could 
be detected in the above systems, they might be detected in the system 
used in the present studies. Experiment 4, Fig. 11.12, shows the 
effect on the proliferative response to oxazolone of mixing 5 x 10 
lymph node cells with thymocytes or with cortisone resistant thymocytes. 
The results did not show any sign of synergistic or suppressive effects 
resulting from mixing cell suspensions. They are however difficult to 
interpret for two reasons: 
mice which had been injected with cortisone resistant thymocytee 
or thyinocytes gave no appreciable response, despite the results 
from earlier experiments (Pig. 4 and Fig. 9) where the same doses 
produced significant responses; 
mice which had been injected with mixed cell suspensions, and 
painted with alcohol, showed lower background proliferation than 
recipients of lymph node cells which had been painted with 
alcohol. 
Thus although there was no absolute difference in the amount of 125 1-UdR 
incorporated by recipients of lymph node cells and recipients of the 
cell mixtures, comparison with the groups of animals that had received 
alcohol might suggest that the recipients of cell mixtures produced 
a greater specific response to oxazolone than could be accounted for 
by the sum of the responses. 
This type of experiment should be repeated several times with different 
cell canbinations and the effect of cell number ehould be properly 
controlled, in order to attain an acteptable result that conclusively 
shows suppression or synergy. 
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5. Factor of inimunisation of oxazolone 
Antigens differ in their ability to stimulate T cells to divide, thus 
oxazolone (Carter et al., 1969) and histocompatibility antigens appear 
to stimulate large numbers of T cells. In contrast there is little 
T cell proliferative activity which in induced by salmonella H-antigens 
(Carter etal., 1969; Davies etal., 1970), pneumococcal polysacch&ride 
III (Davies et al. 1970; Kruger & Gerehon, 1971) or polyvinylpyrrolidone 
(Kruger & Gerahon, 197). It could be postulated that the ability to 
stimulate large numbers of T cells into mitosis is in some way 
correlated with the ability to produce delayed hypersensitivity and 
contact sensitisation. It seems plausible therefore that the T cell 
proliferative response to oxazolone may have some features in common 
with the proliferative response to histocompatibility antigens. This 
hypothesis was explored in experiment 5, which was designed to 
investigate whether lymphocytes from a mouse which had been previously 
senaitised to oxazolone would produce a heightened proliferative 
response to that antigen. 
Inmiunisation against strong transplantation antigens fails to elicit 
a heightened secondary response measured by graft vs host activity, 
in contrast to the memory response which is produced by imniunising 
across weak histocompatibi]ity differences (S$jnoneen, 1962; Ford & 
Simonsen, 1971). This could either be because the proportion of cells 
reactive to a strong transplantation antigen is so high in the 
uninimunised animal that the maximum possible increase would only 
slightly elevate the graft vs host response (aimonsen, 1962) or (a hypothesis 
ted byFord 8 Gowans, 1967, and supported by the experiments 
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of Rolgtad and Ford, 1974) because proliferation of lymphocytee to 
strong transpiantat ion antigens is directed more towards producing 
cytotoxic effector cells rather than cells able to give a secondary 
proliferative response. Some of the products of T cell proliferation 
to oxazolone are cytotoxic in vivo (Ashereon et al., 1973 a ) In 
experiment 5, lymphocytes were obtained from the lymph nodes of mice 
14 days after they had been senaitised to oxazolone. Day 14 was 
hosen to ensure that few blast cells would be present and by day 14 
the products of proliferation appear to be well disseminated throughout 
the body (Asherson & Zeinbala, 1973). The batch of anti-theta serum 
used was not very efficient in killing only 28% of the lymph node cells, 
it did however kill 66% of cells from immuniaed mice; possibly this is 
because primed cells have more theta antigen on their surface, or because 
they are more susceptible to lysis for some other reason. Kerbal (1974) 
found that blast cells removed from animals 4 days after oxazolone 
treatment were more susceptible to anti-theta than normal cells. 
Despite the apparent inefficiency of the anti-theta serum, it depressed 
considerably the ability of normal lymph node cells to transfer 
responsiveness to oxazolone. Mice which had received cells from 
immuniaed donors incorporated significantly higher amounts of 5I-UdR 
in their draining lymph nodes than did recipients of normal lymph node 
cells. It is reassuring that the recipients of normal lymph node 
cells incorporated as much 1251-UdR as would be predicted from the 
lymph node dose response curve shown in Fig. 11.10. Thus there was 
a real specific elevation of the magnitude of proliferation produced 
by primed cells. The Vactor of limnuniestion for traneplanatation 
antigens has been calculated by constructing dose response curves of 
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normal and imimmised cell populations, and comparing the number of normal 
cells to immuniaed cells which are necessary to produce a certain level 
of response (Ford & Simonsen, 1971). tJnfortwiately, this experiment 
was not done in the present study, but using the lymph node dose 
response curve of Fig. 11.10, it is possible to estimate approximately 
that th 	
5
e amount of isotope which was incorporated by 3 x 10 cells from 
immunised donors (2.9 ± 0.08) would require more than 106  normal lymph 
node cells, to achieve the same level of incorporation. It may be 
possible to increase the Factor of Inununisation for oxazolone by 
experimenting with different imxtnmisation schedules. Anti-theta serum 
depressed the ability of primed cells to transfer the proliferative 
response, but to a level considerably above the amount of 5I-UdR 
which was incorporated by recipients of. anti-theta treated normal 
lymph node cells • The spurious quality of the anti-theta serum 
precludes any definite statement, but it seems possible that S cells 
formed part)of the immune population, and proliferated in response to 
oxazolone. 
6. Effect of adult thymectomy on the ability of lymphocytes to 
transfer the proliferative response to oxazolone 
Extirpation of the thymus in early life results in severe impairment 
of cell-cediated immunity (Miller, 1961; Arnason et al., 1962) and 
some humoral antibody responses (Miller &0eoba, 1967). It results in 
severe depletion of the number of lymphocytes found in the thoracic 
duct *nd blood (Miller MtcIié1L, 1967; Agnew, 1967) and in the T 
dependent areas of lymph nodes and spleen (Parrott et al., 1986). 
Adult thymectomy however does not produce visible imziiunodeficiencies 
until at least six months after thyinectomy. For example, mice that 
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had been thymectomised when they were 4-8 weeks old, showed a depressed 
ability to mediate graft vs host responses some seven months later 
(Taylor, 1965; Miller, 1968) and their ability to produce haeviolyein 
to sheep erythrocytea was not severely depleted until 11 months after 
thyinectomy (Metcalf, 1968) • Adult thymectomy impairs recovery from 
procedures which in normal mice cause tild and reversible dnmsige to the 
iriimune system such as a single dose of 350R (Miller, 1962) or administra-
tion of a single dose of Antilymphocyticaera (Jeejeebhoy, - 1985). 
It would be expected to affect the lymphocyte population after 6 months in 
the following ways: 
The short-lived T cell population would be depleted. This may 
be apparent after 1-2 weeks (Cantor, 1972c) 
The pool of long-lived, recirculating lymphocytes may be 
depleted. As the long-lived cells outlive their life-span, 
or become depleted due to excessive use or possibly damage, 
they will not be replaced by the thyrnue.., 
It would therefore be expected to find some depression in the ability 
of lymphocytes from thyectomiaed mice to transfer a day 4 proliferative 
response to oxazolone. 
The first experiment showed that there were fewer lymphocytes in the 
blood of 7 month old thymectanised mice (5.45 x 106  per ml) than in 
the blood of 7 month old normal mice (6.8 x 106  per ml). It is 
however possible that the latter figure is abnormally high as young 
mice gave a blood count of 5.55 x 10 6 per ml. The response of mice 
which had been reconstituted with peripheral blood cells from 
thymectomised donora was delayed rather than completely auppreased. 
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Thus 3 days after oxazolone they gave no significant response, but at 
day 4, the amount of DNA synthesised in recipients of oxazolone was 
significantly greater than the mice which had received alcohol. The 
delaying effect was not due to age, because on day 3, the lymphocytes 
from the thymectomised mice were, cell number for cell number, less 
responsive than the lymphocytes from 7 month old mice. 4 days after 
oxazolone there was no appreciable difference in the ability of 
peripheral blood cells from thymectomised or normal mice to transfer 
the response. The dose response experiments in these studies 
(experiments 11.3) showed that low doses of cells are characterised by 
a lag phase before responding. These results do therefore suggest 
that the blood of adult thymectomised mice contains fewer cells able to 
proliferate in response to oxazolone than does the blood of normal mice 
of the same age. Miller et al. (1963) found that the ratio of small 
cells/large cells in the blood, dropped from 5.6 in normal mice to 2.2 
in mice which had been adult thymectomised, suggesting a lack of the 
iminunocompetent small lymphocyte in the thymectomised animal. It 
should be noted that these results may be distorted due to the fact 
that 1/8 of the blood which was obtained from thymectomised donors 
was contributed by a donor with one thymus lobe. 
Lymph node lymphocytes from thymectomised and 7 month old donors 
transferred the proliferative response to oxazolone as well as 
lymphocytes from young mice. Possibly blood is depleted of iinrnuno-
competent cells sooner and to a greater extent than are the lymph 
nodes • Adult thymectomy has been shown to produce depletion of 
lymphocytes in the T dependent areas of lymph nodes and spleen 
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(Liii1er etal., 1963; Ietcalf, 1960; Fuller, 1965). 	Presumably the 
lymph nodes of thymectomised mice contain a higher proportion of B 
cells than do normal lymph nodes, and as 13 cells probably proliferate 
in response to oxazolone on day 4 (Davies ot al., 1969b) , the present 
experimental systei can probably not detect the T cell deficiency. It 
is also possible that, because oxpertients using adult thymectomised 
imice tend to be variable (Fuller, 1905), 12 more donors had been used 
in the present studies a T coil deficiency in the lymph nodes might 
nave been detected. 
The second experiment utilised mice which had been left 0 months after 
thymeotomy. The absence of any difference in the ability of lymph 
node cells from thymectomised and normal donors to transfer the response 
to oxazolone accords with the results from the first experiment. 
Other workers in this laboratory have investigated the ability of 
old and thymectomised mice to transfer responses to oxazolone into 
irradiated recipients (N. Anderson & H.S. Fuicklem, pers. comm.). 
They found that 106  lymph node co1l, spleen cells and peripheral blood 
cells from 29 month old mice were sionificantly depressed in their 
ability to transfer responses to oxaolono compared to 3 month old mice 
(P 0.001; 0.02; 0,001; respectively). 	In another experiment however, 
they failed to detect any difference in the responsiveness of lymph 
node cells, spleen cells and peripheral blood cells from formal 30 
month old mice and 26 month old mice viNich had been adult thymect.miised 
at one month of ago. 
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These results, considered with the present studies, suggest that 
either: 
(1) the ability of lymph node cells to respond to oxazolone is 
not diminished by adult thymectomy, or 
(ii) the ability of lymph node cells to respond to oxazolone is 
diminished by thymectomy, but the effect is obscured by 
age in g. 
The first hypothesis is possible if sufficient B cells proliferate to 
oxazolone on day 4 to obscure the T cell deficiency. The second 
suggestion implies that any depression in the response to oxazolone 
which is caused by thymectomy is not apparent until at least 8 months 
after thymectorny. 
To conclude, these results suggest: 
There is a population of lymphocytes in the blood that is 
reaponsive...to oxazolone, and that is depleted within 6 
months by adult thymectomy. 
There is a population of lymphocytes situated within the lymph 
nodes, that are responsive to oxazolone and that are not depleted 
within 8 months by adult thymectomy. They could be long-lived 
T cells or B cells. 
7. The proliferative response of thymocytes to ferritin and PVP 
This experiment (Figs. 11.14 and 11.15) was designed to investigate the 
following: 
(i) The present studies (11.3) have shown that the proliferative 
response to oxazolone fails to increase in magnitude after about 
10 
8 
 thymocytes and 10 lymph node cells have responded. 
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Does this phenomenon occur using antigens other than oxazolone? 
If a decline in the amount of proliferation does occur, does 
it happen when a certain amount of DNA has been synthesised, or 
when a certain number of thymocytea are present? 
Polyvinylpyrrolidone (PVP) has been reported to be a T independent 
antigen (Fahey It ., 1965). Kruger and Gershon (1972) 
investigated whether 5 x 107 thymocytea could transfer the 
proliferative response to PVP into irradiated recipients, the 
response was measured in the spleen. The experiment was 
repeated using 5 x 107 and 108  thymocytea and measuring the 
response in the lymph nodes. 
In order to investigate points (1) and (ii) it was decided to use an 
antigen which produces moderate stimulation of T cells. From the 
results of Kruger and Gershon (1972), ferritin produced approximately 
as much stimulation of T cells as did sheep erythrocytes. It is 
difficult to determine how much of the DNA whidi was synthesised by 
recipients of thymocytea and ferritin (Fig. 11.14) was a specific 
response to ferritin, because the amount of DNA synthesised in recipients 
of thyinocytes in response to saline is so high. Mice which had been 
repopulated with 108  thymocytes did not produce a greater response than 
those which had received 5 x 10 
7 thymocytes; the greatest incorporation 
of 125 1-UdR (2.36 ± 0.1) was considerably lower than the maximum that 
was incorporated by thymocytee that were responding to oxazolone 
(Fig. 11.8, 2.98 ± 0.07). The latter observation could form the basis 
of a pro;osition that a 'switch-off mechanism' does occur during the 
response to ferritin and it occurs after considerb1y Ieee DNA has been 
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synthesised, than in the oxazolone response. This would imply that 
the mechanism which controls the azount of cell division which occurs 
during a response is aediated not by effectors which respond to soo 
critical level of proliferation independent of the antigen, but by 
effectors which are antigen dependent. 1owever, because of the 
high responses of oice which received saline and no antigen, it is 
pertinent to question whether there is any response to ferritin in 
Fig. 11.14 0.1 ag of ferritin was injected without adjuvant, as 
described by Lruger and Gershon (1972). They did apparently have saio 
difficulty in dissolving it, thus possibly the ferritin was not 
adequately dissolved in the present experiment. 
Kruger and Gorshon (1972) reported that irradiated mice which received 
5 x 10 thyniocytes and PYP, failed to incorporate 5I-Uda in response 
to the antigen. The results if Fig. 11.15 show that irradiated 
recipients of 10 8 thymocytos and PVP incorporated siiificantly more 
than did irradiated recipients of thycocytes and saline. The 
response was measured 5 days after the antigen and the standard errors 
were large. These results may suggest that thoro is no such pbeno2enon 
as a cop1eto inability to stimulate T co1l. They may however be due 
to experimental error, or even the presence of some 3 coils in the 
thymocyto population. 
To obtain a ucaningfu1 picture of the Einotics of T cell proliferation 
and its antigen dependence, experiments of this type could be performed 
using a variety of antigens. It is obviously important to measure the 
response over several days and include non-stimulated control groups of 
animals. 
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CHAPTER I I I 
THE P.NTII3ODY }ESP0NSE TO OXAZOLONE 
ITR0DUCT ION 
It is established that mice respond to transplantation antigens by the 
production of at least two types of effector cells, cells that produce 
and release antibody and cells which display a cytotoxic activity 
ageinst target cells carrying the senaitising antigen (Brunner &. Cerottini,1971). 
Antibodies have been detected in the sera of nice possessing skin 
allografta (Amos et al., 1954; Borar & Hilderuann, 1960; Rolatad et 
al., 1974) and they have also been detected by the presence of plaque 
forming cells (Hilde2ann & Pinkerton, 196; Hildomann, 1967; 
Cerottini etal., 1971) and rosette foriing cells (UickleD etal., 
1970). Despite the suggestive correspondence between the time course 
appearance of plaque forming cells and the time of acute graft 
rejection (Hildemann, 1967) there is no direct evidence that allo-
antibodlea play a role in initiating craft rejection. Thus the 
passive transfer of the ability to reject skin allografte is achieved 
by lyphoid tissue and irmunised sera are ineffective (Ltedawar, 1938). 
It is theoretically possible that alloantibody plays no part in the 
rejection of allografts, but indirect evidence suggests that anitbody 
ay regulate cell mediated immunity. For oxample: 
(1) The identification of multiple classes of circulating antibodies 
with distinctive biological properties (Fahey et a., 1964a 
1964b; Adler, 1986; Cohen & Uilstein, 1067; Pol?ter & Lieberian, 
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1967) focuses on the possibility that some classes of antibody 
do partake in allograft immunity and that this may not be detected 
using whole hypeririiiune ant i-sert3. 
(ii) Lymphocyte mediated cytotoxicity in vitro is complex and may 
involve a numbor of pathways. Thero is evidence that T cells 
can be effectors and that bumoral antibody can induce cytotoxicity 
of thymus independent coils (Poririann et al., 1972) or it can 
inhibit cytotoxic reactions (Laciennan, 1972). 	If the 
conclusions from in vitro work on cytotoxicity can be 
extrapolated to include cytotoxic reactions that occur during 
allograft rejection or contact senitisation, it is possible 
to envisage a system controlled or partly controlled by 
different classes or sub-classes of antibody. 
It is well established that low molecular weight compounds that 
elicit contact sensitisation elicit hapten specific antibodies 
(Benacerraff & Coll, 195). The role of these antibodies in 
initiating or reu1ating the extent of the lesions associated with 
contact sensitisation is equivocal. Circulating antibodies kayo 
been detected in the serum of mice sonsitleed with ozo1one 
(Asicenaso & Ashereon, 1972) and evidence suggested that VG2, which 
is cytophilic for macrophages, may be responsible for the ability 
of acrophages to transfer contact sensitisation to oxazolone 
pas1vo1y (Zembala & Asherson, 1970; Askormase, 1971). This 
information accords well with the reports which suggest that antibody 
cytophilic for macrophages enhances cell-todiateci immunity, whick 
has been induced by certain antions (Parish, 1972). In the present 
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studies various aspects of the antibody response to oxazolone were 
investigated: 
(1) The primary antibody response over a period of 42 days was 
followed. Some mice were given a second application of 
oxazolone 21 days after the first, and the antibodies produced 
as a result of the necond contact were assayed. The secondary 
antibody response to particulate antigens such as sheep red cells 
is well defined (Celada, 1971) and provides a reference point 
for comparing the 'secondary response to oxazolone. 
(ii) Class specific-antisera were used to detect antibodies of the 
clauses G1, YG2a, '(G2b and VA in the aera of mice undergeing 
a primary and secondary response. 
In Qapter II evidence was presented to suggest that there may be some 
homeostatic mechanism which regulates the T cell proliferative response 
to oxazolone. In normal mice it is possible that antibody of other 
serum factors may regulate, that is suppress, the response to oxazolone. 
There is no direct evidence to support this suggestion, but there is 
evidence from a variety of sources that in certain experimental systems, 
both antibody and other unspecified serum factors may be responsible 
for inhibiting T cell mediated immunity. For example, it 10 well 
establiahed that antibody can suppress or enhance lymphocyte cyto-
toxicity in Jvitro systems (Perlmann et al., 1972; Maclennan, 1972). 
It has been suggested that antibody may modulate the extent of the 
histological lesions associated with some types of delayed hyper-. 
sensitivity (Turk 	., 1972; Turk & Parker, 1973) • Recent 
experiments have demonstrated how important is the ronte and dose of 
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antigen in detor3ining the outcome of an inrnurLe response, that is the 
contribution nade by circulating hwnoral antibody and that made by T 
cells effecting delayed hypersensitivity (Lagrange et 01., 1974a). 
Those and other experionts suggested that sensitised effector 'F cells 
could be inhibited fron expressing delayed hypersensitivity to sheep 
orythrocytes by antibody to sheep erythrocytes (Lagrange 	., 1974b; 
F.ackaness etal., 1974). The suggestion that sone classes of antibody 
can inhibit some T coll-rediated immunity, is consistent with the idea 
of an inverse relationship between delayed hypersensitivity and hunoral 
antibody production, a suggestion supported by Parish and co-workers 
(1972). 
Loss convincing and sometimes confusing evidence has suggested the 
existence of factors in immune serum (onzoian ot al., 1974) or in 
calf thymus (Kiger et al., 1972) or calf spleen (Garcia-Giralt 
1972) that can non-specifically suppress T cel1-iiediated immunity, 
and in some instances T cell proliferation. The array of factors 
identified have not, as yet, been characterised sufficiently to be 
directly comparable. It is possible that some instances of suppression 
could involve a variety of factors acting in different ways. Some may 
include inhibitors of a non.-iimuunologioal nature such as the tissue 
specific mitotic inhibitors, "cb1oraOs" (3u1lough & Rytomaã 1965). 
Despite the equivocal nature of some of this evidence, it would appear 
to justify the investigation into whether passively administered 
hyorimmulLe serum to oxazolone could suppress the proliferative response 
in normal animals. 
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?AIERIALS AND METHODS 
Mice 
3-4 conth old male mice of the inbred strain CBA/H were used. 
Itimunisation of mice 
Mice were sensitised with 10 mg of oxazolone dissolved in 0.1 ml of 
absolute alcohol at 600C. They were shaved on one side of the thorax 
and the oxazolone was applied with a pipette. Control mice were shaved 
and received 0.1 ml of hot alcohol. 
Preparation of sera 
L..ce were bled from the retroorbital plexus. The blood was allowed 
to clot at room temperature, the serum removed and stored at -600C. 
Leaaurement of DNA synthesis 
1251-labelled 5-iodo-2 0 -deoxyuridine ( 125 IUdR) was obtained from the 
Radiochemical Centre, Amersham, and was adjusted immediately before 
use to a specific activity of 6 mCi/mg by the addition of cold IUdRS 
Mice received 5 x 10 8  moles of 5-fluorodeoxyuridiue (FUdR, Roche 
Products, Ltd.) in 0.1 ml intraperitoneally one hour before receiving 
1 Pci Of 	in 0.1 ml by the same route (Hughes etal., 1964; 
Pritchard & Micklem, 1972). The mice were killed two hours later and 
the axillary and brachial lymph nodes and spleen were removed and 
fixed in 4% formaldehyde and alcohol. The tissuee were washed in 
125 70% alcohol for several days to remove unincorporated. 	I-UdR 
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(Elkins, 1970). The axillary and brachial nodes from one aide of the 
animal were counted together for 5 minutes, the apleens were counted 
separately for one minute, and the injected dose was counted in an 
Auto-Packard Gunma counter • The background counts were subtracted 
from the organ counts, and the counts per minute were adjusted to the 
counts that would have been obtained from an injected dose of 10 6  cpm. 
The calculation was therefore as follows: 
125 	 reount. from organ in cn x 10 uptake = log10 L 	iected dose in cpn 	61 
It can be seen that the terms 'cpm' cancel out, and the 5I-UdR uptake 
is the 10610 of the proportion of the injected dose that was 
incorporated.. 
Detection of antibodies to oxazolone 
The method of coupling sheep red cells (sheep cells in Alsevers, 
Tissue Culture Services Ltd., Slough) to oxazolone and the haexnagglutin-
ation technique were performed essentially as described by AskEase and 
Asherson (1972). 
1. Coupling of sheep erythrocytes to oxazolone 
Buffers: the buffers which were used were phosphate buffered saline 
(PBS), pH 74; Ethylenediamlnetetraacetic acid, disodium salt (EDTA), 
pH 8.4; and EDTA-aaline, pH 7.5. 
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Procedure: 0.25 mis of 1% oxazolone in ethanol (10 mg/mi) was squirted 
using a 1 ml syringe and a 27 gauge needle, into 10 mls of EDTA, pH 8.4. 
This was immediately added to 5 mis of 30% washed sheep erythrocytee in 
PBS • It is important that the oxazolone/EDTA mixture is added as soon 
as possible to the blood, otherwise a precipitate forms and coupling is 
unsuccessful. The oxazolone, EDTA and blood mixture was agitated 
gently at room temperature for 30 mina • The reaction was stopped by 
adding 4 vole of cold EDTA-ealine, pH 7.5. The cells were washed 3 
times in PBS. Some lysis of the red cells occurred during this 
procedure. 
The coupled cells were stored as a 5% suspension in PBS at 4 0C and were 
used either the same day or the next day. 
2. Direct haemagglutinat ion technique 
A 1:4 dilution of mouse serum which had been previously absorbed with 
sheep erythrocytea was serially diluted two fold (using Takataky loops) 
in 0.05 mis of PBS containing 2.5% normal rabbit serum in 'V' bottom 
znjcrotitre plates (Biocult Linbro is MCV 96). The contribution made 
by 198 (2-mercaptoethanol-sensitive) and 78 (2-mercaptoethanol-resiatant) 
antibodies was estimated. Each serum sample was diluted in duplicate 
rows of wells. 0.05 mia of 0.2 H 2-mercaptoethanol was added to each 
well of one row, the control wells received 0.05 mls of diluent. 
0.05 mis of 0.1% oxazolone-coupled red cells in diluent was then added 
to all wells. The plates were covered with a Microtitre plate sealer 
(Cooke Engineering Co.) and incubated at room temperature for 1-2 hours, 
and at 40C overnight before being read. The last well showing 
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agglutination was taken as the end point. 
3' 1eaagglut that ion technique to dstect class sDecifio inniunoglobuith 
Rabbit antisera against mouse immunoglobulins, YGl, YG2a, G2b, A 
and total (G (nomenclature after Herzembergpt ., 1969) were prepared 
by Josephine Riddaway as described by Pritchard et al., (1973). 
The following assay was kindly performed by Janice Lire • The direct 
haemagglut Inst ion technique was performed as described above • The 
plates were incubated overnight and the titrea of total antibody and 
ME-resistant antibody were read • The aupernatant was then removed 
without disturbing the pellet and 0.1 ml of dilute anti-serum added to 
the wells that had received mercaptoetbanol. The contents of the wells 
were resuspended, recovered and incubated overnight at 4
0 C • The last 
well to show agglutination was read as the end point. Pilot studies 
by Janice Ure showed the optimal dilution of rabbit anti-sera. Thus 
anti- YG was used at 1:800, anti- YG2b at 1:400, anti- YA at 1:400. 
Control sera were of two types: 
sera from immunised mice was tested against uncoupled red cells, 
sera from unimmised mice were tested against oxazolone-coupled 
red cells. 
The results are expressed as log2 of the titre. Thua if the greatest 
dilution to show agglutination was 1:4, this was expressed at 22. 
9 . 
EESULTS 
1. Antibodies in the sera of mice given one or two applications of 
oxazolone 
iice were painted with 10 og of oxazolone distributed between two shaved 
areas, one on each side of the flank. Half the mice were painted with 
a second application of 10 og of oxazolone on the same shaved regions, 
21 days after the first application. Individual mice were not bled 
more freqtEfltly than once every three weeks. The sera from these, mice 
were stored at -600C and used for the two experiments which are 
represented in Figs. 111.1-111.6. 
In Figs. 111.1 and 111.2, antibodies were detected by direct haemagglutiu-
ation. In Figs. 111.3 and 111.4 the same serum samples as used above 
were augmented with anti- V G sera. 
In a separate experiment, Figs. 111.8 and 111.6, the'esistant 
antibodies were augmented with class specific anti-mouse immunoglobulin 
era. 
Each point on a graph represents the mean titre of the sera from 5 mice. 
a) Undeveloped antibody, Figs. 111.1 and 111.2 
The primary response over 40 days is shown in Fig. 111.1. Sera from 
unitununised mice gave titres of 22  or less. No antibody above that 
found in uniminunised mice was found on days 3, 4 or 5 • On day 6 
however, antibody titrea, including both !1 and 2-ME resistant 
antibody were found at titres of 26_27;  the 2-ME resistant antibody 
appeared to be declining by day 28 and was no longer detectable by 
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day 40. The titres of 2-ME sensitive antibodies remained constant 
between days 14 and 40. 
The response to a second administration of oxazolone was measured 
3,7,14,20,35 and 42 days after the second dose. Antibody of titres 
27_28 were found on day 3 • This corresponds to the amount of 
antibody which was present in the sera before the administration of 
the second dose. Between days 7 and 14, however, there was a boost 
to the response, measured as an increase in the titre of both the 
total and the 2-ME resistant factions of antibodies. The total 
response appeared to decline between days 14 and 21 to a level of 
28 which remained constant over the time period studied. The response 
thus showed hiherrtitres of both JM and 2-ME resistant antibody 
over the whole period, than was found during the primary response 
(Fig. 111.1) and there was no decline in the levels of 2-ME resistant 
antibody. 
b) Developed antibody, Figs. 111.2 and 111.4 
The total antibody and the 2-ME resistant antibody were augmented with 
anti-KG sera, and the results ebown in Figs. 111.3 and 111.4. The 
primary response is shown in Fig. 111.3. It can be seen that the 
anti-sera developed antibodies on day 5 that had not been revealed 
using direct baemagglutination (Fig. 111.1). Titrea of 3 G reached 
210_211 on day 10 (possibly before) and remained at this level over 
the time period which was studied. Augmentation with anti-sera did not 
reveal a tall in the XG on day 21 as the previous results in Fig. 111.1 
had suggested. 
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The secondary response is shown in Fig. 111.4. The pattern of the 
response is similar to the undeveloped results (Fig. 111.2), but are 
all several wells higher. Unfortunately, the titres which were present 
on days 7 and 14 were above 216 and were not repeated to obtain the 
exact end-point. 
c) Augmentation of antibodies with anti- Gl, anti- Y G2a anti- G2b, 
Fig. 111.5 ahows the results of augmenting the 2ME-resistant antibody 
produced from mice which had been given a single applicatinn of oxazolone, 
with anti-sera against different classes of antibody. Sera from 
unimmunised mice gave titres below 22  in both direct and developed assays. 
The total ( G of the primary response appeared to consist predominantly 
of YG1. Some YG2a and Y G2b were detected but not until days 21 and 
35. The day 10 resulte for b' G2a and VG2b showed one mouse out of 5 
producing these classes of antibody. No augmentation was found with 
anti- A sera. 
Fig. 111.6 shows the results of developing the 2ME-resistant antibody 
from mice which had received 2 applications of oxazolone • Anti- b Gi 
and anti-'( G2a augmented the response almost to the same degree, 
although the day 8 response in S'Gl was too high to be measured exactly. 
There was augmentation by anti-ZFG2b serum. No development was 
produced with anti-A serum. 
2. The df ot of passively administered antibody on the proliferative 
response of lymph node cells to oxazolone. Table III • 1 
Hyperiinmune serum was obtained from mice 14 days after their third 
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exposure to oxazolone. Normal (unirradiated) mice were injected 
intravenously with hyperimmune serum or saline, followed one hour later 
by a skin application of oxazolone or alcohol. The following groups 
of mice were thus obtained: 
Group A received 0.125 mis of hyporimmune serum and oxazolone 
Group B received 0.125 mla of saline and oxazolone 
Group C received 0.125 mis of hyperiimnune serum and alcohol 
Group D received 0.125 mis of salino and alcohol 
The animals were injected with 125 1-UdR 3 and 6 days after they had 
received oxazolone or alcohol. The proliferative response in their 
draining axillary and brachial lymph nodes, and spleen were estimated 
by measuring the amount of 
125I-UdR that was incorporated. The 
response was measured 3 days after oxazolone in order to detect mainly 
T cells and 6 days after oxazolone to detect mainly B cells (Davies 
et al., 196b). As can be seen from Table 111.1, there was no 
significant difference in the amount of DNA synthetised by mice which 
had received serum and mice which had received saline, on either das y8 
or 6. 
Fig. 111.1 
Titres of heagg1utinating antibody in sera of CBA nice after receiving 
a single application of 10mg of oxazolone before addition of developing 
antig1obilin serum. Each point represents the mean titro, + SE. 
(, 2-E resistant; • , total; shaded area represents titrea 
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Fig. 111.2 
Titreg of haemagglutinatthg antibody in sera of CBA mice after 
receiving two applications of 10mg of oxazolone before addition 
of developing antiglobulin serum. Each point represents the 
mean titre, zt SE©, 2-ME resistant; • , total; shaded area 
represents titres produced by sara from unimmunised mice, U 
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Fig. 111.3. 
Titre* of haemagglutinating antibody in sera of CBA mice after 
receiving a single application of 10mg of oxazolone, after the 
addition of developing antiglobulin serum. Each point represents 
the mean titre, ± SE. CD, 2-ME resistant •; total; 	shaded 
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Fig. 111.4 
Titres of haOiagg1utinating antibody in aera of CBP i, after 
receiving 2 applications of 10mg of oxazolone, after addition of 
developing Antiglobul1i serum. Each point represents the 
mean titre, ± SE. @, 2-Ps resistant; •, total; 	shaded area 
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Fig, 111.5. 
Augmentation of 2 ME-resistant haemagglutinating antibody in 
aera of CM mice, after receiving a single application of 
oxazolone, with anti-. 'G serum; anti- b'G1 serum; anti-G 
serum; anti- 'G2b serum; anti- S'A sertzm. "Undeveloped 
antibody" represents haemagglutinatlng antibody in the absence 
of mercaptoethanol and developing anti-sera. The shaded areas 
represent 2-ME resistant antibody before addition of developing 
anti-serum. The dotted lines show titres obtained from the sera 
of unlinmunised mice. 
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Fig. 111.6 
Augmentation of 2ME-re.ietant haemagglutinating antibody in sera 
of CM mice, after receiving two applications of oxazolone, with 
anti- (G serum; anti- 'G serum; anti-'G serum; anti- YG2b 
serum; anti- A serum. 'Undeveloped antibody' represents 
haemagglutinating antibody in the absence of mercaptoethanol and 
developing anti-serum. The shaded areas represent 2-ME resistant 
antibody before addition of developing anti-serum. 
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TABLE 111.1. 
Effect of passive antibody on the proliferative response of the 
axillary and brachial lymph nodes and spleen 
125J1R mean ± SE 
oup No. Day.3 Day 6 mice 
Draining Contralateral Spleen Draining Contralateral Spleen 
A 4 3.15±0.006 2.66±0.12 3.82±0.02 2.95±0.03 2.11±0.14 3.88±0.03 
B 4 3.09 ± 0.08 2.51 + 0.10 3.80 ± 0.05 2.88 ± 0.06 2.15 ± 0.16 3.83 ± 0.20 
C 4 1.82±0.10 1.65±0.17 3 .00 ± 0 . 13 1.85±0 ,14 1.90±0.09 3 . 63 ± 0 .04 
D 4 1.69±0.16 1.76±9.06 3.15±0.09 2 .07 ± 0 .05 2 . 04 ± 0 .08 3.62±0.07 
Group A received hyperimmune serum and oxazolone 
B received saline and oxazolone 
go C received hyperimmune serum and alcohol 
of D received saline and alcohol 
M . 
DISCUSS ION 
The method of detecting antibodies to oxazolono was essentially the 
came as that described by Aekenase and Asherson (1972). They found 
that using a constant amount of oxazolone and increasing the numbers 
of sheep cells to be coupled, they detected less antibodies in the sera 
of unimmunised mice. In the present studies a mixture of 30% sheep 
red cells were coupled to oxazolone. Preliminary studies consisted of 
coupling 18% sheep red cells to oxazolone, but it was found that these 
coupled red cells detected fairly high titres in unimmunised mice, thus 
it was decided to use 30% sheep orythrocytes. All titrea obtained in 
those results were lower than the general levels obtained by Aøkenase 
and Asherson (1972), possibly because they coupled oxazolone to 15% 
hoop red cells. Thua in the present studios, the technique may have 
been detecting a narrow a ectruz f antibodies (of high avidity) 
compared to the study of Aekenao and Asherson. 
The antibody response to one and two 4pplications of oxazolone was 
examined to investigete whether there was a distinguished secondary 
response and to compare the features of this response to those obtained 
using well documented antigens such as heterologouc red cells • The 
response to a second dose of oxazolone was different from the first 
response, in that it reached titres of 211 (1:2048) compared to the peak 
response to the first antigen of 2 (1:178). The secondary response 
is thus considerably greater than can be accounted for by the sum of 
the antibody already present plus the antibody formed by a duplicate 
response. The studieu which were reported in Chapter II (Experiment 5) 
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suggested the existence of a Factor of Immunisation of oxazolone which 
was mediated definitely by T cells and possibly by B cells. The function 
of the T cells may only be concerned with the histological lesions 
associated with delayed response, but they could also contribute as 
'helper' cells to the memory component of the humoral response (iitchison, 
1971). 
The characteristics of a secondary humoral response to heterologOus red 
cells that distinguish it from a primary response have been well 
documented (Celada, 1971). They are as follows: 
(1) a reduced or absent lag period before the appearance of antibody 
forming cells; 
an earlier and higher peak of antibody forming cells and circulating 
antibody, often of higher affinity; 
an early bias towards the synthesis of 78 antibodies. 
Information about the features of the secondary humoral response to 
antigens that are grafted or paintød on the skin Is sparse (Celada, 1971). 
In the present studies mice were given a second dose of oxazolone 21 
days after the first. At this time, as can be seen from Fig. 111.1 
the primary response had not yet declined. In discussing the results 
shown in Fig. 111.2 it is therefore necessary to distinguish between. 
a boosted primary response and a true secondary response. A secondary 
response implies cellular differentiation as a result of contact with 
the second dose of antigen that is qualitatively different from the 
cellular differentiation that occurs as a result of initial contact 
between unprimed lymphocytes and antigen. In other words, according 
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to the X, Y, Z scheme of Sercarz and Coons (1962), in the present studies 
it is not possible to distinguish whether, as a result of the second 
application of ozo1one, more X cells are going to Z cells, or whether 
the Y cells are differentiating to Z cells. Nevertheless, within the 
limits imposed by this uncertainty it is possible to discuss the 
features of the secondary response to oxazolone with reference to the 
criteria described above. The presence of a reduced or absent lag 
period before the appearance of circulating antibody in the secondary response 
(Fig. :itI 2)' cannot be ascertained because it is obscured by the 
antibody present at the time the second dose was administered. Regarding 
the second criterion, higher titres of antibody were produced between 
days 7 and 14 of the secondary response than at any time of the primary 
response. There appeared to be little difference between the 
contribution of IS (2-PE resistant) and 193 to the titres of either 
the primary or the secondary response. The highest titrea of antibody 
produced during the secondary response occurred between days 7-14, not 
deaonetrably earlier than the peal. .titres which occurred during the 
primary response. The third criterion is not appropriate because (0 
was detected early during the primary response simultaneously with the 
detection of X U. It may be aigniiiccint that the 6G declined after 
day 21 during the primary response, although augmentation with anti-s G 
aerun did not confirm this trend. Thus quantitatively the response to 
a second dose of oxazolone was considerably greater (about twenty-fold 
between days 7 and 14) than the response to one dose of antigen. 
Figs. 111.5 and 111.6 are the results of experiments which utilised 
class-specific anti-aera to augment the antibody titres which were 
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detected during the primary and secondary responses. They suggest that 
there may be qualitative differences between the responses • In the 
primary response the major contribution to the '30 was made by 1(01 
antibody with some participation by G2a and very little G2b. In 
the secondary response, however, there was a considerably greater 
contribution made by 9G2a and )G2b. Anti- (A sera failed to detect 
any WA antibodies to oxazolone, which accords with the results reported 
by Askenase and Asherson (1972). This is not particularly surprising 
in view of what is known about IA. 'A is manufactured chiefly by 
the gut associated lymphoid tissue (Mandel & Asof sky, 1968; Guy-Grand 
et  a• 1974) and tends to be lost in various secretions (Tomasi & 
Zigelbaum, 1983; Tomasi et al., 1965; South et al., 1966). 	It is 
interesting that the present studies detected 3'02 antibody in both 
the primary and secondary responses, in view of the cytophilic nature 
of 'G2 (Nelson et al., 1967; Hay & Nelson, 1969) and Its possible role 
in mediating delayed hypersensitivity when attached to macrophages 
(Zembala & Asherson, 1970; Askenase, 1971; Parish, 1972). 
It seems conceivable that there could be qualitative differences in the 
antibody responses which are initiated by antigens which are painted 
on the skin and antigens, such as heterologous erythrocytea, which are 
injected intravenously or intraperitoneally. Such differences could 
arise from several sources • One is the nature of the antigen and the 
fact that low molecular weight seneitiethg agents combine with epidermal 
amino-groups. This produces ant igenic epitopes which may be more 
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similar to 'self-antigens' than are the epitopee found on heterologous 
erythrocytes. Secondly is the way the antigen is presented to the 
immunocompe tent cells and the involvement of macrophages. Thus 
oxazolone may reach the draining lymph nodes in soluble combination 
with protein in the lymph (Hall & Smith, 1971) which could affect the 
way it is handled by macrophages, its presentat ion and per. istance in 
an immunogenic form • These factors are important in determining the 
nature of the primary and secondary response (Celada, 1971). 
In experiment 2 an attempt was made to suppress the proliferative 
response of lymph node lymphocytes to oxazolone with passively 
administered antibody. It is well documented that passive antibody 
can suppress both Y M and the IG production by B cells in vivo 
(reviewed by Uhr & Moller, 1968) and in vitro (Lang 	j., 1969; 
Pierce, 1969; Feldmann & Diener, 1970). The way in which passive 
antibody affects delayed hypersensitivity is however equivocal. It is 
well known that passive antibody directed against allograftg may suppress 
the rejection process, a phenomenon known as "immunological enhancement" 
(Kaliss, 1988; Snell etal., 1960; Moller & Mller, 1966; Uhr & 
Mller, 1968). The manifestation of delayed hypersensitivity produced 
by antigen other than allografti appears to be less easily suppressed 
by passive antibody (Uhr & Moller, 1968) and indeed it has been shown 
that passive antibody can promote the delayed response (Liew & Parish, 1972). 
There is some evidence in the literature that the delayed response to 
sheep eryth.rocytes can be suppressed or diminished by passive antibody 
to sheep red cells (Axelrad, 1968; Mackaness et al., 1974), and Crowle 
and Th.i (1965, 1968) suppressed the delayed, but not the immediate, 
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hypersensitivity response to ovalbumin with passive antibody to 
ovalbumin. 
Indirect evidence that anitbody may regulate the extent of the 
histological lesion associated with some types of delayed hypersensitiv-. 
ity stems from the experiments of Turk et al. (1972 1973). They 
found that pretreating guinea-pigs with cyclophosphamide 3 days before 
gensitisation with dinitrofluorobenzene (DNPB) results in an increase in 
the intensity and duration of the contact senaitisation response which 
is elicited by challenge with DNFB. The results of experiment 2 failed 
to detect any affect of anti-sore against oxazolone on the proliferative 
response of lymph node cells to oxazolone. It was reasoned that the 
anti-sera could act by either combining with antigen and th'Ia Inhibiting 
the recognition of antigen by antigen sensitive T cells, or by acting 
directly on antigen sensitive lymphocytes. The antibody was administered 
on the same day as the oxazolâne as has been shown to be necessary to 
elicit a suppressive response with other antigens (Lang., 1969; 
Pierce, 1969; Moller & Wig&ell, 1965). A criticism of the experiment 
is that only one injection of hyperiznmune serum was administered and 
previous workers who achieved suppression used anti-sera daily for 
7 days (Crowle & Hu, 1965, 1968) or for 3 days (Axelrad, 1968). 
Some corroboration of these results is provided by Turk et al. (1972), 
who did not detect an increase in paracortical proliferation in the 
lymph nodes of cyclophoiphamide treated guinea-pigs, and Mackanesa 
et al. (1974) who suppressed the delayed hypersensitivity response to 
sheep erythrocytea by passively adminiateredM without suppressing the 
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uptalce of 3E-thyaidine in the draining lyrph nodes. 
There is little inforeation in the literature regarding the effect of 
antibody on T cell proliferation. There is however evidence froz3 a 
variety of sources that a factor can be isolated from ianune sera or 
lyiiiphoid organs that can suppress, aoaspecifically, T cell teioted 
jamunity, an enplo of such a factor is "Iraunoregulatory Aiphaglobulin". 
The relationship between 'Iimunoregu1atory Aiphaglobulin' and the other 
T cell suppressive factors that have been reported (Lowbray, 1903; 
Caenter et al., 197; Care ia-Giralt at al., 1972; Kiger at al., 1972; 
Aabroso, 1973) is unhnovn. These reports include several examples 
whore the factor has been postulated as preventing T cell activation 
and proliferation (Cooperband at 01. 1972; Carpenter at al., 197i 
CarciaGirait etal., 1972). It is conceivable that some of the 
factors involved in suppressing T cell proliferation in the above 
oxmples are tasue-specif Ic mitotic inhibitors such as 'chaloaos' 
(8i1loub & LIytcmaa, 1965). Evidently some mechanism regulates and 
suppresses T cell proliferation, the nature of the nzochanisn, whether 
it io a class of antibody or a factor released by T cells, or indeed 
other coils remains unmown. 
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•jii1 ;4 
1. Antibody of Classes I G1, Y G2a, YG2b and I i against oxazolone, 
were detected in the sera of mice which had been immunised with 
oxazolone, confirming the results of Askenase and Asherson (1972). 
2 • The response to a second dose of oxazolone was distinguishable 
from the response to one dose by the following features: 
the titres of antibody produced in the secondary response 
were greater than those produced during the primaryf 
response. 
there were more antibodies of the class ' G2 produced during 
the secondary response. 
3. No experimental evidence was obtained to suggest that the mechanism 
which regulates the proliferation of lymphocytes to oxazolone 
includes factors in hyperimmune serum. 
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HAPTERS IV & V 
CELL RE(IUTh4ENT DURING THE RESP(48E TO OXAZOLONE 
The important phenomenon that lymphoid tissues respond to antigen 
primarily by means of the cells circulating thxo ugh them, as q)posed 
to residential cells, was demonstrated by experiments that showed 
heavily irradiated lymph node (Ball & Morris, 1984) or spleen 
(Taliaferro & Taliaferro, 1956; Ford & Gowans, 1967) were capable of 
giving normal haemolysin responses, provided they were perfused with 
lymphocyte rich medium. The recruitment of circulating cella by 
antigen stimulated lymphoid tissue is therefore an early event in the 
initiation of the immune response. It follows that an understanding 
of the kinetics of cell circulation, the factors that govern it and 
the mechanism of cell recruitment must provide insight into the 
initiation and possibly regulation of the bximune response. 
chapter IV describes the development of an isotopic label, hitherto 
unused to study cell localisation. Chapter V is a study of the kinetics 
of cell recruitment during the response to exazolone. The following 
account briefly describes our present understanding of lymphocyte 
circulation and recruitment. 
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INmceuc'rIoN 
1. Lymphocyte Circulation 
1*. The kinetics of T and B cell circulation 
Early experiments (1936-1965) which involved the measurement of 
lymphocyte output from the thoracic duct of various animals revealed 
that the ntwber of cells entering the blood each day was in excess of 
the number present in the blood (reviewed by Gowans, 1966). A 
possible explanation for this phenomenon was the existence of a continuous 
reciroulation of cells between the blood and the lymph. The demonstra-
tion that the profound fall in output of lymphocytes which occurs during 
the chronic drainage from a thoracic duct cannula (Mann & Higgins, 1950) 
could be prevented in rats by the continual infusion of small lyzphocyte$ 
(Gowans, 1967) and that thoracic duct cells were not newly formed 
(Gowans, 1957) supported this contention. The direct evidence which 
demonstrated blood to lymph circulation was the infusion of 32 P labelled 
(Gowens, 1957) or 51Cr labelled (Shorter & Bollmn, 1960) lymphocytes 
intravenously into syngeneic rats and the subsequent recovery of large 
ni.ber of labelled cells in the thoracic duct. Additional support, 
this time in sheep, was provided by Hall & Morris (1964) who showed 
that the cells present in the efferent lymphatics of a peripheral lymph 
node were not newly formed by the lymph node. 
The major route of lymphocytes from blood to lymph is through the 
lymph nodes (Gowans & Knight, 1964). The main point of entry is 
through the post-capillary venules (Gowans & Knight , 1964) and the main 
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exists are the efferent lymphatic. (Ball & Morris, 1962, 1963, 1964, 
1965). Recirculating lymphocytes also pass through the spleen, 
entering and probably leaving by vascular channels • Evidence for this 
route of circulation was provided by experiments which involved the 
intravenous itJeotion of labelled lymphocytes which migrated to the 
spleen (Gowans & Knight, 1964; Goldechneider & McGregor, 1968a; 
Parrott & de Sousa • 1971) and the fact that spleen, became depleted 
of cells after thoracic duct drainage (McGregor & Gowana • 196a; 
Goldsohneider & McGregor, 19685; Spr.nt, 1973) or extracorporeal 
irradiation of the blood in the calf (Cottier etal., 1984). 
In young adult rats the output of colic from the thoracic duct falls 
precipitously over three days of drainage until a total of about 
2 x 109 cells have been withdrawn; after five days the output levels 
off at a value approximately 10-20% of that on the first day (Cowan., 
1957; Caffrey It Al.j 1962; McGregor & Gowans, 1963) • A similar 
pattern of cell depletion is found during thoracic duct drainage of 
mice (Sprent, 1973). This pattern of mobilication suggests the 
presence of two populations of cells, a rapidly and a slowly re-
circulating population. It is conceivable that the cells obtained 
after 48 hours of drainage may not be a normal recirculating pool and 
may only be obtained as a result of the abnormal stress imposed by 
chronic cell depletion (Cowan. & Knight, 1964). 
Thoracic duct lymphocytes consist of about 80% T cells (Miller & 
Sprent, 1971). In order to study the circulation of the T cell 
component advantage was taken of the fact that T cells from rats 
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incorporate about fifteen times as much 3H-uridine as B cells 
(Howard et 81., 1972). Ford and Siiznond (1972) studied the time 
taken for 3E-uridine labelled thoracic duct cells to travel from blood 
to lymph in splenectomised rate. They found a transit time across 
lymph nodes of 12-18 hours as opposed to a spleen trait period of 
2-6 hOurs (Ford, 1009; Bradfield & Born, 1973). Forc (1969) 
calculated the size of the intrasplenic pool of recirculating small 
lymphocytes (in the rat) to be probably 400-500 x 106 cells. This 
pool belongs to the same pool of cells that recirculate through the 
lymph nodes (Ford, 1960; Bradfield & Born, 1073) and is probably mainly 
T cells (prent, 1973). 
Evidence that the B cello present in thoracic duct lymph are recircul-
ating cells stems from studies on the thoracic duct lymphocytes of 
'3' rats (Howard, 1972), 'B' mice and athymic flu/flu mice (Sprout, 
1973). Howard (1972) showed the thoracic duct lymph of 'B' rats 
contained 26% as many lyuphocytes as normal thoracic cuct lyni, and 
* aimilar long lived nature. There are differences in patterns of 
recirculat ion between T and B lymphocytes. Sprent (1973) compared 
the distribution of "Cr labelled normal thoracic duct lymphocytes 
(TDL) and TDL from 'B' mice or mu/nu mice in syngeneic recipients. 
Cimilar quantities of B TDL and normal TDL localised in the apleen four 
hcurs after intravenous inject ion, but more mormal TDL tere found in 
the lymph nodes • The movement of cells from spleen to lymph nodes, 
between four and twenty-four hours that characteristically occurs with 
normal TDL and lymph node cells (Zatz and Lance, 1070) was absent using 
1 3' T1)L. This result may suggest a propensity for B cells to 
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circulate through the spleen at a slower rate than T celia, and this 
suggestion is supported by experiments which have shown it. takes 
longer to mobiliøe B cells by thoracic duct drainage than T cells. 
After the intravenous injection of labelled rat TDL into syngeneic 
recipients the peak recovery of cells issuing from the thoracic duct 
occurred after about eighteen hours of drainage, with low levels of 
recovery occurring after 24-36 hours (Ford & SirnTonds, 1972). Howard 
(1872), however, discovered that during thoracic duct drainago of 'B' 
rats, low numbers of cells were recovered after 18 hours compared to 
normal rats but there was a steady flow of cells between 18-48 hours. 
The possibility that the later phase of recovery represented B cell 
mobilisation was also suggested by the finding that the ratio of B/T 
cells in the thoracio duct lymph of mice increased from 15% after 
12 hours of drainage to 50 after four days (Sprent, 1973) • Continuous 
drainage of lymphocytes for three days was sufficient to produce depletion 
of T areas of spleen but in Nu/Nu mice no depletion of B areas was 
found after the sane treatment (Sprent, 1973). 
There is evidence that many of the circulating B cells are memory cells 
and that unprimed B cells are newly formed seseile lynphoáytes (Strober, 
1972; Strober & Dilley, 1973a, 1073b). 
lb. Circulation within the lymph nodes and spleen 
It is well established that within the secondary lymphoid tissue there 
are discrete compartments to which T and 8 cells preferentially migrate 
and occupy (Parrott & de Sousa, 1071; do Sousa, 1973). Lyinphoid 
tissue has been termed ecotaxis We Sousa, 1971) and elucidating the 
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mechanisms which control it may contribute to the understanding of how 
antigen and adjuvauts affect cell traffic through lymphoid tissue. 
Experiments of two types established the existence of T dependent areas 
within the peripheral lymphoid tissue: 
Histological examination of the 131mph bodes and spleen from 
neonatally thymectomieed rate (Wakeman et al.,1962) and mice (Parrott 
etal., 1966), nu/nu Dice (do Sousa etal., 1969; do Sousa & Pritchard, 
1974), adult thyzuectomised, bone marrow reconstituted mice (Davies et 
al., 1969a, 1969b, 1970), and children with di George's syndrome 
(Cleveland ot al., 1968; Auguat, 	al 1970) revealed a paucity of 
cells within the paracortex and the post-capillary venules of the lymph 
nodes and the per iarteriolar sheath of the splenic Malpighian body. 
Isotopically labelled cell populations from various sources 
migrated to distinct areas; labelled thoracic duct cells and thymocytes 
migrated predominantly to T dppendent areas (Gowana & Knight, 1964; 
1rrott et al. • 1968; Parrott, 1967; Goldschneider & McGregor, 19685; 
Ford, 1969; Parrott & de Sousa, 1969; Bradfield & Born, 1973; 
Sprent, 1973). Spleen cells tended to spread over various compartments 
(Parrott et al., 1966; Parrott, 1967; Parrott & do Sousa, 1969; 
Mitchell, 1972). Lymph node cells migrated primarily to T dependent 
territory (Salfour et al., 1971) but also to the peripheral nodules 
of lymph nodes (Austin, 1969). The cella that were found to migrate 
to T independent areas were bone marrow cells (Parrott & do Sousa, 1971; 
de Sousa, 1971), thoracic duct lymphocytes from 'B' mice (Howard, 1972; 
Sprent, 1973) and nu/nu mice (Sprent, 1973), spleen cells from 'B' 
mice (Mitchell, 1972) and Ig positive lymph node cells from 'B' mice 
(Gutman & Weisamnp, 1973). 
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These experiments established the T dependent areas to be the para-
cortex in the lymph nodes and the periarteriolar sheath of the spleen. 
The areas usually not occupied by T cells are the superficial cortex, 
eiina1 centres and medulla of the lymph nodes and the red pulp, 
orminal centres and surrounding corona in the spleen. T and 3 co11 
do, however, share some comon territory. Both cell types enter 
lymph nodes by the poøt capillary venules (Cutnan & Weissmera, 1973; 
Niewezihuis & Ford, 1974). The T coils proceed thromgb the paracortex 
to the offerent lymphat ice, but the B cells move towards the thperuicia1 
cortex to localise mainly in the germinal centres from where they return 7 
to the medulla to enter the efferent lymph. B and T cells also share 
a common point of entry to the aplenic follicles through the sinus in 
the marginal zone where they show no preference for specific arcas 
(Litchoil, 1972; Cutman & Weisemsa, 1073; Niewenhuis C4 Ford, 1974). 
T cells migrate to the poriartoriolar sheath and 3 cells localise 
mainly in the lymphatic corona around the germinal centres and in the 
germinal centres. Bone marrow coils tend to localise in the red pulp 
(do Sousa, 1971). The routes by which cells leave the spleen are not 
clear, T lymphocytes possibly leave the periartoriolar sheath to the 
venous sinus by bridging channels across the marginal zone (Mitchell, 973). 
The transit time of B Ocils through the spleen is thought to be longer 
than the 6-6 hours time of T cells (Ford, 1975). 
Various factors could dotermine the segregation of cells  into these 
compartments. They include the mrchitccturo of the lymphoid organs 
and properties of the lymphocyte membrane. Examination of the roticulin 
framework of the lymphoid organs has not revealed any barriers wtween 
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the primary nodule and the rest of the lymph node cortex or between the 
outer and inner layers of the Malpighian follicle in the spleen (Denz, 
1947; de Sousa, 1969). Zonal differences do, however, exist that 
coincide with the thymue dependent and independent areas. The 
reticulin fibres in the mid cortex of lymph nodes and the periarteriolar 
sheath of the spleen are arranged in an open pattern (Denz, 1947; 
Sainte.-Marie & Sin, 1968), whereas the medulla and red pulp of the spleen 
have a comparatively close network • This raises the possibility that 
some characterieticaof T lymphocytes attracts them to the open network 
and similarly some property of B lymphocytes may attract and retain 
them in the close network. A possible mechanism for the latter may lie 
in the existence of a mesh of dendritic cells with long cytop]aamio 
p frocessea which IS found in T independent areas (White, 1963; Miller & 
Nossal, 1964) and which possesses intercellular deposits of immtmoglobulin 
(1lfour & humphrey, 1967). It is known that B cells possess ig 
receptors (Raff, 1970), receptors for Pc pieces (Basten et al., 1971) 
and C '3 (Bianco ot al., 1970). It is conceivable that the prominent 
exposure of these receptors would enable the cells to become entangled 
in the areas where innnunoglobulin and ant igen/antibody complexes are 
deposited. At present there is no experimental evidence to support 
this contention and indeed an attempt to demonstrate that local antign/ 
antibody complexes attract primed cells was unsuccessful (Balfour ot al., 
1971). 
lc, Circulation of activated T and B cells 	/ 
There is evidence that some recently activated lymphocyte., that is 
lymphoblasts, stop recirculating and extravasate from the circulation 
to areas such as intestinal mucosa, akin and possibly other non-lymphoid 
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tissue. 
5-10 of rat thoracic duct cells are large lymphocytes (flarcheai and 
Gowana, 1964). When these celia were labelled with tritiated 
thymidine and injected into syngeneic rec, large numbers were 
found in the lemma propria of the small intestine (Gowane & Inight, 
1964; (3riscelli etal., 1969; Guy-Grand etal., 1974). These cells 
contain prominent endoplasmic reticulum and are therefore possibly B 
cells (riarchesi & Cowans, 1964). The lyanphoblasts induced in the 
thoracic duct by a variety of antigens also homed predominantly to the 
small intestine (Smith & Ifall, 1971; Hall etal., 1972; Halatead & 
W11, 1972; Parrott & Ferguson, 164). The antigens that were used 
in the above experiments, Bordtella pertuss ia, Corynybacterium parvum, 
bovine gemmaglobulin, sheep red cells, tumuur cells, hunnn influenza 
vaccine and Nippostronjyiva, do not exclude the possibility that some of 
the lymphocytes were T cells, but evidence suggests that many of the 
coils found in the inte8tine were B celia • For example, some of the 
large lymphocytes in the lemma propria differentiated into plasma 
cells (Smith & Mali, 1971; Mall et al., 1972) and many contained IA 
(Guy-Grand et al., 1974). It is interesting that the majority of 
immunoglobulmn containing TDL contain predominently 'A, in striking 
contrast to the YM and IG content of spleen and peripheral lymph node 
cells (Jensenius & Williams, 1974; Guy-Grand at al., 1974). Peyor's 
patches and the mesenteric lymph nodes are also rich sources of 3A 
(Cuy-Graud et al., 1974; Tornasi Bienenstock, 1968) The 
search for a correlation between the 'A producing cells in the gut 
associated lymphoid tissue (GALT), TDL and the propensity for TDL to 
119. 
hco to the get has led to the aJMzcept of a YA cycle (CuyCrand ot 
1974; Ford, 1975). Jfter ant2.gonic et2nulation, the Peyer's patches 
release YA producing cells which reach the thoracic duct lymph via 
the cesonteric nodes and efforent licpbatics. The coils are distributed 
by the blOod and home in large numbers to the lemma propria, and in 
lesser numbers to the spleen, lymph nodes and probably elsewhere. The 
GPÔLT cay not be the only source of lymphoblasts that hoce to the intestine. 
This is sucated by the experiments of aall et al. (1972) and Milatead 
& gall (1972) which demonstrated that stimulating animals in the loge with 
a variety of antigens produced lymphoblaste in the thoracic duct that 
homed in large numbers (after 24 hours, 80% of the recoverable radioa 
activity) to the small intestino. liall et al. (1972) point out that 
the commithont of a large proportion of each generation of newly formed 
activatod coils to protect the out wu1d be immunologically advantageous, 
for the gut has a large surface area and is continually exposed to 
foroige antigens such as bacteria and pathogons. The fate 0f the 
lymphoid cells that settle in the lamnie propria Is unImoim. 
o factors which attract or cause binat coils to migrate out of the 
intestinal capillaries are unknown • The suggestion that the But 
antigen that produced the blast collo directs their homing (incon 
otaL, 1968), seems untenable in view of the migration of activated 
TL to the gut of unsuckled neonates (a1stead & Ul1, 1972) and to 
foetal gut transplants (Parrott & Ferguson, 1974; Guy-Grand 
1974). Large lymphocytes produced in the mesenteric lymph nodes tend 
to return to mesentoric lymph modes (Gricol1i ot ml., 1909; Guy-
Grand ot al., 1974) or the intestine (Dineen et al., 1960; 
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Guy-Grand et al., 1974) suggesting a possible affinity between A 
producing celia and the intestinal muooga. 
Any conclusions regarding the nigration of activated T cells to the gut 
are tentative at present, but a consensus of opinion from the available 
evidence would probably be that activated T cells migrate to the gut in 
smaller amounte than activated B cells. Parrott and Ferguson (1974) 
found that 3H-thyznidine labelled lyuiphoblasts from mesenteric nodes of 
young nice and mice injected with Nippoetrongylus brasiliensis were found 
in Peyer 'a patches and the lemma propria, while lymphoblasta from 
oxazolone priied lymph nodes did not migrate to villi • Ford and 
Sedgely (reported in Ford, 1875) produced activated T cells by injecting 
parental strain thymocytes into irradiated F1 hybrids and collected 
the TDL 3-5 days later. Large numbers of activated T cells were found 
in spleen and Peyer's patches, but very few in the lamina propria. A 
similar result was obtained by Herbert oni (pers. cmm.), using the 
same source of activated T cells and labelling with 25 I-UdR, who 
found 1-4% of activated T cells ln'the:lAming propria compared to 
10-20% of normal TDL. These results are in contrast to those obtained 
by Sprent and ri1ler (1972b) who also used cells activated by injecting 
parental thymocytes into irradiated F1 recipients. The TDL were labelled 
with 3H-thymidine or Cr and they found that after injection into 
syngenoic recipients the activated cells had a greater affinity for the 
gut than normal TDL. 
There is accordance however that some populations of activated T celia 
extravasate into areas of inflammation. Lymph node cells removed 
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4 days after the donor mice had received oxazolone and labelled with 
51 	125 	
eOXS 
Cr or 	IUdR migrated to inflamed / (Aeherson et al., 1973a; Slese & 
Parrott, per. • comm.). The cells were found to be T lymphoblasts and the 
propensity for blast cells to migrate rather than the small lymphocytes 
present in the population was ahown by the fact that a greater percen-
tage of 125 
	labelled cells migrated to the ears than the same cells 
labelled with Cr. Blast cells present in the thoracic duct of rats 
immunised against Listeria, do not recirculate (UcGregor et a]., 1971) and 
move to sites of inflammation (Kosteretal., 1971; ioster & McGregor, 
1973). Rosentreich et a].. (1971) showed that peritoneal exudate cells 
in imnunised guinea pigs were short lived cells able to mediate delayed 
hypersensitivity, providing indirect evidence that T lymphoblasts move 
to sites of inflammation. 
The long term fate and function of these cells is unknown, although 
some have been shown to transfer adoptive immunity against the antigen 
that produced them (Koater et al., 1971; Koater & McGregor, 1971), and 
Sprent and Miller (1972o) found that activated TDL were specifically 
cytotoxic in vitro and invivo. 
2. Lymphocyte recruitment 
Antigen has two discernible effects on lymphocyte circulation: one is 
the nonapecif Ic retardation of cell tratf Ic through the stimulated 
lymph node or spleen, the second is the specific selection of antigen 
sensitive cells. The relationship between these phenomena is not 
clear. 
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2a. 9pecif to recruithent 
The most convincing expericents which dernonstrate selective recruitcent 
are 
those that show selective depletion of antigen reactive coils in 
the circulating pool 24-36 hours after antigen a&iinistration. TDL 
collected 24-36 hours after the intravenous injection of sheep 
orythrocytes were unable to transfer a primary response to irradiated 
recipients, although the response to a non-cross-reacting antigen was 
not impaired in mice (Spront et al. , 1971) and rats (Rowely et al., 
1972). The response was restored five days later. Similarly, 
circulating' 1-12 reactive cells wore depleted in mice or rate stimulated 
with hietocompatibility antigens. Parental TDL from mice (pront 
et ml., 1971) or rats (Rowley ot aL, 1972) that had received F1 coils 
2 days earlier cave a doproesed graft vs host response when injected 
into the F1 strain that had been used to inmuniso but cave a normal 
response In a third party hybrid recipient. The response was 
restored when TDL were removed and tested 3 days after the inject ion 
02 F1 cells, and gave a heightened graft vs host response when removed 
5 days after larnunjeation. The reciprocal experiment to the above, 
which demonstrated the same phenoeuon, involved draining the TDL from F1 
rats that had received parental coils 1-2 days earlior. 75 o? the TDL 
wore of parental strain origin, and gave a reduced graft vs host activity 
cainat the F1 recipient strain, but not a third party F1 (Ford c Atkins, 
1971). The spleen and lymph nodes of the hybrid recipients had there-
foro filtered andremoved specific 142 reactive cells from the circulation. 
The spleene from irradiated rabbits which had been injected with bone-
mrrow cells from normal rabbits produced plaque forming colic in 
response to sheep erythrocytes and horse orythrocytes, however the 
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ability of bone-marrow to transfer responses to sheep red cells was 
abrogated by giving the bone-marrow donors sheep red cells 8-24 hours 
before transfer. This treatment did not depress the response to horse 
red cells (Abdou & Richter, 1969). This experiment suggests that 
the bone-marrow of these rabbits contained iminunoconipetent cells that 
were recruited 8-24 hours after the intravenous injection of antigen. 
The diffictUty in interpreting these experiments in terms of the 
recruitment of antigen reactive cells is the possibility that some 
other factors could be involved. The transience of the phenomena 
however supports the recruitment explanation rather than some form of 
tolerance. 
A more direct method of demonstrating the retention of cells in the 
stimulated organ at the expense of the circulating population is to 
use a double isotopic labelling technique. Atkins and Ford (e!rd, 
1975) labelled parental strain lymphocytes with either 3H- or 
uridine and injected them into F 1 recipients together with an unreapon-
sive population (F1 hybrid or tolerant parental lymphocytes) labelled 
with the alternative isotope. By 24 hours the label of the responsive 
population was always in surplus in the spleen and deficient in the 
thoracic duct lymph. 
Tess -experimenta demonstrate that unprimed- T--cells -are--specifically 
recruited. There is no real evidence that unprimed B cells are 
recruited or that they circulate (Strober & Dilley, 1973a, 1973b). 
The question of specificity has also been applied to the recruitment 
of primed cells, where both T and B cells are involved. (Rowley et al, 
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1972). Experiments have deuonstrated the specfiC depletion of antigen 
primed cells in the circulation following antigenic stimulation. The 
TDL frau a rat that had been primed to tetanus toxoid were unable to 
transfer a secondary response to an irradiated recipient if the donor 
had received tetanus toxoid 24 hours before transfer. The spleen, 
however, transferred the response during this period (Rowley 	al. 
1972). TDL from donors immunised to tetanus toxoid and swine 
influenza virus were added to the perfusate of an isolated spleen that 
had received tetanus toxoid or a control antigen 3 hours previously. 
Coils specifically responsive to tetanus toxoid accumulated in the 
spleen over a 10 hour period. This was shown by the inability of 
the perfusate to transfer a baeiolysin response to tetanus toxoid, 
and the ability Of perfused spleen fragments to transfer the response 
(Ford1 1972). Although this experiment demonstrated by functional 
moans the recruitment of cells responsive to tetanus toxoid, a double 
labelling experiment failed to confirm the phenomenon. Ford (1972) 
labelled cells primed to tetanus toxoid with 3H-uridine and normal 
cells with 14C-uridine and compared their accumulation in the isolated 
spleen 24 hours after challenge with tetanus toxoid • He I oid the 
ratio of radioactivity produced by immune cells to the amount of 
radioactivity associated with normal eells asconsistently unity. 
Possible explanations for the failure of t:ia experiment to reveal 
specific recruiient could be that the donors were labelled several 
weeks after immunisat ion, and thus many non-immune cells would also 
become labelled. There may therefore have been too few labelled antigen 
reactive cells; also 3H-uridine could underestimate the contribution 
wade by specific B cells • Other double labelling experiments have 
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however detected differences in the recruitment of immune and non-immune 
lymphocyte populations. Emeson and Thurah (1971) compared the distrib-
Ut ion of immune and non-immune lymphocytes that had been imnunised to 
HZ antigens and heterologous red cells (Thurah & Emeson, 1972) and 
labelled in vivo with 311-thvmidine or 14C-thymidine. Each recipient 
received memory cells to one antigen (fox example, sheep red celia) 
labelled with 3H-thymidine and memory celia to the other antigen (chicken 
red celia) labelled with 34C-thymidine. The recipients were injected 
subcutaneously (or grafted in the B2 experiment) with sheep erythrocytes 
in one flank and chicken red cells in the contralateral flank. They 
measured the ratio of label associated with the immune population to 
that associated with the non-immune population in the lymph nodes 
draining both flanks. The 'non-immune' population was the immune 
population to the alternative antigen. After 24 hours they found 
memory cells to one antigen had preferentially accumulated in the 
lymph nodes that had been stimulated to that antigen. If there had 
been no preferential accumulation of cells, the ratio of label from 
immune to non-immune cells would have been unity. They found a ratio 
in the H2 system of 1.08 or 1.00 and in the erythrocyte system of 
lf 1-2. Thus although the figures were significantly different from 
the Null hypothesis (P( 0.01) they showed that specific accumulation 
accounts f or only a small proportion of the cells retarded by the 
draining lymph nodes. 
2b. Non-gpecific recruitment 
Antigen-induced retardation of cell traffic through a lymph node 
was first noticed by Hall and Morris (1962, 1963, 1965) who reported 
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a depression in the number of cells in the efferent lymph draining sheep 
popliteal nodes. They found a 50% decrease in cell number within 
30 mini of the subcutaneous administration of antigen, which fell to 
20% between 2-3 hours, and was restored to normal 5 hours after antigen 
(Ball & 1Lorria, 1965). Although this effect could be due to a reduced 
entry of lymphocytes from the blood, Ford (1969) showed that a large 
dose of sheep red cells did not alter the entry of calls from the 
perfusate into an isolated spleen, but did inhibit their exit. 
Subsequent experiments utilised isotopically labelled lymphocytes 
which were infused into syngeneic recipients which had been immunised. 
An accumulation of radioactivity in the stimulated lymphoid tissue 
was subsequently found (Zatz & Lance, 1971a, 1971b; Exneson & Thursh, 
1971; Ford, 1972; Thureh & Emeson, 1972; Frost & Lance, 1974a, 
l974b). 
Antigen that is injected intravenously or intraperitoneally attracts 
cells to the spleen and antigen that is administered subcutaneously 
attracts them to the draining lymph rddes (Zatz & Lance, 1971a). The 
time taken to initiate the 'lymphocyte trap' and the period it lasts 
varies with the antigen and the experimental design, but antigen-
mediated accumulation of lymphocytes can be detected as early as 30 mini 
after antigen (Hall & I1orria, 1965; Zatz & Lance, 1971a) and may still 
be present after 72 hours (Zatz & Lance, 197la) • Greatest accumulation 
probably occurs between 12-48 hours after antigen (Zatz & Lance, 1971a; 
Ford, 1968; Thurab & Emeson, 1972). A variety of antigens olicLt the 
recruitment of circulating cells. Hal]. & Morris (1965) using sheep, 
demonstrated that human serum albumin, ovalbumin, Salmonella typhi 
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organ isze, chicken red cells, Liateria conoclto&enea, and Ascari s 
lumbricoides were effective. By niesauring the accuzziulation of 
51Cr labelled iytpbocytea in ciice, Frost and Lance (1074a, 174b) found 
the soluble antigens bovine gaa globulin, bovine serum albumin and 
tetanui toxoid to be ineffective in unprired anirale, but 'bcauee cell 
trapping in primed animals. These re.4te appear to be at variance 
with those of Hall and iori-is (1905). Other antigens that cause 
trapping are allografte (Eceson & Thursh, 1971; Frcit & Lance, 19744), 
sheep red cells (Thurab & Eineson, 1072; Ford, 1968, 1969; rost & 
Lance, 1974a) ,chioken red cells (thurs.b 1mes6n, 1972), keyhole limpet 
basmocyanin • Salmonella B antigen, pneumococcsl polysacharide III, tumour 
extracts, xenogenic sara, heat agglutinated bovine gamma globulin, and 
xenogenic grafts (Frost & Lance, 1074a). 
Conventional immunogene are not the only substances that cause 
accumulation of circulating lymphocytes in locally stimulated lymphoid 
tissue, other substances include adjuvants (Taub et al., 1070; 
Dresser et al., 1970; Frost & Lance, 1074b) and particles such as 
latex, silica, carbon and carageenan (Frost & Lance, 1074b). The 
duration, lasting several weeks, of trapping caused by adjuvante is 
prolonged compared to that caused by antiena. The magnitude is 
similar to that produea by strong irmiunogens with the exception of 
ç,, parvum which ehows particularly strong trapping of a phonic mature. 
It has been postulated (Frost & Lance, 1074b) that adjuvants cay in 
part owe their adjuvanticity to their ability to trap cells. This 
hypothesis must remain valid until the discovery of an adjuvant, as 
censured by Its effect on the antibody response to a weak immunoen, 
MIM 
which does not cause the local accumulation of circulating cells. The 
tagitude of trapping caused by particles is similar to that elicited by 
and the duration is variable. 
Another effect antigen or antigen-cell interactions may produce that 
could facilitate the exchange of cells between blood and lymph node 
to to increase the permeability of the local vascular system (Kelly 
et al., 1972; May et al., 1973; May, 1973). During a primary response, 
not only vascular dilation, but redistribution and enlargement of the 
lymph node vascular network occurs (Merman et al., 1972). Whether 
these changes oocur rapidly enough to account for the increase in cell 
recruitment within one hour of antigen is questionable. 
20. Iechanisos of cell recruitment 
To understand the mechanisms of cell recruitment it is important to 
elucidate the relationship between the non-specific and the opocif La 
phenomena. A gross alteration in cell traffic would alloti more time 
for the soloctivo mechanism to select antigen reactive cells. This 
argument is only valid if the normal rate of movement of cells through 
a stimulated organ is too slow to allow the efficient depletion that 
has been demonstrated. It is possible that the retardation of 
lymphocytes that are traversing the substance of the node or spleen 
serves some other function, for etp1e, it has been shown that a tightly 
packed anoxic environment favours blast transformation (roorhead et al., 
i7). At present too little is Imown to confidently relate the 
specific and non-specific phenomena. 
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Non-specific recruitment, whatever its function, is undoubtedly mediated 
by antigen. The possible types of interaction are as follows: 
(1) Interaction between lymphocytes and antigen, within or 
outside the lymph node, that releases some factor which 
alters lymph node architecture and hinders the movement 
of celia. 
(ii) Interaction between antigen and macrophages, resulting in an 
alteration of macrophage structure, for example swelling that 
could block the sinus and impede cell movement. 
Some experiments suggest that lymphocytes are not of vital importance 
in initiating cell trapping. The magnitude of trapping found in 
mice which were treated with 1500R or high doses of corticoateroids 
or antilymphocytic aera and mice which were irradiated and bone-marrow 
reconstituted and mice which were irradiated, bone-marrow reconstituted 
and again irradiated, was found to be unaltered by these treatments 
(Frost & Lance, 1974a). This type of experiment, however, only shows 
that intact lymphocytes within the lymph nodes are not essential, it 
does not exclude the possibility that it may require very few cells 
to interact with antigen and release a trapping substance • Thua 
labelled cells could initiate their own trapping, with exponential 
kinetics. It has been suggested that soluble factors produced during 
lymphocyte activation,, such as migration inhibition factor (MIP), may 
regulate lymphocyte trafic in the draining lymph node • MW has been 
detected in sheep, in the efferent lymph from popliteal nodes which 
were draining a tuberculin (hay t al, 1973) and a Concanavalin A 
injection (Hay, 1973); and in the rabbit, in the afferent lymph which 
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was draining a diptheria toxoid injection (Kelly., 1972). 
Kelly et al. (1972) found that when NIF from guinea pigs was injected 
into the afferent lymphatics of rabbits, it produced paracortical 
diateneton and dense aggregations of cellular plugs in the pare-
cortical sinuses, similar to those described by de Sousa and Parrott 
(1869). Recently, Fctat and Lance (1974b) reported that the sub-
cutaneous injection of MIP into mice caused trapping of labelled 
lymphocytes • It has been suggested that the soluble factors may act 
by increasing the number of cells that enter the lymph node through the 
post-capillary venules. 	(Kelly It flj,, 1972; Hay, 1973). 
racrophages may play a role in the recruitment of circulating cells in 
view of the correlation between the ability of substances to trap cells 
and their attractiveness to macrophages. Thus soluble proteins which 
are relatively inefficient at inducing trapping are poorly taken up by 
inacrophagea, but particulate matter and high molecular weight substances 
which are good at inducing trapping are also attractive to macrophagee 
(Unanue & Cerottini, 1870). Although a simple exp1aitiou for the 
non-specific recruitment of circulating cells implies a physical 
blocking of the lymph node sinuses, it is interesting that the flow of 
efferent lymph is at no time restricted (Frost & Lance, 1974b; Hall, 
1974) • This observation may indicate a more subtle method of impCding 
tho lymphocyteS 'progress .T 	
- -- - 
Theories on how lymphocytes are selectively recruited are compounded by 
ignorance of where they are selected. Although a special affinity 
between lymphocytes and the endothelial cells of the post-capillary 
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venulee has been suggested (Gowans & Knight, 1964; Gesner, 1966), there 
is no real evidence that they regulate the entry of lymphocytes. The 
post-capillary venules are obviously major entry points, because their 
endothelial cells which are normally high cuboidal become very thin in 
the lymphocyte depleted cortex of neonatally thymectomised mice 
(Parrott et al, 1966) or in the homozygous nu/nu mouse We Sousa 
1969) • The thinl flattened walls rapidly assume a normal appearance 
after the intravenous injection of lymphocytes (Goldschneider & 
McGregor, 1968b). Although Hall and Morris (1962, 1963) found few cells 
in the afferent lymph of sheep popliteal nodes, Kelly (1970) found many 
cells in the afferent lymph of rabbits draining an intradermal depot of 
antigen, and demonstrated their localisation in the popliteal node. 
Thus while the post-capillary venules may be the main point of entry 
of recirculating cells, afferent lymphatics afford an entry route for 
cells draining the dermis. An interesting experiment by McConnel et 
al. (1974) showed that cannu].ation of the efferent lymphatic from a 
single popljteal node of a sheep primed to PPD over a 4 week period, 
combined with repeated injections of PPD, resulted in the specific 
abrogation of the systemic response to PPD. Thus efferent cannulation 
caused the disappearance of antigen specific cel'1 non-specific e11s had escaped into 
the circulation. These results suggest either that antigen specific 
cells are recruited from the post-capillary venules, allowing non- 
- ---epecitic-cel-13--to-paaB-on,---or-tha4 cel-la- are- non-apecif ica -ily recrufted 
into the substance of the node, where specific cells are retained and 
non-specific cells are returned to the blood. This implies that some 
cells exit via the post-capillary venulen. Additional evidence that a 
selective screening mechanism exists at the level of the endothelial 
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cells lining the post-capillary venulee was derived from experiments in 
sheep which showed the specific depletion of MLC reactive cells in the 
efferent lymph of both stimulated and contralateral nodes within 30 
hours of administration of allogeneic cells (Hay et 	, 1974). These 
authors point out that an alternative explanation (which might also 
apply to the I1cConnel experiment) is the production of suppressive 
factors; thus the specific cells would be present in the circulation, 
but unresponsive. 
Any selective screening function performed by endothelial cells implies 
the presence of tightly bound membrane antigen. At present, information 
about the physiology of the endothelial cell membrane is lacking due to 
the difficulties involved in working with this tiseuc. The endothelial 
cells could also play a role in the non-selective recruitment of cells, 
it their permeability could be altered by various factors. One of the 
problems about crediting the endothelial cells of the post-capillary 
venules with a special responsibility for regulating lymphocyte traffic 
is that another mechanism has to be invoked for the spleen, where post-
capillary venules are absent. 
Various experiments have shown that modifying the membrane of lymphocytes 
with various enzymes changes their migration pattern. Concanavalin A 
(Gillette at al., 1973) caused the redistribution of lymphocytes from 
the lymph nodes to the spleen, and trypsin-treated cells (Woodruff & 
Gesner, 1968) showed deficient localisation in lymph nodes. Various 
experiments have demonstrated that the removal of alalic acid residues 
by glycosidasee (Geaner & Ginsburg; Gesner, 1966), neuraminidase 
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(Woodruff & Gesner, 1969) or Newcastle Disease Virus (Woodruff & Woodruff, 
1972a, 1974) produced a decrease in the number of lymphocytes that migrated 
to the lymph node and spleen and produced an increase in the number of 
cells found in the liver. Glycoproteins are however ubiquitous 
structures on the surfaces of rnmiu1ian cells and they almost certainly 
play an important role in many processes that involve interactiona 
between cell membranes (Cook, 1968). The possibility therefore that 
the failure of these treated lymphocytes to enter lymph nodes is a 
secondary effect of the removal of glycoproteina, due for example to 
increased susceptibility of the cells to sequestration by the liver, 
cannot be excluded. 
3. LabellinR techniues for studying cell localisation 
A variety of radio-isotopes are at present available to label lyinpho-
cytee and allow their localisation in vivo to be followed. Various 
cell constituents may be labelled - DNA, RNA and protein. An ideal 
isotope for labelling cells would have the following properties: 
(1) All lymphocytes would be labelled with equal intensity; the 
isotope would not favour one cell population above another. 
Alternatively, the isotope would be highly and reproducibly 
selective for an identifiable sub-population. 
The incorporation of the isotope would be stable, and it would 
not elute from lymphocytes- -during the period of etudy. 
Any isotope that 10 released from dead or damaged cells would 
be In a form that is not reutilleable by other cells. 
The process of labelling lymphocytes would not affect the 
immun000mpetence or behaviour of the lymphocytes. 
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No isotope studied to date possesses all of these properties. The 
important point is to realise how far these characteristics apply to 
the particular isotope in question, and to match the isotope with the 
requirements of the experiment. Physical properties of the isotope 
such as the half-life and whether it decays by P or S emission are 
other details to be considered • The advantages and limitations of some 
isotopes which are commonly used to label lymphocytes are described 
below. 
3a. 13 Emitters 
(i) Isotopes that label DNA 
3H-thymidine and 4C-thymidine are incorporated into proliferating cells 
during the DNA synthetic, phase of their cycle. They can be used to 
label cells in vitro or in vivo. Qhen used in vitro only large 
lymphocytes will become labelled, although the percentage which are 
labelled depends on the time of incubation. labelling in vitro has 
been used to study the localisation of large lymphocytes (Hall 
1972) • When used in vivo, different regiztes of 3H-thymidine 
administration can distinguish between long-lived and short-lived cells 
(Everett C Tyler-Caffrey, 1967). A recommended regime for labelling 
long lived and short lived lymphocytes in the rat is to give daily 
injections of 3H-thymidino for 20 days or 5 days and allow some time 
interval - before 'harvesting the cells (Ford & Hunt, 19731. Some newly 
forced long-lived lymphocytes will be present after 5 days of labelling. 
Using this technique, the localisation pattern of long-lived and 
abort-lived lymphocytes has been studied (Parrott & do Sousa, 1971) and 
the migration of short-lived cells to the peritoneal exudate of rate was 
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observed (Koster & McGregor, 1971). The disadvantages of the 3R-
thymidine label is that some label released from dead cells is re-
utiliøed (Feinendegen et al., 1966; Mitchell et al., 1963; Robinson 
et Al., 1965) and in high enough eoncentrat ions the 3H-thyinid ins can 
damage cells and inhibit their proliferation. (McGregor, 1969). 
(ii) Isotopes that label IA and RNA 
and 4C-label1ed adenoalne, uanosine and cytidine label RNA and 
DNA and uridine which labels RNA may also become incorporated into DNA 
(Comings, 1966). The most commonly used of these isotopes are 
adenosine (Gowans, 1962; GowanS & Knight, 1964; Parrott & de Sousa, 1966) 
and 3H-uridine (Ford, 1969; Ford & Bimmonds, 1972; Howard et al., 1972; 
Gutman & Weisaman, 1973; Sprent, 1973). 14C-uridine has been used 
(Ford & Sitnmonds, 1973) as has 3H-cytidine ( Saints-Marie and Peng, 
1974). 
3H-guanosine is rarely used, possibly because it is somewhat 
insoluble (W.L. Ford pers. comm.). Gowans (1862) using 3H-adenosine 
noticed an uneven distribution of label amongst small lymphocytes, and 
this phenomenon was studied by Howard (1972) who demonstrated that 
3H-uridine was incorporated into T celle from rats about 15 times as 
heavily as into B cells. This preference for 'T cells has been found 
to be characteristic for all the nuc1eoides that are incorporated into 
RNA. (Howard, unpublished results). Tua, when using a 3H-nucleoaide 
to label a heterogeneous lymphocyte population in vitro, large lynipho-
cytes and T cells will be more heavily labelled than B cells. 
uridine appears to have some marginal advantages over the other 
nucleos ides in terms of the quantity that is incorporated (W . L. Ford, 
pars. comm.). Approxirately half the radioactivity is lost from celia 
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within twelve hours of labelling, and is subsequently lost more slowly 
at about 20% a day due to the metabolic turnover of RNA (Ford & Bunt, 
1973). 50% of the activity was recovered in cell-free thoracic duct 
lymph or urine of rats which had been injected 24 hours previously 
with 3H-uriciine labelled thoracic duct cells (Goldschneider & tcGregor, 
1908b). Similarly, G. Rannie (pers. coem.) recovered 23% of the 
injected dose in the porfusate of a rat which had been injected 24 hours 
previou1y with 3R-uridine labelled thoracic duct cells. 
(iii) Isotojes that label proteins 
3H-leucine was used by Gowans (1962) for autoradiographic estimations 
and Black (1974) for quantitative localisation studies. It labels 
more than 95% of all the small and large lymphocytes in autoradiographs 
exposed for 14 days. Information about its rate of elution and 
reutilisation is lacking, but the suggestion that it does elute in vivo 
stems from the fact that 32.1% of the injected dose was recovered from 
the perfusate of a rat that had been injected with labelled thoracic 
duct cells 24 hours previously (G. Rannie, pers. comm.). 
3b. Emitters 
(i) Isotopes that label DNA 
125 IUdR is incorporated into DNA by dividing cells (Hughes et al., 1964). 
It has been used to label diiding -cells in vitro (Hall et al., 1972; 
Asherson et Al., 1973a) and in vivo (Aeherson et al., 1973a). It does 
appear to be more stable than the isotopes that are incorporated into 
ENA or proteins, its rate of elution from tumour cells is impressively 
low at 4% over 24 hours (P. Chishoim, pers. comm.). Although it has 
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been claimed that it is not reutilised (Hughes et al., 1964), this in 
controversial (G. Harris, pers. comm.). 1251-UdR is toxic in high 
concentrations, -: 
although H. Monie (pera. comm.) used different concentrations of 
to label rat lymphoblasts and found no difference in their 
localisation patterns. The disadvantage of 1251-UdR is that at present 
it is only used to label blast cells. Any long term regime designed to 
label long lived lymphocytes might encounter toxicity problems. 
(ii) Isotopes that label protein 
(ii.a) 51Cr 
51 has been used extensively to estimate cell localieation quantitatively 
(Zatz & Lance, 1970, 1971a; Zatz et al., 1971; Lance & Taub, 1969; 
Zatz et al., 1973a, 1973b; Dresser et al., 1970; Frost & Lance, 1974a; 
Zatz & Gershon, 1974; Sprent & Miller, 1972b; Sprent, 1973; Aeherson 
& Aliwood, 1972; Aaherson et al., 1973a), 	It has a half-life of 
28 days and is bound mainly to intracellular proteins (Ronai, 1969). 
Labelling is, however, uneven, large lymphocytes take up most label 
(Howard et al., 1972). The elution of 51 Cr from lymphocytes 	itro 
is high, 50-60% over 24 hours (Ronai, 1969). The fate of the eluate 
in vivo is uncertain. A major proportion will be rapidly excreted 
(Bainbridge 	., 1966) and although it has been claimed that only 
2% of the label released from dead cells can be reutilined by lynipho... 
oytea (Hunting et al., 1963; Bainbridge It al., 1966), the possibility 
that released label may reattach to erythrocytes cannot be excluded. 
Thus experiments have demonstrated that the red blood cells of rats 
contained 6% of the injected dose, 24 hours after the intravenous 
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injection of 5 Cr labelled thoracic duct cells (K. Don aLd, unpublished 
results). High concentrations of 51 Cr have been shown to produce an 
increase in the number of cells that localise to the liver (K. Donald 
unpublished results). 
(ii.b) Technetium-99m 
Technetiuni-99m (99m TO has been used to label human red cells (Smith, 
1974; Atkins et al., 1972) and various murine and human nucleated 
cells (Gillespie et flj., 1973). When used in conjunction with stannous 
chloride, it appears to be firmly fixed within the cell, three cycles 
of freeze-thawing released only 10% of the isotope. Murine sarcoma 
cells, when incubated for 48 hours failed to release any isotope 
(Barth & Gillespie, 1974). Cells that  have been labelled with 99m Tc 
were found to contain the isotope in the nuclear, mitochondrial and 
miorosomal fractions. Few expertmnts have been done to date regarding 
the behaviour of labelled lymphocytes, although it has been shown that 
labelled cells can incoroorate 3  H-thvmidine. 3 H-leucine and 3H-wlvcine 
(Barth & Gillespie, 1974). If it were satisfactorily demonstrated that 
labelling with 99m To does not affect the immunocompetence of lympho-
cytes, and when the distribution of label among different lymphocyte 
populations is established, this would provide a useful label for 
localisation studies. The half life of six hours which is useful for 
clinical studies may-be somewhat prohibitive for large scale animal 
experiments. 
(ii .c) 788e-eelenoinethionine 
75 Se-selenomethionine is an analogue of methionine in which sulphur is 
replaced by selenium. The isotope of selenium, øe has a half-life 
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of 120 days. Studies to be reported in Chapter IV reveal that the 
amino-acid is incorporated in vitro by a variety of murine lymphocytes 
into the TCA-precipitable fraction of cells. The elution,reutiliaation 
and effect of the isotope on lymphocyte immunocompetence are investi-. 
gated in Chapter IV and the results suggest that 75Se-aelenomethionine 
may provide a useful isotope for lymphocyte localisation studies. 
The experiments which are reported in Chapter V investigate the kinetics 
of lymphocyte localisation in response to oxazolone. Two features of 
these experilLenta make the use of a v emitter desirable: 
Differences in the amount of localisatjon are to be estimated. 
The experiment requires treatment of lymph nodes from .120 mice. 
The advantages of a emitter over a P emitter are the ease of tissue 
preparation and the consequent reduction in experimental error. These 
advantages are especially beneficial when large numbers of lymph nodes 
are to be treated. 
The experiments which are performed in Chapter V require that a non-
dividing cell population is labelled, thus excluding the use of 
5i_un. 51 was not used because of the uncertainty of Its effect 
on lymphocy-to.- -immunocompetence and the pose ibil-ity that it labels red 
cells. It was decided to investigate the use of a X. emitting amino-
acid, 758e-selenojnethionine as a possible alternative '$' emitting 
isotope. 
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CEAPTER8 IV & V 
MATERIALS AND METW)DS 
Mic 
Three to four month old male mice of the inbred strain CBA/}1, C57B1/1 
and (CM/H x C57B1/10) F1 were used. 'ihymua donors were six to ten 
weeks old. 6 week old nu/nu mice were kindly provided by Dr. Helen 
Pritchard. 
X-irradjatjon 
X-irradiation was administered with a Westinghouse machine under the 
following conditions; 230kV; 15 MA; 0.5mm Cu and 10mm Al filtration; 
dose rate 66r/min. 
Cell suspensions 
Lymph nodes and thymuses were gently homogenised in ground g]ass tubes, 
and filtered through steel mesh. Bone marrow cells were extruded from 
femurs and humeri using a lml syringe and a 27g needle • The source of 
lymph node cells were the axillary, brachial, inguinal and mesenteric 
lymph nodes. All suspensions were prepared in Hanics BBS (pH 7.4, 
adjusted with 1.4% sodium bicarbonate), at 0-4°C. Viability was 
estimated with nigrosin and the cell volume was adjusted- to the 
required number of cells per recipient in 0.4mle, and injected into 
the tail vein. 
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4. Oxazolone 
2-etboxy-methylene-4-phenyl oxazolone (8.D.H.) was diesolved in absolute 
alcohol at 600C and 10% w/v. In Chapter IV, 8mg of oxazolone was 
a pplied to a shaved area of skin on the left flank in order to 
stimulate mainly the axillary and brachial nodes. In Chapter V 
mice were anaesthetised with Nembutal and 8mg of oxazolone was applied 
to the left hind footpad, which was subsequently covered with a plaster 
of Paris bandage ("Gypsona", T.J. Smith & Nephew Ltd., England) to 
localise the response mainly to the popliteal and inguinal nodes. 
Controls received 0.1nls of absolute alcohol on the shaved flank in 
Chapter IV, and to the left footpad of anaeathetiaed mice in Chapter V. 
5' Measurement of DNA synthesis 
DNA synthesis was measured by uptale of ±2-I-labelled 5-iodo-2 '-
deoxyuridine ( 5IUdR) (Radiochemical Centre, Ameraham) after the 
method of Hughes et al. (1964) modified by Pritchard and Micklem 
(1972). Mice received 6 x 10 8  moles of 5-fluorodeoxyuridine (FUdB) 
(Roche products, Ltd.) in 0.2 mie øaline ip followed one hour later 
by lpCi of 1251-UdR, adjusted to a specific activity of 5mCi/mg, by 
the same route. Mice were killed two hours later and their nodes 
fixed in formal-ethanol (4% foriaalin and 70% ethanol). Unincorporated 
label was removed by several changes of 70% ethanol over a period of 
57 days, until the washings contained no more than twice background 
counts (Elkins, 1970). In Chapter IV the axillary and brachial nodee 
from one side were counted together, and in Chapter V the inguinal and 
popliteal nodes were counted individually for 8 mine in a Packard Gamma 
counter. The injected dose was counted for one minute. The 
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backgiound counts were subtracted from the organ counts, and the 
counts per minute were adjusted to the counts that would have been 
obtained from an injected dose of 106  cn. The caloulat ion was 
therefore as follows: 
V c from organ x io6l 
1251-UdR uptake = log10 L injected dose in cmJ 
It can be seen that the terms cpn cancel out, and the 125F-UdR uptake 
is the log10 of the proportion of the Injected dose that was incorpor-
ated. 
6 • Plaguing technique 
The 192 and 7S response of transferred spleen cells in irradiated 
recipients to bheep erythrocytei (Sheep cells in Aleevera', Tissue 
Culture Services Ltd., Slough) was tested by a modification (Wortis et 
al., 1966; Dresser & Wortie, 1967) of the Jerne plaque technique 
(Jerne et al., 1963). Agarose Indubiose, A37, FF9760 (L'Industrie 
Biologique Francaise, Cennevillies, France) was used for top and 
bottom layers. The cells were prepared in phosphate buffered saline 
(Miahell & Dutton, 1967). 
7 • Labelling techniques 
75 • 	 - 	 -- -- 	
---- -- 	 - -------- 	 ---- -- 
(a) 	Se-L-seienoinethionine 
(i) 
75Se-L-selenomothionine ( 75Sem) was obtained from the Commiesariat 
a L'energie Atoanique (91-Gif-Sur.-Yvette, France; British importers are 
Micro-Bio Ltd., London). The specific activity varied from 21mCi/mg - 
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68mCi/mg. The half life of 756e-gelenium is 120 days. The isotope 
was supplied at a concentration of 500pCi/ml and was diluted for use 
to l0O&Ci/ml. 
(ii) The medium 
The medium which was used for labelling mouse lymphocyte. was Hanks 
BBS, pH 7.4, containing 5% foetal calf serum (Biocult Labs •, Ltd.) and 
2% Minimal Essential Medium vitamins (Biocult tabs. Ltd.) and 200 unita/ 
ml of a etreptomycin/penecillin mixture (Biocult Lab,. Ltd.). The 
medium which was used to label rat thoracic duct cells was phosphate 
baffered saline (Miehell & Dutton, 1967) enriched as above. 
The concentration of isotope which was routinely used was 2LCi/10 7 cells. 
Lymphocytes were washed three times in Hanks BBS, and added to the 
medium containing isotope to give a final concentration of 2 x 10 7 celle/ 
ml. The pH of the medium sometimes became more acid on addition of the 
isotope (depending on specific activity). This was corroctedby the 
addition of 4.5% sodium bicarbonate (Biocult Labs. Ltd.). The cultures 
were gassed with a 10% CO2/Air mixture before being incubated for 60 mine 
at 370C in a gently shaking water bath. At the end of incubation, cells 
were washed three times in Hanims BBS at 0-4°C. The eupernatant from 
the last wash was usually retained e After washing, viability of 
labelled cells was assessed using the nigrosin dye exclusion test. 
cell suspensions were adjusted to a concentration of usually 12.5 x 10 6 
cello/mI, and 0.4m1 aliquots injected into the tail vein. An injection 
dose was retained to count the radioactivity. 
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Removal of organs 
At various times after injection of labelled cells riice were killed 
and a variety of lyvaphoid tissue and non-lyinphoid tissue was rerioved. 
The lymph nodes which were excised were the pairs of axillary, brachial 
and inguinal nodes and the mesenteric nodes • The paired axillary and 
brachia] nodes were counted together, the paired inguinais were counted 
together and the three mesenteric nodes were counted together. Other 
organs that were excised were the spleen, liver, both femurs, both 
lungs, the whole thymus and a known volume of blood removed from the 
retroorbital plexus. In some experiments the blood was separated by 
centrifugation and the plasma counted separately from the cells. When 
the intestine was counted it was cut into manageable sections. Peyer 'a 
patches are included in the intestinal counts • The organs were counted 
immediately after extirpation, with no tissue preparation, in the 
Packard gamma counter. 
Expression of results 
Experiments utilised groups of 4 to 6 mice. The mean cpm for each 
organ per group was calculated and expressed as a percentage of the 
injected dose. The standard deviatIon was also expressed as the 
percentage of the injected done • When the results are expressed as 
the 'total lyiiph nodes', this figure was arrived at by taking the counts 
in the paired axiliary, brachial, inguinal and 3 mesenteric nodes, and 
multiplying by 2 (Zatz & Lance, 1970) • In some experiments where 
quantitative differences tere to be estimated, only the mean of the cpm 
was recorded. In the experiments using rats, results were expressed 
either as the percentage of the injected dose per gram of tissue, per 
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ml of fluid,) or as the percentage of the activity found in the lymph 
nodes. 
311_methionine 
3I3-L.methionine (Bad iochemical Centre, Amersham, Bucks.), specific 
activity 55mCi/mgwas incubated with mouse lymphocytes at a concen-





3ff-leucino (Radiochemical Centre, Amershazn, Bucks), specific activity 
420mCi/mg was incubated with mouse lymphocytes at a concentration of 
1OCi/107 cells • The labelling medium and subsequent washings were 
as described for SOM.  
S. Experiments utilising rat thoracic duct cel1 
These experiments were performed in collaboration with Us • P. Chisholni 
and Dr. G. Rannie, in the laboratory of Dr. W.L. Ford (Pathology Dept., 
Edinburgh). The thoracic duct of male adult rats of the inbred strain 
AO were cannulated and circulating lymphocytes were collected by the 
technique described by Ford and Bunt (1973). 
(a) 24 	cultures ofthorio duct cells 
Thoracic duct cells were labelled with Sen, washed 3 times and 
resuspended at various concentrations in RX%U 1640 medium (Biocult 
Labs. Ltd.) supplemented with 2CmU Hepee, 0.8gm/i sodium bicarbonate, 
glutamine, non-essential amino acids, sodium pyruvate, penecillin/ 
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etreptanycin and 10% foetal calf serum. They were cultured for 24 bra 
in 1 ml aiiquote in the wells of Linbro tissue culture plates 
(813-16-24-TC multi-dish disposal trays) which were covered and Incubated 
at 370C on a gently rocking platform. 
24 hr cultures of rat tumour celia 
WF/G1 tumour cells, an in vitro established cell line from a Gross 
vt*us-induced lymphoma of Wiatar-furth rats, were labelled with 758em, 
and cultured at 5 x 10 cells/mi in 1 ml aliquots under the same condi-
tione described above for the thoracic duct cells. 
Perfusion of rats 
Rats that had been injected with labelled thoracic duct cells were 
perfused 24 hra after the injection of cells prior to the removal of 
organs • The chest and abdominal cavities were opened and the animals 
were perfused with phosphate buffered saline for 30 mine, through a 
cannula passing into the left auricle and with the vena cava severed to 
allow collection of the perfusate from the abdaninal cavity. 
Autoradiography of lymphocytes labelled with 3H-methionine 
Lymphocytes labelled with 3R-methionine were adjusted to a concentration 
of 2.5 x 106  cells/mi, and 0.2ml aliquote were gently spun on to clean 
slides iña:oytocentrifuge (Shandon Co. Ltd.). The slides were dried 
in air and fixed overnight in methanol • They were then dried and dipped 
in liquid gel emulejon (Ilford, X2 Nuclear Research Emulsion in Gel form), 
again dried in air and stored in black sealed boxes at 0-4 0C. A smear 
of non-radioactive sample was treated similarly to serve as a background 
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control. The autoradiographa were left for 15-17 days before developing 
(oda1, D19) and fixing. They were immediately placed in 10% 
formaldehyde for 10 mins to prevent wrinkling of the autoradiographic 
film, rinsed in tap water for 30 mins and dried in air overnight. 
Loishman's stain was used to stain the slides. 
10. Estimation of 
3
H-leucine incorporation 
In Chapter V, lymph node lymphocytes were labelled with 311-ieucine and 
injected into syngeneic recipients. The proportion of lymphocytes 
localising in the lymph nodes was estimated by homogenising the nodes 
in cold 10% trichloroacetic acid (ICA) to precipitate the protein. 
The precipitate was filtered and collected on Thatman glass fibre 
filter paper, and allowed to dry at 37
0
C overnight. 3 to 4 mis of 
0.5% Butyl PBI) acintillator in toluene was added to each sample and 




USE OF SE-SELENQETHIONINE AS AN ISOTOPIC MARKER FOR CELL 
LOCAL ISAT ION STUDIES. EVALUATION OF THE TECHN IWE 
RESULTS 
In this chapter experiments were performed to investigate the parameters 
of incorporation of 758em by various cell types, and the properties of 
the labelled cells with a view to evaluating the potential of the isotope 
as a cell marker in cell localisation studies. 
A. Parameters of incorporation of the isotope 
1. Kinetics of incorporation. Fig. IV.l. 
Liouse lymph node lymphocytes were incubated in 10 ml volumes with 7 Sem 
at concentrations of lpCi, 5Ci and 10pCi/lO 7 cells. Aliquots were 
removed after incubation for 60 mine, and 10 mis of isotope-tree Medium 
199 (Riocult Ltd.) was added immediately after the removal of the second 
aliquot (arrow on Fig. IV.1). Another aliquot was removed immediately, 
and after the subsequent time intervals shown. The aliquots were 
estimated for cell viability, and the supernatant removed. The pellet 
was washed three times and counted for radioactivity. Although each 
sample was expected to contain about 107 cells, only about 2 x 106  cells 
were present. The uptake did not increase proportionately with the 
concentration of isotope. After 60 mina of incubation approximately 
11,000 cpm were present in 2 x 10 6  cells incubated with 1Ci, 18000 cpu 
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with 5jCi and 40,000 cpm with lOjiCi. There was no detectable decrease 
in the counts present in the cell pellets over a ten hour period. This 
does not mean that there was no elution of label over this time period. 
It was discovered in retrospect that .the cold medium which was added 
after 1 hr only contained enough methionine to dilute the pool of 
isotopic selenoznethionine by 1/2. Thus a continual process of loss 
and uptake of 758em, if It were occurring, would not be iLthibited to 
a noticeable extent, by the presence of a relatively small quantity 
of cold methionine. 
2. 	Incorporation into the TCA insoluble cellular fraction. Fig. IV.2 
Mouse lymph node cells were iücubated in 10 ml volumes with 2iCi/10 7 
cells, and an aliquot containing 10 cells was removed after 60 mine. 
Isotopeafree Medium 199 was added after the first aliquot had been 
removed. Further aliquota were removed at the times shown in Fig. IV.2. 
The cell viability of the aliquota was estimated. The cells were washed 
3 times, the supernatants discarded, and the final cell pellets counted 
for radioactivity. The same pellets were then homogenised in 2mls of 
cold TCA. The precipitates which formed were deposited on glass fibre 
filters which were counted for radioactivity. The counts found in the 
TCA precipitable factions, that is protein, RNP. and DNA, were found to 
be approximately 75% of the total counts over 24 hi's. The a].iquota 
removed up to 8 bra contained 
10 
 viable cells, the cpm decreased at 
24 bra to a value approximately 30% of the initial value, and at 24 lire 
the viable cell count had decreased to approximately 2 x 106  cells/mi. 
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3. Elution of the isotope. Pig. IV.3 
In order to investigate the non-specific elution of 758em from labelled 
viable lymphocytes, a highly viable population of lymphocytes, removed 
in a way least likely to damage them, was used. Thoracic duct cells 
from A0 strain rats were labelled with 358em at a concentration of 
2JiCi/107 cells. After labelling and washing, the cells, which had 
retained 100% viability, were resuspended in enriched R%1I 1640 medium 
and cultured at concentrations of 10
5
. 107 and 5 x 10 cells/mi in imi 
quantities. At 1, 2, 6 and, 24 hra after establishing the cultures, the 
amount of label lost from the cells at their different concentrations 
was estimated. A 0.5ml sample of aupernatant was carefully removed and 
counted for radioactivity, the remaining cells and supernatant were 
counted for viability and radioactivity. The percentage of the total 
counts found in the eupernatant was calculated as follows: 
%. 	 - [c in total supernatant (cpm in 0.5 ml x 2) 	lxioo n aupe 	
- 	
pa 
Ltota1 cpa (cpa in cells + cpa in 1 ml supernatantJ 
Each point in Fig. IV.3 is the mean cpu from duplicate cultures. It 
should be noted that as much as 3-9% of the total counts were found in 
the medium immediately after labelling (time 0). At 2 bra, 16-19% of 
the total counts were found in the supernatant, 28-34% at 6 bra which 
increased to 54-64% by 24 bra. It is therefore apparent that over the 
24 hr period the cells lost 50-55% of their label. The viability 
during this period was 95% at 6. bra, and 85% at 24 bra. There was no 
significant difference in the rate of elution from cells incubated at 
different concentrations, and no difference in their viability. 
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Incorooration and elution of isotope by tumour cells. Table IV.1 
W.F. tumour cells were labelled at a concentration of 21ICi/107 cells 
and cultured in the presence and absence of 10 syngeneic rat lymph node 
cells. The release of isotope into the eupernatant was estimated as  
described for thoracic duct cells. The results are shown in Table IV.l 
where the individual results from duplicate cultures are recorded. 
They were very variable which was probably due to the fact that only 
11 
5 x lO cells were present in each culture representing about 770 cpxn. 
Therefore a release of 10% of the label into the eupernatant would have 
represented only twice background level • From these results it is 
difficult to conclude how much label was released prior to 24 his, but 
the cells probably released 30-50% of their label over a 24 hr period. 
The presence of 10 lymphocytes did not appear to affect the release of 
label. 
Incorporation of isotope by different 1y!phocytes. Table IV.2 
Lymph node lymphocytes, thyrnocytes, cortisone resistant thymocytes, 
spleen cells and bone-marrow cells were labelled with 2pCi/107 cells 
in duplicate cultures • The spleen cell suspension had been treated 
with Tris-ammonium chloride to lyse red blood cells. After labelling 
and washing the cells 3 times, the viability was assessed, supernatant 
removed and the cells counted for their radioactive content. The 
results are shown among the results of Table IV.2 and are coded Be Vl. 
The bone-marrow cells and thymocytes produced higher counts than other 
lymphocytes. Table IV.2 presents a summary of the results of labelling 
lymphocytes, in terms of isotope incorporation,' derived from all the 
75 
experiments which were performed using Bern. The specific activity 
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and the batch number of isotope is included to detect if there is any 
correlation between specific activity and the amount of isotope incor-
porated. In the third experiment (Be 111) gassing with a CO2/air 
mixture was omitted and the counts associated with these cells were 
relatively low. A reasonable approximation of the number of counts to 
be expected from 107 lymphocytes is 100,000-240,000 cpm • The super-
natant from the last wash was found usually to contain about 5% of total 
counts and never more than 10%. 2pCi produce about 4 x 10 
6
cpm, thus 
lymphocytes incorporate about 2-5% of the activity which is provided. 
6. Autoradion-raphy of cells labelled with 3li-methionine 
This experiment was designed to ascertain whether 3H-niethionine aabolled 
all lymphocytes, whether the intensity of labelling varied with lympho-
cyte populations, and whether there was any correlation between intensity 
of labelling and size of the lymphocyte. In order to ascertain if both 
B and T cell populations incorporated 3U-inethionine, lymph node lyinpho-
cyteg from CBA mice (T and B cells), lymph node lymphocytes from nu/nu 
mice (almost all B cells) and thymocytee (almost all T cells) were 
labelled with 3H-methionine and autoradiographe were prepared. The 
number of cells ''- containing grains, and the number of grains they 
contained is shown in Table IV.3. Cells containing less than 5 grains 
were considered to be unlabelled, by this criterion 97% of CBA lymph 
node lymphocytes, 91.5% of nu/nu lymph node cells and 97.6% of thymo-
cytes were labelled • The majority of lymph node cells from CBA and 
nu/nu mice possessed 5-20 grains per cell in contrast to preparations 
of CBA thymocytes in which 46% of the cells possessed 5-20 grains and 
50% contained 20-50 grains. It is possible that the tendency of 
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thymocytee to show a greater labelling intensity was due to some 
property of T cells • however it was noticed that the greater number 
of grain counts were associated with larger cells • Therefore the 
approximate size of the lymphocyte (small 5-E$i, medium 8-10, large i0-i+) 
was noted with the grain count • The results which are presented in 
Figs. IV.4a, 4b and 4c show a direct correlation between grain count 
and cell size. The grains were not observed to be associated with 
any particular region of the ce1ls(P 1ates IV.1 to IV.3). 
B. Reutilisation studies 
The experiments in this section were designed' to discover whether iso-
tope released from dead and dying cells, or cells killed in
,
situ, for 
example as a consequence of an immune response, could be reutilised by 
lymphoid cells. 
1. Localisation of supernatant counts. Table IV.4. 
The supernatant from the third, wash if labelled cells may contain as 
many as 10% of the total (cells plus supernatant) counts • It is 
important to know where these counts are found after intravenous injec- 
6 
tion of labelled cells. 5 x 10 labelled lymph/cells containing 
35,250 cpin were injected in 0.4m1 aliquots into 8 recipients. The 
supernatante from the third wash contained 3,470 cpm/0 .4m1 and was 
injected in 0 .3m1 quantities into a further 8 recipients. The 
distribution of radioactivity in various organs was measured at 2 and 
24 bra • At 2 hr 3 • 2% of the eupernatant counts were found in lymph 
nodes and 2 • 9% in the spleen. These figures decreased to 2 • 9% and 1 • 3% 
respectively by 24 hre. The hajority of recovered supernatant counts 
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were found in the liver at both tines • Only about 18% of the total 
activity injected in the eupernatant was detected at 24 bra. Regarding 
the localiaation of the lymphocytes it is interesting to note the 
redistribution of cells between the spleen and lymph nodes which 
occurred between 2 and 24 Lrs. 
2. Localisation of celia killed by freeze-thawing. Table IV.6. 
The experlLlent was designed to detect what proportion of dead cells 
or label released from dead cells could be detected in lymphoid tissue. 
Spleen cells were labelled and adjusted to a concentration of 2.5 x 
cells/mi. This suspension was divided into 2 aliquots. One was 
injected in 0.4 ml doses intravenously into 10 recipients. The other 
aliquot was frozen and thawed 4 times before being injected in 0 .4m1 
doses into a further 10 recipients. 5 recipients from each group were 
sacrificed 24 and 72 bra after the intravenous injections. At 24 bra 
the amount of radioactivity found in lymph nodes and spleens of 
recipients of dead cells was 5 and 10% of that found in mice which had 
recoived live cells. Significantly more activity was found in the 
lungs of recipients of dead cells than in the lungs of recipients of 
live cells, by 24 hrs. In both instances the majority of the counts 
found in the blood were present in the plasma. The micej sacrificed 
at 72 bra to ascertain if reutilisation had occurred with tine. 
Although the ratio of activity in the lymphoid tissue of recipients of 
live cells to that of recipients of dead cells had decreased, this was 
entirely due to a decrease in the counts present in the recipients of 
living cells • There was no increase in radioactivity in the lymph 
nodes or spleen of recipients of dead àells. The activity in the 
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lungs had also largely disappeared. Unexpectedly, there was no increase 
in the amount of activity recovered in the liver of mice injected with 
dead cells. The total recovery of counta was 40-5054 using live celia 
and 30-40% with dead cells. 
3. Localisation of allogeneic cells. Tables IV.6, IV.? and IV.C. 
The aim of this experiment was to determine whether lymphocytes killed 
in aitu release label in a form that can be reutilised by previously 
unlabelled cells. It is assumed that the outcome of the host's 
response to the injection of allogeneic cells will be the death of the 
labelled cells. On the basis of this assumption, it would be predic- 
ted that, if there is no reutilisation of label, detectable radioactivity 
should eventually be eliminated. 
s x 106  labelled CM (112-k) and C57B1. (112-b) lymph node lymphocytes 
were injected separate3y into 15 syngeneic and 15 allogeneic recipients. 
Thus a four way transfer was accomplished. 5 mice in each group were 
killed 3, 5 and 11 days after the transfer. 9.4% and 5.3% of syngeneic 
cells were found in the lymph nodes and spleen of CM mice at 3 days 
compared to 1.5 and 0.9% of allogeneic cells. Therefore oulyE and 
17% as many cells were found in the allogeneic lymph nodes and spleen 
as were found in ayngeneic lymph nodes and spleen. Similarly at 5 
days the amount of radioactivity recovered from the lymph nodes and 
spleen of recipients of allogeneic cells was about 11 and 15% of that 
recovered in the syngeneic transfer. After 11 days, 'however, the 
difference was not so marked, but this was due to a decrease in the 
levels in the syngeneic tissues. The disappearance of label in 
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C57B1 recipients of allogeneic cells was not as pronounced as in the CBA 
recipients, especially in the ipleen where the localieation of ayngeneic 
cells was very low. There were no significant discrepancies In other 
organs between the groups. 
The immune responses in these recipients would have included both host 
vs graft and graft vs host components, and the possibility that lympho-
cytes making a graft vs host response do not localise normally in mice 
cannot be excluded. The following experiment was therefore designed 
to investigate the localisation of semi-allogeneic cells which will be 
subjected to a host vs graft response. 
4. Localisation of aemi-allogeneic lymphocytes. Table IV.9a and IV.9b. 
The localisation of Fl hybrid lymphocytes in normal and sensitised 
parental strain mice was investigated. Mice were immunised with iO 
spleen cells, injected intraperitoneally 8 days before the transfer 
of labelled cells to produce an accelerated rejection of F 1 lymphocytes. 
15Seni labelled (CBA x C57B1) F1 lymph node lymphocytes were injected 
into normal CBA and C57B1 mice, sensitised CM and C57B1 mice and syn-
geneic F1 mice. The mice were killed 24 bra later. An can be seen 
from Table IV.9a, surprisingly lees radioactivity was found in the 
lymph nodes and spleen of uneenaitised CBA and C57B1 mice than was found 
in the equivalent tissues of F 1 mice. There was a considerably enhanced 
elimination of label in sensitised recipients, the CM Dice performing 
better than the C57B1 mice. Table IV.9b expresses the amount of 
radioactivity recovered in normal and sensitised recipients of semi-
allogeneic cells as a percentage of the amount recovered from the 
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equivalent tissues of F recipients of F 1 cells. 
There was no significant difference between any of the groups in the 
distribution of label in any of the other org8ne. The total 
activity recovered was 40-50% in the allogeneic transfers compared to 
64% in the syngeneic transfer. 
C. Studies on the iinraunocomi,etence of labelled cells 
The iminunocoapetence of labelled cells was assessed by their ability 
to localise to antigen, proliferate in response to antigen and produce 
YLI and YG antibody. 
1. Localisation and proliferation of labelled cells. Fig. IV.5. 
In Chapter II it was demonstrated that the ability of lymphocytes to 
transfer the proliferative response to oxazolone as measured by uptake 
of 5 I-UdR, 4 days after transfer into irradiated recipients, provides 
a sensitive assay of T cell furttion. In the present experiment 
advantage was taken of the fact tt the gamma radiation from 125I and 
75 Sem can be easily distinguished, and therefore organs containing 
both isotopes can be counted. Ten irradiated recipients were injected 
with 2.5 x 106 755em labelled lymph node cells and 10 with the same 
number of unlabelled lymph node cells • Half the mice in each group 
were painted with oxazolone and half with alcohol. Four days after 
the application of antigen the localilation of labelled cells in the 
draining and contralateral axillary and brachial nodes was measured 
by counting in the 75Sein channel, and the proliferation of labelled 
125 
cells was estimated by measuring the incorporation of 	I-UdR in the 
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same lymph nodes • No difference was found in the proliferative 
response of labelled and normal lymphocytes in either the draining, 
contralateral or alcohol stimulated nodes. An accumulation of 
labelled cells was found in the lymph nodes of recipients of oxazolone, 
75 
where the counts in the draining-nodes derived from Sem were 3 times 
those found in nodes of unstimulated mice. 
2. Ability of labelled spleen cells to transfer a primary humoral 
response to sheep red cells. Fig. IV.6 and IV.?. 
(a) Response of 2 x 10 
7 cells. Fig. IV.6 
Ten irradiated recipients were given 2 x 10 ThSem labelled spleen 
cells intravenously and 10 were injected with 2 x 10 normal spleen 
cells • The same day the mice received 108  sheep erythrocytes by the 
same route. Five and 7 days later the apleens of the irradiated 
recipients were plaqued against sheep erythrocytea and the number of 
direct and indirect plaque forming cells were determined • The results 
revealed no significant difference in the number of plaque forming 
cells present in the epleens from recipients of labelled or normal cells. 
'G antibody producing cells were not detected until day 7. As a 
precaution to ensure that labelled cells did not lyse red cells non-
specifically, control mice received saline in lieu of sheep erythrocytes. 
The spleens from these recipients produced about 50 plaque forming cells 
per spleen. Prior to plaquing, spleena were randomly counted for 
radioactivity and were found to contain about 16,000 cpa (that is, 8% 
of the injected dose). 
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(b) Response of io_io cells. Fi2. IV.? 
The above experiment utilised one dose of spleen cells. It is possible 
that the presence of a small number of damaged cells in the labelled 
population may not be detected in this system. 
Mice were lethally irradiated and repopulated with 	3 x 10, 
6 x iO or 108  labelled or normal spleen cells. One group of mice 
were lethally irradiated and were not injected with lymphocytes. The 
mice received 108  sheep red cells intravenously the same day. Seven 
days later the spleens of the recipients were plaqued against sheep red 
cells and the number of IN and 'G producing cells were determined. 
Recipients of labelled and unlabelled cells produced similar dose 
response curves (Fig. IV.?). The number of plaque forming cells per 
spleen increased concoinmitantly with the number of cells that the 
recipients had received. Lice which had been irradiated and not re-. 
populated failed to produce plaques to Bheep erythrocytes. 
D. Localisation of labelled cells from various sources 
1. 	 Table IV.1O. Fip, IV.8. 
5 x 106 labeled lymph node cells were injected intravenously into 36 
syngeneic recipients and groups of 6 were killed 6, 24 hrs and 2, 3, 4 
and 5 days later. The percentage of the injected radioactivity which was 
found in various organs after 6 and 24 hro is shown in Table IV.10. 
The decline in activity recovered from the lymph nodes, spleen, liver 
and blood over 5 days is shown in Fig. IV.8. 
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Table P/. 10 shows that more activity was recovered from the lymph nodes 
24 hours after injection of cells than at 6 hi's, and less activity was 
recovered from the spleen. The total aziiount of radioactivity recovered 
from the excised organs was 83.7% of the injected dose at 24 hra and 
73.7% at 24 hi's. Radioactivity in the lymph nodes and spleen declined 
over 5 days with levels in the spleen reaching 14% of their peak value 
which occurred at 6 hi's and 33% of their 24 hr. value. Levels in the 
lymph nodes did not fall as rapidly over 5 days, being 30% of their. 
peak 24 hr value and 50% of their 6 hr value. Localisation in the 
liver remained at 16-20% througiiout the period, and the radioactivity 
recovered from blood decreased from 10% at 6 lire and 24 bra to 7-8% 
over days 3, 4 and 5. 
Cortisone resistant thymocytee. Tablo IV,11 
6 x 106  labelled cortisone resistant thymocytes were injected intra-
venously iflto 9 recipients, 6 were killed at 6 hi's and 3 at 24 hi's. 
As can be seen from Table IV11, the activity recovered from the lymph 
nodes did not change between 6 and 24 hi's, but the activity recovered 
from the spleen decreased during this period. It should be noted that 
there were only 3 mice sacrificed at 24 hi's and the variations imply 
that the values for lymphoid tissue and spleen may be unreliable. The 
total aviount of radioactivity recovered was 70.7% of the injected dose 
at 6 hi's and 54% at 24 lire. 
Thymocytes. Table IV.12. 
s x 106  labelled thymocytes were injected into 15 recipients, and 
groups of 5 were killed at 6, 24 and 120 hi's. 
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As can be seen from Table IV.12 the amount of radioactivity recovered 
from the lymphoid tissue and spleen was extremely low, 3.5  and 5 • 6% 
of the injected dose at 0 bra. Indeed, the activity recovered from 
all orcana counted was only 38.1% of the injected dose. By 24 bra 
the amount of activity recovered declined, with levels in spleen and 
liver decreasing uore rapidly than levels in the lyznphoid tissue. 
The levels of activity in the lymph nodes remained constant between 
6 and 24 hrs. At day 6 only 19.5% of the injected dose was recovered. 
4. Eat thoracic duct cells. Table IV.13 
Thoracic duct cells are a more viable population than lymphocytes that 
have been teased away from an organ. Therefore the localisation in the 
spleen, liver, lymph nodes and blood was compared with the results 
obtained from mice. In previous experiments reported in this chapter, 
4-10% of radioactivity was found in the blood; it WSS decided to 
perfuse one rat to remove the blood from all the tissues to ascertain 
whether and to what extent the blood content of an organ contributes 
to its radioactive counts. 
2.18 x 108  labelled rat thoracic duct cells in 3.6 mis were injected 
intravenously into 2 syngeneic rats weighing 250 gms. The rats were 
sacrificed 24 bra later • One rat was perfused for 30 mins with phos-
phate buffered saline before removing any organs. Samples of various 
organs were removed, weighed, and counted for radioactivity. The 
results in Table IV. 13 were expressed as the percentage of the 
injected dose/gm tissue or Qi fluid and as the percentage of lymph 
node activity. Localisation in the liver was very low. The rat liver 
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weighs about 10 gin and the activity recovered represented about 3.8% of 
the injected dose. The localisation in the spleen was low compared 
to localiaation of lymph node lymphocytes in the spleens of mice 
(Table IV. 10). The spleen weighed 600 mg and the percentage of the 
injected dose that was recovered from the spleen was about 4%. The 
amount of activity recovered from the lymph nodes of the non-perfused 
rat was 14% of the injected dose/gin tissue, and from the perfuaed rat 
was 10% of the injected dose. The total lymph nodes in the rat weigh 
about 1 gin. The total blood contained about 4.9% of the injected dose, 
of which about 2.9% was found in the plasma, and 0.72% was associated 
with red blood cells. The counts found in the perfusate represented 
3.48% of the injected dose, of which 2.36% were found in the supernatant 
and 0.81% in the cells of the perfusate. 
5. Localisation of "Cr labelled spleen cells. Table IV.14. 
Previous experiments suggested that the localisation patterns of 
75
Sem 
labelled lymphocytes and Cr labelled lymphocytes differ slightly, 
especially regarding localisation in the spleen. To confirm that this 
phenomenon was due to the label and not simply to those of different 
experimental conditions, the localisation of Cr labelled spleen cells 
was investigated and compared to the localisation of freeze/thawed 
spleen cells from the same cell suspension. The results are shown in 
Table IV.14. The localisation of live 5 Cr spleen cells at 24 hrs are 
similar to the results reported by other workers (Bainbridge 
1966; Zatz & Lance, 1970). The levels had declined by 72 hrs. It 
is interesting that no activity was detected in the thymus except in the 
case of dead cells at 72 hra. The difference in the amount of activity 
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recovered from the lyaph nodes and spleen of recipients of live and 
freeze/thawed cells were similar to that obtained when cells were 
T.abolled with 
75Sei. The acotmt of activity recovered from the 
slooi and lymph nodes of recipients of dead cells was considerably 
loss than that recovered from the equivalent tissue of recipients of 
Uvo cells. At 72 bra, however, the discrepancy was not as marhed. 
When 7 e labelled spleen coils were injected the activity of lymphoid 
tissue and spleen had decreased by 72 bra in both recipients of live 
and dead celia. In this experiment, however, the activity decreased 
only in the recipients of live cells. It was observed in the oxperiment 
which utilised 75Ser (Table IV.5) that there was no tendency for the 
label from dead cells to be found in the liver. This phenomenon was 
also observed in this experiment. In the present studies, however, 
sigtificantly larger amounts of activity wore recovered from the 
kidneys of recipients of dead cells than in the kidneys of recipients 
of live cells. 
P.W-0.1 
CBA thyiocytea ieaed with 3 J-ethionineo 
la: a large thyocyte (14p) with 20-50 graine. 
1.b: two tudiim sized thyriocytea (C& and C&) with 20-30 
viue an -20 grains respectively 
los a large thyriocyto (13&) with 30+ c'ains 
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CM 17mph node lymphocytee labell.d with 3H-methionjns 
a medium sized lymphocyt. (lO&) with 5-20 grains 
a largs lymphocyte (lSi&) with 50+ grains. 
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Nu/riu 1ym*i node lymphocytes labelled with 3H-u*thionine. 
a large (14) and a medium sized lymphocyte (9p) with 
80+ and 8-20 grains respectively. 
two medium sized lymphocytes UOP and 814) with 20-80 
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Incorporation of Am by CM lymph node lymphocyt.a, cultured 
AR vitro with li • 51C1 and 1OpCIJ1O7 celia, for 60 mm, in 
n1ca BOB and 10% foetai calf serum and subs.qu.ntiy in the 













Incorporsticii of 75 Sem by CM lymph node lymphocyte., cultured 
in vitro with 2pCi/10 cells/mi for 60 nine in Hank. B88 and 10% 
foetal call serum and subsequently in the presence of 'cold' 
Medium 199. Radioactivity found in 10 cells A and in the 
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e1eaøe of 75 Gem from labelled rat thoracie duct lymphocytes, 
1, 2, 4 9 6 and 24 hrs after being cultured in vitro at 
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Fics. IV.4, 4b and 40. 
Diøtribution of silver grains aiiongat 3H-methionthe-labelied CM 
lymph node lymphocytes (a), CM thymocytes (b) and lymph node cells 
from the athyinic flu/flu mouse (o ) • The number of small collø 
modium sized coils 	and laro cells 	containing 45, 5-20, 
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Fig. IV.5 
Uptake of 125 	by the draining: and contralateral 1111111 axillaryIUdR 
and brachial lymph nodes Of irradiated (900R) recipients of 
oxazolone and the draining and contralateral 	lymph nodes 
of irradiated recipients of alcohol, 4 days after administration 
of antigen and 8 days after receiving 20 x 106 758ea-labellcd or 
normal lymph node cells intravenously, The Sem content of the 
draining 	and contralater&1 1111 ~ 11  axillary and brachial lymph nodes 
of recipients of oxazolone and the 75Sam content of the draining 
and contralateral 	lymph nodes of irradiated recipients of 
alcohol, 5 days after receiving 2.8 x 10 6 708em labelled lymph 
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Fig. IV.6 
PFC reaponøe to sheep erythrooytas of spleena from mice which had 
been irradiated (90011) and injected intravenously with 2 x 
normal or 8Sem-labelled spleen celia and i0 8 sheep erythrocytes, 
measured 8 and 7 days after irradiation and injection of cells 














labelled 	normal 	 labelled normal 
cells cells cells 	cells 
Day5 	 Day7 
Fig. IV? 
PFC response to sheep orythrocytes of spleona from mice which had 
been irradiated (900R) and injected intravenously with 101,  3 x 1O7 , 
75 	 5 6 x 10 or 10 normal or Som-labeUed spleen cells and 10 sheep 
erythrocytesp measured 7 days after irradiation and the injection 
of lymphocytes and antigen. 
IM response from recipients of normal celia 
i response from recipients of labelled cells 
from recipients of normal cells 
00< 
response from recipients of labelled celia 
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Recovery of radioactivity, expressed an percentage of the injected 
dose in the spleen A , lymph nodes 0 , liver U and blood • of 
CBA mice 6 hrs and 1-5 days after the intravenous injection of 




























Percentage of radioactivity in the supernatant of culturea 
containing 5 x 10 76-&eiu-labelled WF tur2our cells in the 
presence and absence of 10 7 syneneic lyiziph node cells 
Time after initiation of culture (houre) 
Culture 
	
0 	1 	 2 	 6 	 24 
WF + LN 	BG 	80 	22.0 	ND 	 33.0 
WF + LN 	11 	80 	 8.5 	10.5 	16.0 
WF only 30 18.0 6.0 25.0 33.0 
WP ôUy 80 9.4 4.0 16.3 48.0 
80 = bacRround counts 
WF = WF tumour cells 
LN = lymph node cells 
ND = Not determined 
TABX1 IV2 
Incorporation of 75-selenoiethionine 
Details of lymphocytes 	Details of 75-aelenoiLethionine 
typo pCi/1 7 cpn/107 	3pocific Activity batch CO2 
$01 INC 5 90,154 38.2iiiCi/mg 602 + 
$011 LNC 5 134,000 it to + 
SeX IX LNC 5 43,460 it of 
$eIVT LNC 5 96,000 it " + 
SolV LNC 5 300,000 21 	mCi/mg, 833 + 
LNC 5 200000 It " + 
8eV LNC 2.5 160,000 to It + 
SeVi LNC 2 50,000 if It + 
Thy 2 161,000 " to + 
CRT 2 91,000 to + 
Sp 2 90,000 C' 
to + 
Br.2 2 130,000 go + 
SeVil Thy 2 240,000 C' + 
SoiX LNC ° 2 200,000 " " + 
Se$BC Sp 2 220,000 	'52.60Ci/rng 993 + 
SeX LC1 2 ND 64.6mCi/mg 86 + 
SeC CRT 2 137,000 to It + 
SeT TDL 2 240,000 68.5nCi/mg 385 + 
SeX1 LNC 2 90,000. C' + 
- ----- 
Unless otherwise stated the cells were obtained from CBA mice 
o Cello obtained from (CMX 210) F1 mice 
40 RAT thoracic duet coils 
LNC = lymph node cells; 	Thy = thymocytes; 	(T = cortisone resistant 
thymocytes; 
SP = spleen cells; BM = bone Earrow colic. 
TABLE IV. 
Diatribution oZ grains aongat 1pocites labelled 
with 3 H-Methicnino 
nw/flu lyrnph 437 	8.60 	66.9 	32.08 	P1.06 
Imodes 
Thymo©ytor 	249 	24 	45.78 	50.20 	2.80 
TABLE IV.4 
Distribution of radioactivity in CBA mice 2 and 24 hours after 
the intravenous injection of 0 x 10 6  75-Sem labelled lymph node 
cells containing 35,620 cpi, or supernatant from labelled cello 
containing 3,470 cpm 












2 	cells 14.2 	16.1 14.9 	1.7 	3.7 0.1 	3.8 	54.3 
mean 
SD 3.8 	3.5 0.8 	0.7 	0.8 0.07 	1.4 
	
2 	Sup 	3.2 	4.4 	12.. 	00 	0.4 	1.2 	4.9 	27.2 
mean 
SD 	1.4 	0,3 	2.0 	0.4 	0.4 	1.2 	0.4 
24 	cells 
20.4 	8.8 	12.6 0.76 1.4 	02 	3.7 47.7 
mean 
SD 	4,4 	0.1 	1.4 0.2 0.1 	0.02 	0.9 
24 	sup' 2.9 	1.3 	9.5 	1.1 	0.4 	0.3 	3.0 	18.5 
moan 
SD 	1.6 	0.4 	1.7 	1.3 	0.5 	0.5 	1.9 
= aupernatant 
SD = standard deviation 
TABLE IV.8 
Distribution of radioactivity in CBA mice 24 and 72 hours after the 
intravenous injection of 107 75-Sem-labelled live and freeze-thawed 
- syngeneic spleen cells 
Percentage of administered dose in various organs 
Time Inoculum 
(hours) Total lymph Spleen Liver 




(x2) nodes cells 	Pl?sma 
24 	Live 
mean 9.6 8.3 10.8 0.82 1.1 0.16 0.7 	2.2 14.0 
4.1 	02.0 
SD 1.3 1.0 0.5 0.2 0.3 0.02 04 	0.8 3.9 0.3 
Freeze-thawed 
mean 0.5 0.8 11.3 0.3 6.7 0.1 0.9 	2.7 11.8 4.9 	
40.1 
SD 0.1 0.2 0.7 0.04 2.0 0.02 0.3 1.8 0.5 
72 	Live 
mean 
	 4.1 	3.5 	13.2 	0.6 	0.7 0.2 
	
3.0 	2.1 	9.3 	3.3 
	
39.9 
SD 2.8 	 l.1 	0.02 	0.05 0.06 
	
0.1 	0.2 	2.1 	1.2 
Freeze-thawed 
mean 	 0.3 	0.6 	12.4 0.4 	1.2 0.1 	1.1 	1.7 	8.3 3.8 	
29.8 
SD 	 0.09 	0.07 	1.0 0.03 	0.1 	0.1 	0.2 	0.3 	0.9 
SD = Standard deviation. 
TABLE IV.6 
Distribution of radioactivity in CBA and C57B1, BlO mice three 
days after the intravenous injection of 5 x 10 6  75-Bern labelled 
aflogeneic or syngeneic lymph node cells 
Percentage of administered dose in various organs 
Donor 	Recipient 
strain strain Total lymph Femur Blood 
nodes 
Spleen 	Liver Lung Thymus 	
(l) 
BA 	CBA mean 9.4 5.3 	12.7 	0.3 0.9 	0.2 	3.9 
SD 0.6 0.5 	1.0 	0.1 0.2 	0.2 	0.7 
BlO 	CBA mean 	1.5 
	





0,1 	0.6 	0.1 	0.1 	- 	0.9 
810 	810 mean 	7.7 
	





0.6 	2.1 	- 	0.2 	- 	0.4 







13.9 	0.2 	0.5 	0.1 
0.7 	- 
2.4 
SD - Standard deviation 
TABLE IV.7 
Distribution of radioactivity in CBA and C57B1, BlO mice 
five days after the intravenous injection of 8 x 106  75-Sem labelled 
allogeneic or syngeneic lymph node cells 






Liver Blood Lung Thyinue nodes 
CBA 	CBAI mean 6.4 	2.7 11.9 	0.2 07 	0.1 	207 
SD 1.3 	0.6 1.2 	0.04 0.1 	0.02 	0.1 
BlO 	CBA mean 
SD 
BIO 	BlO mean 
SD 
0.7 0.4 10.4 0.2 0.4 0.1 2.9 
0.1 0.1 0.5 0.1 0.02 0.02 0.0 
4.3 1.8 12.9 0.2 0.5 0.1 2.3 
0.4 0.2 0.8 0.03 0.03 0.01 0.1 
CBA 	BlO mean 
	
1.1 	06 	12.9 0.2 	0.8. 	0.1 	2.2 
SD 
	
0.2 	0.1 	0.6 0.02 0.04 0.02 	0.1 
SD = Standard deviation 
TABLE IV.8 
Distribution of radioactivity in CBA and C57B1, BlO mice 
eleven days after the intravenous injection of 5 x 106 75-Bern labelled 
allogeneic or syngeneic lymph node cells 
Percentage of administered dose in various organs 
Donor 	Recipient 
strain strain Total lymph Femur Spleen 	Liver 
Blood 
lung Thymus 
nodes (x2) (1) 
CM 	CM mean 1.6 0.7 	7.2 	0.2 0.4 	0.1 	2.5 
SD 0.06 0.1 	0.4 	0.01 0.04 	0.02 	0.6 
BlO 	CBA mean 	0.8 
	
0.4 	8.3 	0.2 0.4 	0.1 	ND 
SD 	0.2 
	
0.1 	1.5 	0.04 0.04 0.02 	ND 
510 	BlO mean 	1.7 
	
0.8 	9.5 	0.4 0.4 	0.1 	1.7 
SD 	0.6 
	
0.2 	3.6 	0.6 	0.1 	0.02 	0.5 
CM 	BlO mean 	0.6 
	
0.3 	7.8 	0.1 0.4 	0.1 	1.4 
SD 	0.06 
	
0.03 	0.3 	0.03 0.02 0.01 	0.2 
SD = Standard deviation 
TABLE IV.9a 
Distribution of radioactivity in aeneitiaed and normal CM and 
C57B1 mice and in (CMX X C67B1) F1 mice 24 hours after the 
intraveneous injection of 2.7 x 10 75-labelled (CM X C57B1) 
F1 lymph node lymphocytes 
Percentage of administered dose in various organs 
Recipient Sans it- Total 
strain 	ised 	lymph Spleen Liver 	14mg Thyzuus 	Total 
nodes 
CM 	- mean 5.9 	6.9 27.2 1.2 	1.5 	0.5 	9.4 52.6 
	
SD 	1.9 	1.2 	2.2 0.3 	0.5 	0.1 	0.5 
CM 	+ mean 1.16 	2.0 28.4 1.3 	1.8 	0.6 	8.4 43.8 
SD 	0.4 	1.0 	46 0.3 	0.2 	0.2 	1.1 
F1 	mean 19.1 	11.2 24.0 1.1 	1.7 	0.6 	64 64.0 
SD 	2.7 	2.9 	3.1 0.7 	0.9 	0.4 	1.1 
C5781 	+ mean 2.8 	2.8 30.0 1.8 	1.7 	0.6 	8.2 48.6 
SD 	0.9 	0.9 	8.4 0.8 	0.4 	0.1 	0.8 
C57B1 	- mean 4.1 	4.3 27.6 1.8 	1.7 	0.7 	5.8 45.7 
SD 	2.3 	1 15 	4.6 0.2 	0.4 	0.2 	0.8 
• CM and C57B1 mice which had received 108  (CM x C87B1) F1 spleen 
cells i.p. eight days prior to the injection of labelled cells 
SD = Standard deviation 
TABLE IV.9b 
Amount of radioactivity in lyrnphoid tissue of recipients of aeiai-allogeneic 
lymphocytes expressed as a percentage of the amount of activity 
recovered from the equivalent tissue of F1 recipients of F1 cells 24 hours 
after the injection of 758em labelled cells 
% activity in tiesue 
Donor 	Recipient 
	
Total lymph nodes 	Spleen 
F1 	Normal CBA 	 31 	 62 
F1 	Senaitised CM 	 6 	 18 
F1 	Normal C57B1 	 31 	 38 
F1 	Sensitised C57Bl 	 15 	 25 
[activity 
activity in recipients of seini-allogeneic celisi
% activity = 




Distribution of radioactivity in CBA mice 6 and 24 hours after 
the intravenous injection of 5 x 106  ls-sem labelled syngeneic 
lymph node cells 
Percentage of administered dose in various organs 
Time 
(hours) Total lymph 
Spleen 	Liver Femur Lung Thymus 
Blood 
Total nodes (1) 
6 	mean 20.7 	28.5 	19.4 2.2 	2.4 0.2 10.6 	83.7 
SD 2.8 	5.7 	3.8 0.2 	0.6 0.05 0.8 
24 mean 	28.4 	12.9 	19.6 	1.0 	2.8 0.3 	8.9 73.7 
SD 	4.6 	1.7 	1.9 	0.2 	1.4 	0.05 	0.2 
SD = Standard deviation 
TABLE IV.1l 
Distribution of radioactivity in CM mice 6 and 24 hours after 
the intravenous injection of 6 x 10 6 75-Bern labelled syngeneic 
cortisone resistant thyinocyte. 
Percentage of administered dose in various organs 
Blood 
Time 	 Femur 
Total 	 (imi) 
____________ 
(hours ) lymph Spleen Liver 	 Lung Thymus 	 Total 
nodes 	 cells plasma 
6 	mean 11.5 21.9 21.8 2.6 2.8 	0.2 3.0 8.2 	70.7 
SD 1.7 1.2 3.1 0.4 0.6 1.1 1.0 
	
24' mean 11.7 	8.5 22.6 	1.0 1.8 	0.2 	4.2 	4.4 	54.0 
SD 	3.1 	3.1 	3.9 	0.1 	0.4 	0.05 	1.5 	1.5 
SD = Standard deviation 










5.3 	0.6 	0.7 	25.8 
0.8 	0.1 	0.2 
3.6 	0.4 	0.6 	19.5 






Distribution of radioactivity in CBA mice 6, 24 and 120 hours 
after the intravenous injection of 5 x 106  75-Bern labelled 
syngeneic thymocytea 
Percentage of administered dose in various organs 
Time 
(hours) Total lymph Femur Total Spleen 	Liver 	Blood nodes (x2) 	
Lung 
recovery 
6 	mean 3.5 	8.6 	18.3 	6.7 1.8 	2.2 38.1 
SD 0.3 	0.4 	2.3 	1.0 0.1 	0.3 
SD = Standard deviation 
TABLE IV.13 
Distribution of radioactivity in AO rats 24 hours after the 
intravenous injection of 2.1 x 10 8  75-Bern labelled syngeneic 
thoracic duct cells 
Tissue 	 Non-perfused 	 Perfused 
percent percent 
inj. dose percent inj. dose percent 
/gmorml ac. /gmorml 
ui act. 
Liver 0.45 2.67 0.38 3.78 
Spleen 7.17 42.27 7.86 77.60 
L.Kid. 0.88 3.43 0.39 3.86 
R.Kid. 0.60 3.54 0.39 3.86 
Gut 0.96 5.64 0.83 8.15 
Testis 0.16 094 0.14 1.36 
Epid. 0.07 0.44 0.06 0.57 
Abdo.Sk. 0.17 0.99 0.08 0.75 
FP.Sk. 0.15 0.86 0.09 0.00 
Muscle 0.08 0.48 0.06 0.63 
Lung 0.94 5.82 0.37 3.69 
Thymus 0.25 1.47 0.19 1.84 
IN 16.96 100 10.13 100 
Sal, 01. 0.21 1.22 0.09 0.91 
Brain 0.07 0.41 0.06 0.59 
Tail 0.20 1.15 0.08 0.82 
Bone 0.22 1.31 0.17 1.68 
Blood 0.29/mi, 4.5% total 0.33/mi, 4.9% total 
Plasma 0.37/mi, 3.3% total 0.33/mi, 29% total 
Blood, WBC 0.11/mi, 0.67% total 
Blood, RBC 0.15/mi, 0.92% total 
L.Kid. = left kidney; R.Kid. = right kidney; Epid. = Epididiinis; 
Abdo.Sk = Abdominal skin; PP.8k = Foot Pad skin; LN = Lymph Nodes; 
Sal. Gi = Salivary glands. 
TABLE IV.14 
Distribution of radioactivity in CEA mice 24 and 72 hours 
after the intravenous injection of 10 7 51 Cr labelled live or 
freeze-thawed syngeneic spleen cells 
Percentage of administered dose in various organs 
Time 	
Inoculum 
(hours) Total iyxiph 
Spleen Liver Femur 
	 blood(lml) 	Kidney Total 
nodes 	 (x2) Cells Plasma Gut (x2) recovery 
24 	Live 	mean 18.8 22.1 17.1 1.5 4.9 0.0 0.2 0.2 4.5 0.8 	70.2 
SD 3.2 2.2 3.5 0.2 1.4 0.0 0.08 0.05 0.8 0.2 
24 	F/T mean 	1.2 	1.9 10.5 	0.6 5.0 	0.0 	0.1 	0.7 	1.0 6.5 	27.1 
SD 	0.7 	0.4 	5.1 	0.2 2.8 	0.0 	0.03 	0.2 	0.2 0.1 
72 	Live 	mean 15.1 17.3 19.6 0.9 3.8 0.0 0.1 0.02 3.0 0.6 	60.3 
SD 2.9 1.8 3.0 0.2 1.5 0.0 0.05 0.02 0.7 0.1 
72 	F/T mean 1.5 3.1 15.7 0.5 2.1 0.2 0.1 0.1 0.7 5.6 	29.7 
SD 2.3 2.4 3 0.2 0.7 0.3 0.1 0.1 0.7 2.0 
= Freeze/Thawed 	SD = Standard deviation 
TABLE IV.15 
Distribution of radioactivity found in perfused ratS 24 hours after the intravenous 
injection of thoracic duct cells labelled with different isotopes 
Results are expressed as per-cent injected dose/gin tissue or /inl fluid 
Tissue Uridina(5)' 
14 
Uridine(2) 7 8eni(l) 
3 leucine(1) ]eucine(l) 
Liver 0.37 (0.24-0.49)' 0.58 (0.58-0.58) 0.38 0.22 0.56 
Spleen 16.34 (11.07-25.07) 21.08 (16.0-26.0) 7.86 12.30 16.95 
L.K. 0.42 (0.34-0.56) 0.29 (0.23-0.35) 0.39 0.49 0.31 
R.K. 0.41 (0.32-0.60) 0.27 (0.23-0.31) 0.39 0.46 0.28 
Gut 0.58 (0.35-0.92) 0.54 (0.45-0.63) 0.83 1.41 038 
Testis 0.23 (0.09-0.37) 0.03 (0.03-0.03) 0.14 0.24 0.11 
Epid 0.056(0.05-0.07) 0.03 ( " 	 " 	 ) 0.06 0.15 0.08 
Abdo.sk. 0.13 (0.05-0.22) 0.04 (0.03-0.05) 0.08 0.18 0.14 
F.P. ak 0.084(0.02-0.17) 0.05 (0.04-0.06) 0.09 0.29 0.16. 
Muscle 0.124(0.070.22) 0.02 (0.02-0.02) 0.06 0.17 0.07 
Lung 0.72 (0.41-0.95) 1.08 (0.93-1.12) 0.37 1.23 1.85 
Thymus 0.24 (0.11-0.33) 0.27 (0.26-0.28) 0.19 0.62 0.31 
LN 15.47 (11.75-20.21) 11.84 (10.3-13.3) 10.13 19.23 13.43 
Sal.G1. 0.27(0.17-0.36) 0.13 (0.12-0.15) 0.09 0.37 0.14 
Brain 0.08 (0.02-0.24) 0.02 (0.02-0.02) - 	 0.06 0.15 0.14 
Blood, tot 4.72 (3.61-6.17) 1.68(1.35-2.01) 4.9 5.5 3.94 
Plasma 	" 2.50 (2.31-2.70) 0.52 (0.35-0.68) 2.9 6.0 1.98 
Perfusate 23.4 (14.6-33.0). 2.81 (2.34-3.28) . 3.48 32.14 ND 
Sup.Perfua 24.4 (18.9-29.9) 1.85 (1.7-2.00) 2.36 ND 0.67 
* the number in brackets indicates the number of animals 
x numbers in brackets indicate the lowest and the highest amount of activity recovered from that organ. 
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DISCUSSION 
1 • The isotope 
758e-selenomethionine is an analogue of methionine containing selenium. 
The isotope of selenium, 758e-aelenium has a ha].f life of 120 days. 
It decays by 100% electron capture to stable arsenic emitting a number of 
rays, the majority of which (55.5% and 58.6%) have energies of 0.136 and 
0.265 MeV. 
Clinically, 758e-.aelenomethionine has been used for detecting diseases 
of the pancreas (Blau and Bender, 1962), malfunction of the parathyroid 
gland (Potchen, 1967), and detection of malignant lymphouiae (Herrera et 
3., 1968). However the long biological half life of 758e-aelenomethionine 
and its facile placental transmission do not render it an ideal isotope 
for clinical use (Sodee et al., 1965). Experimentally, it has been used 
to study the regulation of platelet production in rodents (Harker, 1970; 
Amorosi eta].., 1971; NaJean & Ardaillou, 1969:. Evatt & Levin, 1969; 
Penington, 1969), and the rate of turnover of iauman erythrocytes (Penner, 
1966). 
The question of whether the metabolic pathways which utilise seleno-
methionine and methionine are identical has not been unequivocally 
established. The data appear to be best interpreted by the suggestion 
that the short term ut].lisation of the two amino acida is very similar. 
In the longer term however there may be differences in the utilisation and 
catabolism of the products containing the isotopes. The time course of 
incorporation of the two amino acide labelled with 4C into liver protein 
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phosphatidyl-choline and PXA was found to be very similar ('Pan et  
1964), as was their ability to be activated to the adenosyl amino acid 
and act as rnethyl donors (Dreri.r & Natori, 1960). 75Se-se1enoethionine 
was incorporated by hens into egg white protein. The isotope was 
located in the same part of the peptide chain as 35S-ethionine (Armando 
& Gittr, 1968), but differences in cetabolicii were apparent by the failure 
to detect 758e-eelenocyateino in egg white protein. While the turnover 
of vausole protein was approxinate1y similar when assessed using either 
75&-'ee1enoiethicmine or 3N-lyeine, the turnover rate of serum and liver 
proteins appeared abnorxxl1y low with 758e-selenomethion1ne due to 
recycling of the coiapound (Watorlow g 	., 1068). The uptake of radio-. 
activity in rate injected with 75Se-selenorethionino could be prevented 
by a similtaneous injection of cold selenoetbionine, but not by 
£iethionine, therefore (Holland et al,, 1966) suggesting the presence of 
separate iietabolic pathways. 
After the injection of the pure isotope into an an irial, whole body 
autoradiographe suggest that incorporation most rapidly occurs in those 
organs which possess high rates of protein turnover, the pancreas and the 
liver (Ilanseon & Jaoobseon, 1960. 
2. The labellinM technique 
The procedure which was developed using 758e-eelenornethionine (Sm). 
appears to be a reliable and reproducible method of labelling various 
lyiphocyte populations. On average, 107 cells when incubated with 
2jICi of Sem incorporated 100,000-200,000 opii. This represents only 
about 2% of the counts to which the cells were exposed, and it may explain 
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why after 3 washings, 10% of the total count could be found in the super-
natant. The labelling medium consisted of a balanced salt solution 
enriched with foetal calf serum: complete medium was not used on the 
assumption that the presence of methionine would inhibit the uptake of 
75sem. An experiment to teat this assumption was not performed, but 
the fact that Gowans (1962) labelled rat lymphocytes with 3H-leucine 
in M199 shows that it is possible to label cells with a radioactive amino 
acid in a complete medium. Fig. IV.l showe that incorporation of counts 
did not increase proportionately with the numbers of pCi presented to the 
cellø. It is possible that this effect may be due to an absolute limit 
on the rateof incorporation. This preliminary experiment suggested ,  
that 2pCi or less per 10 
7 cells would provide sufficient incorporation 
of activity for the purposes of most experiments. 
3. Incorporation of Sern by different cell populations 
About 78% of the isotope which was incorporated into lymphocytes was 
recovered in the TCA precipitate (Pig. IV.2). This figure of 75% is 
given credence by the finding of Penington (1969) that 75% of the isotope 
in labelled platelets could be precipitated by perchloric acid. The 
location of the remaining 25% is unclear, but it may be present as the 
free amino acid. 
The most accurate way of investigating the distribution of label among 
diffcrent lymphocyte populations is by autoradiography. The obvioue 
isotope to have used in this experiment would have been selenomethionine 
labelled with either 
14 
 C or 
3H. These compounds were not commercially 
available, therefore 3H-methionine had to be used. An objection to this 
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experiment is that the incorporation of 30-methionine by lymphocytes may 
be regulated by different factors from those that affect the incorporation 
of 
75
Sem. In view of the evidence which suggests that the short term 
metabolism of the two compounds is similar (Foopan et a].., 1964; Bremer 
& Natori, 1964; Armando & Gitter, 1968) and in the absence of auto-
radiographic data iBing selenomethionine, it is expedient (though not 
necessarily valid) to extrapolate from the results using 3R-methionine. 
If a non.uniform distribution of grains amongst the lymphocyte population 
was found it could be due to differential incorporation by T and B celle, 
or differential incorporation by cells of different sizes or different 
metabolic rates • The fact that over 90% of lymph node lymphocytes from 
CM mice, lymph node lymphocyte from nu/nu mice and thymocytes were 
labelled suggests that both T and B cells incorporate the isotope. 
Figs. IV.4a, b and c show the distribution of grains amongst small, 
medium and large lymphocytes and suggest a direct relationship between 
cell size and grain count. This accounts for the observation (Table IV. 
2) that cells which were removed from tissues with high mitotic indices, 
that is, bone marrow and thymus cells, incorporated more isotope (in terms 
of cpm/107 cells) than did lymphocytes from the lymph nodes or spleen. 
C. Elution of label 
One of the major probelms of using radioiaotopea to label lymphocytes is 
the possible elution of label from cells in vivo, the subsequent fate of 
that label and the manner in which it affects the results. 
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Elut ion of label from cells probably reflects the rate of turnover of the 
compound into which the label was incorporated. Isotopes which provide 
the most stable labels, with the possible exception of Technitiujn 99m 
(Barth & Gillespie, 1974) are therefore those which are incorporated 
into cellular components with low turnover rates, such as DNA (Davidson, 
1965). The present findings demonstrate that 75Seni is not particularly 
stable within a lymphocyte and 50-55% is lost over 24 hrs (Fig. IV.3). 
This is equivalent to the rate of elution of isotope from 51Cr labelled 
lymphocytes (Ronai, 1969) and 3H-uridine labelled lymphocytes 
(Goldechneider & McGregor, 1968b). The demonstration of elution 
in vitro may not however accurately reflect the situation in vivo. 
Fig. IV.3 ahowa that the rate of elution in vitro waR not concentration 
dependent between 10 5 - 5 x 10 
7
cells. 
The fact that isotope elutee from cells labelled with 3H-uridine and 
3u-leucine in vivo is suggested by the finding that 23.4 and 32.14% of the 
injected dose was found in the perfuaste of rats 24 bra after the injection 
of labelled thoracic duct cells (G. Rannie, unpublished results). The 
75 equivalent value found from Sam was only 3.4%. This could be either 
because the elutate was excreted, or because it was incorporated into a 
rapidly metabolising tissue, such as intestinal epithelium or pancreas. 
It appears unlikely that eluted 758ew is eubatantially reutilised by 
lymph node cells in view of the results derived from the reutilisation 
studies. Another aspect of the problem of elution is that if an isotope 
is unequally distributed among lymphocytes, the degree of elution may 
also vary • Non-uniform loss of label from lymphocytes over a 24 hr period 
could result in a population disproportionately represented by the cells 
that can be detected. 
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The possibility that 75Sein might be a suitable Isotope for use In 
cytotoxicity assays was investigated by labelling rat WF tumour cells and 
measuring the non-apecific release of label. Uafortunately the 8 x 10 4 
tumour cells that were labelled contained too little radioactivity to 
assess accurately the amount of label released. Nevertheless it appears 
probable that 30-50% of the label was released over 24 bra. This value 
is not inferior to that obtained for the elution of 51 Cr from similar 
cells (67% over 24 bra, P. Chisholm, pers. comm.), but it compares 
unfavourably with the claims that using 	IUdR only 4% of the label is 
released over 24 bra (P. Chisholm, pera. comm.) and that Teohnitium 99m 
is completely stable (Barth & Gillespie, 1974). 
5. Reutilisation studies 
Experiments were designed to encompass several situations which could 
result in host cells, previously unlabelled, becoming labelled. The 
source of label may be: 
as Label in the supernatant. After 3 washes the aupernatant may 
contain 10% of the total count in the in.jected dose. This is an 
overestimate, as the injected cells are resuspended in fresh medium. 
b • Label released from dead cells • Most cel1T; suspensions contain a 
proportion of dead cells, some of the label may be washed away during 
preparation, but some will remain attached to the cells. Label which 
is slowly released from dead cells or cell debris may contribute to the 
radioactivity of host tissues. 
ct label which elutes. As much as 50% of the activity of a cell 
suspension may be bat over 24 bra. 
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Label may be released from fragile cells (such as blasts) if they 
are damaged during the injection procedure. 
Label which is released from lymphocytes if they are killed within 
the lymphoid tissue as a consequence of an immune response. 
It can be seen (Table IV.4) that the contribution made by activity in 
the aupernatant to the activity which was found in lymph nodes and 
spleen was very small, approximately 0.29 and 0.15% of the lymph node 
and spleen activity could be attributed to supernatant. Most of the 
counts in the eupernatant were excreted, although some might have been 
found in the intestine (as was found in Table IV. 5). 
The amount of activity that dead cells can contribute to lymph nodes and 
spleen was investigated (Table IV.5). At 24 bra about 20 times and 
10 times more radioactivity was found in the lymph nodes and spleen of 
recipients of live cells than in the recipients of dead cells. A 
similar difference was found when 51Cr was used as the label, in these 
studies (Table IV. 14) and those of Bainbridge et al. (1966). Bainbridge 
et al. (1966) also injected heat killed (CBA x A) Fl cells into CM 
recipients and found 120 times as much activity in the lymph nodes of 
recipients of live cells as recipients of dead cells. In this experiment 
a considerable amount of the activity from heat killed cells was recovered 
from the liver, a phenomenon not observed with 75Sem frozen/thawed cells 
(Table IV.5) or 81Cr frozen/thawed cells (Table IV.14, and reported by 
Bainbridge 	., 1966). 	It is interesting that relatively high 
activity was recovered from the intestine although there was no difference 
in the intestinal recovery from live or dead cells. This ani the fact 
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that 758em may be rapidly incorporated in intestinal epithelium (Hanaeon & 
Jacobsaon, 1966) suggests that the intestinal activity owes little to 
the locatisation of living cells • Localisat ion in the lungs and 
excretion probably accounts for the number of dead cells that were not 
found in the lymph nodes and spleen. After 72 hre there was a decline 
in the amount of activity which was found in the lymph nodes and apleens 
of all recipients, although this decline was more pronounced in the 
recipients of live than of dead cells. This suggests that the activity 
remaining at 72 bra, 0.3-0.6% of the injected doee, will not disappear 
rapidly, and represents stably incorporated isotope, possibly in host 
cells. A siiilar cc*iclusion may be drawn concerning results obtained 
using 
51
Cr (Table IV. 14). 
Studies on the localisation of allogeneic cells (Tables IV.6,7 and 8 
and semi-allogeneic cells (Table IV.9) were designed to investigate the 
fate of label released from cells killed within the lymphoid tissue. 
A poor recovery of radioactivity from allogeneic recipients was found. 
The fact that the levels of recoverable activity fell between days 3 and 
5 but remained constant between days 5 and 11 suggests that a low level 
of activity, about 0.8-0.4% of the injected dose may be incorporated into 
some low-turnover protein. These results cannot however be interpreted 
simply. It was anticipated that 3 days after the transfer of labelled 
cells, there would be no overt sign of the progressing immune response and 
that localisation in all groups would be equal. Any subsequent decrease 
in activity could be attributed to the death of the cells and elimination 
of their label • However, because no observations were made before 72 brs, 
it is possible that an unknown proportion of the difference in the 
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recovery In lymph nodes and spleen between the allogeneic and syngeneic 
transfer may have been due to a failure of allogeneic cells to localise. 
It was reasoned that the localisation of F1 cells in parental recipients 
uld be simpler to interpret, because the response would be restricted 
to a host vs graft response. This experiment (Tables IV.9a and IV.9b) 
has not however overcome the objection that semi-allogeneic cells may not 
localise normally. However, senaitisation of the parental mice with F 1 
cello resulted in a considerable decrease in the amount of activity 
recovered from the lymph nodes and spleen of parental recipients. This 
decrease must have been due to death of the labelled cells and elimination 
of label. It is interesting that eensitisatoI1 of CBA mice proved more 
effective in olicitiug immune rejection of cells than senstitisation of 
the C5IB1 mice. This may be due to the deployment of different immune 
znechaniems, for example in the contribution made by humoral and cellular 
immunity. These results are similar to those of Bainbridge et., 
(1966) vho found 7.77% and 14.4% of 5 Cr labelled (CBA x A) 1 cells were 
recovered in the lymph node and spleen of A mice compared to 1.54% and 
9.26% of F1  cells found in the equivalent tissues of aenaitised mice. 
The interpretation of this experiment, in terms of the amount of re-
utilis5tioYi, is hindered by the curiously low amount of activity that was 
recovered from the lymphoid tissue of unsennitised recipients of Y l cells. 
This suggests that either semi-allogeneic cells do not localiso normally, 
or that they were subjected to a rapid host vs graft response that rea-
ulted in their disappearance. Parental rat cells have been found to 
localiso in the lymphoid tissue and spleen of F1 hybrid recipients as 
efficiently as syngeneic cells (W.L. Ford, pers. comm.). It is therefore 
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reasonable to assume that F1 mouse cells localise normally in parental 
tissue. Lymphocytes have been found in lymph nodes within 15 mins of 
their injection (Gowans & Kniglit, 1964) and it may be possible that 
within 24 bra they are killed by some iinriune mechanism. On the hasis 
that the localisationuof semi-ailogeneic cells between these strmins 
is normal, these results show that 1.2 and 2% of label from cells killed 
in situ is reutilised in the lymph nodes and spleen respectively of CM 
mice. These figures probably overestimate reutilisation, because they 
may also reflect activity from celia that aurvived the iimiiune response, 
and cell debris remaining in the lymphoid tissue. It is apparent that 
contribution of activity by the blood will be proportionately more in 
the lymph nodes and spleen of the parental strain recipients than in the 
equivalent tissues of 1'recipients. 
Neither of the allogeneic transfer experiments are ideal modelo of 
reutilisation in vivo. A more satisfactory oxperiacntal system would 
be one that allowed normal localisation to occur followed by a treatment 
that would destroy the labelled lymphocytes. 
To aummarise the results from the reutiiiaation studies, 2.9% and 1.3% 
of the supernatant dose, 0.5% and 0.8% of the frozen/thawed colla and 
1.16% and 2.0% of the total label released by cells kIlled in sitm can be 
found in lymph nodes and spleen of CA mice. t7hat bearing do these 
results have to a more normal situation where viability is over 906 and 
coils are not subjected to a host vs graft rC*ponso? A typical 
injected dose contains for example, 50,000 cpm. If this dose contained 
(at a maximum) 6,000 cpm in the supernatant, then the supernatant could 
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contribute 150 cpa throughout the lymph nodes and 50 cpa to the spleen. 
On the assumption that 10% of the cell inoculum was dead, this would 
represent 5,000 cpa which would distribute 28 cpa (0.5%) among the 
lymphoid tissue and 40 cpa (0.8%) to the spleen. The fate of the label 
which elutes from live cells at a rate of 50% over a 24 hr period may be 
explained by the supernatant, dead celia or reutilisation models. Eicauae 
the label has been incorporated, the latter two models are probably more 
representative. Consider the example in which 1.16% of the label is 
reutilised in the lymph nodes and 2.0% in the spleen. Because 25,000 cpa 
(50% of the dose) is being slowly eluted over 24 hrs it may not be 
correct to assume that 1.16% of it, that is 250 cpa, and 2% of it, that is 
800 cpa, is found among the lymph nodes and spleen respectively. Neverthe-
less, at some risk of overestimating the reutilisation this would result 
in levels of about 425 cpa in the lymph nodes and 590 cpa in the spleen 
which do not represent the original inoculum of labelled, living cella. 
6 • Immunocompetence of labelled cells 
There are several ways in which 758em could impair the immunocompetence 
of labelled lymphocytes: 
By the deleterious effects of internal gamma radiation. 
If the label was incorporated into cell surface proteins, the 
selenium moiety could interfere with the functioning of membrane receptors. 
In the long term selenomethionine may not be metabolised in the same 
way as methionine (Bannason & Jacobason, 1966). This could lead to 
metabolic defects that would interfere with the synthesis of many 
proteins. Any disturbance in antibody formation or in the synthesis 
of surface proteins that participate in antigen receptors or in receptors 
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necessary for cell circulation could alter the immune behaviour of 
lymphocytes. 
In the following experiments some parameters of irnmunocompetence were 
investigated; the ability of labelled cells to localise to antigen, 
to proliferate in response to antigen, and to produce humoral antibody. 
The ability of lymphocytes to proliferate in response to oxazolone, as 
measured by the incorporation of 
125
IUdR, was demonstrated in Chapter II 
to be a sensitive assay cf the presence of T cells. The results in 
Fig. IV.5 ahow that after 5 days in vivo 2.5 x 106  labelled cells were 
not impaired in their ability to specifically recognise oxazolone and 
proliferate to the same extent as unlabelled cells. 2.5 x 10 6  lymph 
node cells were estimated from the dose response curve in Chapter II 
(Fig. 11.10) to be a suitably sensitive dose where any deviation in the 
amount of 
125
IUdE incorporation, due to damaged T cells, *ould be 
detected. Within 12 hrs of antigen administration, cell traffic through 
a draining node is retarded and this effect lasts 2 to 3 days (Ford, 1969; 
Zatz & Lance, 1971a; 1971b; Emeson & Thurnh, 1971; Ford, 1972; Thursh 
& Emeson, 1972; Frost & Lance, 1974a). Considerably more counts from 
75Sem were found in the nodes draining the site of oxazolone application 
than were found in the contralateral nodes, providing evidence of an 
accumulation of labelled cells in the antigen-stimulated node. 
The ability of labelled spleen cells to recognise sheep red cells and 
produce humoral antibody was tested and the results are shown in Figs. 
IV6 and IV.?. After 5 and 7 days in vivo (Fig. IV.6) the number of 
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direct (X M) antibody and indirect (1 G) antibody producing cells 
produced by 2 x 	labelled spleen cells was equivalent to those 
produced by normal spleen cells. This implies that a critical number 
of labelled T and B cells were able to home to the spleen of the 
irradiated recipient, and these remained functional as regards their 
ability to cooperate, differentiate, and produce antibody. The fact 
that a 2 or 3 cell interactive process is necessary to achieve 
production means that the kinetics of the cellular interactions of 
labelled cells might not have been identical to those of normal cells, 
even though the same end was achieved. The results in Fig. IV.7 
however suggest probable identity between the labelled and the non-
labelled spleen population, because of the similarity between the 
responses of a variety of doses of labelled and normal cells. Thus 
providing that B cells are the limiting factor in the transfer of the 
haeznolysin response, '758em did not affect the ability of spleen cells 
to migrate to the spleen in irradiated recipients, to recognise sheep 
erythrocytes and produce the necessary interactions with other cell types 
to produce antibody. 
7, Localisation of labelled cells from various sources 
The localisat ion patterns of cells from various sources were examined 
in order to compare the results with those obtained using other i8otopee, 
and to discover whether localisation conforms to that which would be 
predicted on the basis of their known immunocompetence and circulating 
properties. 
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The localisation of lymph node lymphocytes, cortisone resistant thymo-
cytes, thymocytes and spleen cells is compared to results obtained by 
investigators who used 51Cr labelled cells. It is difficult to 
correlate results using 758em with data using tritium labelled compounds, 
as the latter are nearly always expressed as autoradiographic data. 
(a) Localisation of cells in lymph nodes and spleen 
According to Zatz and Lance (1970) the pooled axillary, brachial, 
inguinal and rneaenteric nodes represent about half the mass of total 
lymphoid tissue. This seems reasonable in view of the missing lumbar, 
renal, caudal, popliteal, parathyroid and auricu]ar nodes. Accordingly 
in the present studies the resulta which are presented as 'total lymph 
nodes' were twice the counts obtained from the pooled axillary, brachial 
inguinal and mesenteric nodes. 
(i) Lymph nodes 
The localisation of 
75 
 Sem labelled lymphocytes, from various sources, 
within the lymph nodes, 24 hrs after their injection correlates with 
the results that have been obtained using 51Cr labelled cells (Uainbridge 
etal., 1966; Zatz & Lance, 1970; Blomgren & Andereson, 1972) at least 
within a range of variation to be expected from different experimenters. 
The results conform to localisation patterns predicted on the basis of 
functional activities. The cells that were found to accumulate to the 
greatest extent in lymph nodes were lymph node lymphocytes, followed by 
cortisone resistant thymocytes, spleen cells and thymocytes. It has 
been estimated that 60% of lymph node lymphocytes are recirculating 
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(Zata & Lance, 1970) and it is probable that these consist mainly of T2 
(Cantor & Asofaky, 1970) and some B 2 cells (Strober & Dilley, 1973a, 
1973b). The number of lymph node seeking cells in a lymph node suepen-
'ion is enriched by passaging them through an intermediate recipient 
and collecting the recipienta lymph node cells (Zatz & Lance, 1070). 
This probably eliminates non-recirculating short-lived T and B coils 
and spleen seeking cells • If 60% of lymph node cells are recirculating 
this might represent the expected recovery from lymph nodes and spleen, 
however it can be seen from Table IV. 10 that actual recovery was less 
than this • This is probably due to a number of factors such as damage to 
cells during homogenisat ion or intravenous injection, or loss of label duo 
to elution.1 
- Cortisone resistant thymocytes exhibit some immunocompetence (Blomgren & 
Andersion, 1969; Blongren & Anderseon, 1970; Anderason & Blomgren, 
1970; Cohen et al., 1970; Blomgren & Svedmyr, 1971; Mos ier & Cantor, 1971) 
but lack the ability to synergise with spleen cells in a graft vs host 
response • This auggeèta they are not as mature as lymph node lymphocytes 
(Tigelaar & Asof sky, 1973). There is evidence that thymocytes which 
have recently migrated from the thynius require a period of maturation 
in the periphery before becoming mature recirculating cells (Mosier & 
Cantor, 1971; Cantor & Mosier, 1972). The fact that cortisone resis-
tant thymocytes were found at levels of 11.7% in lymph nodea a.n4 8.5% 
in the spleen confirms that they are able to leave the thyuiva, and the 
comparative lack of lymph node seeking ability conforms to the postulate 
that they aso not functionally as mature as lymph node cells. 
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Spleen cells are a heterogeneous population and there Are several 
components which have been shown not to be lymph node seeking, such as 
the haemopoetic precursors and rapidly dividing cells (Zatz & Lance, 
1970). The components of the spleen which do reach the lymph nodes 
are probably the recirculating T and B 2 cells. 
The low localisation of thymocytee within the lymph nodes of recipients 
is reasonable in view of their immaturity. 
(ii) Spleen 
75Sem labelled lymph node cells, cortisone resistant thymocytee, spleen 
cells and thymocytes appear to localise in the spleen in lesser quantities 
than do similar cells labelled with 5 Cr (Zatz & Lance, 1970; Blomgren & 
Anderason, 1972). Possible explanations are that 75Sem may fail to label 
or damage some spleen seeking population and that 51Cr may overestimate 
splenic localisation by virtue of being reutilised in the spleen or by 
altering membrane receptors and diverting cells to the spleen. 
The only spleen seeking populationa that the above cell suspensions, have 
in common are immsture T cells and dividing T cells. The localisation 
of 758em labelled cortisone resistant thymocytea to lymph nodes was 
similar to that of similar cells labelled with 51 Cr (Blomgren & Anderegon, 
1972) suggesting immature cells are not damaged by 8em. Lvmoh node 
cells and thymocytee which were labelled with 325IUdR were found to 
migrate to the spleen (Zatz & Lance, 1970), however the autoradiographjc 
data with 3H-methjonjne (Fig. IV.4) suggests that dividing cells are 
78 labelled with 8em, and the ability of labelled cells to proliferate to 
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oxazolone (Fig. IV.5) suggests (though does not prove) that blast cells 
are not damaged by the isotope. 95% of thymocytes are immature cells 
which are not normally found in the circulation, and the finding that 24.8% 
of the injected dose, labelled with 51Cr, was found in the spleen 24 bra 
after their injection (Zatz & Lance, 1970) suggests that their presence 
in the spleen may not be immunologically significant. Lack of inf or-
ination about the possible reutilisation of 
51 
 in the spleen (by red 
cells or macrophages) precludes any definite conclusions about these 
discrepant results. 
(iii) The apparent movement of lymphocytes from spleen to lymph nodes 
between 6 and 24 bra. 
This phenomenon, apparent from the results described in Table IV. 10 and 
Fig. IV.8 was also shown to occur using 51 Cr labelled lymph node cells 
(Zatz & Lance, 1970; Bainbridge !.t Al., 1966) and mouse thoracic duct 
cells (Sprent, 1973) • There is strong evidence to suggest that it can be 
explained in terms of lymphocytes leaving the spleen after about 6 bra 
and a proportion of them seeking the lymph nodes • The evidence of an 
intrasplenic pool of recirculating T lymphocytes that have a spleen 
transit time of 4 to 6 bra has been established (Ford, 1972). However, 
the present figures demonstrate that a proportion (3-8% of the inoculuin) 
leave the spleen after 6 bra and were thereafter not accounted for. It 
is possible that these were damaged cells which were trapped in the spleen, 
phagocytosed, and the label consequently released. 
(b) The significance of activity recovered from itasues other than the 
lymph nodes and spleen 
The source of radioactivity recovered from the liver, femur, lungs, 
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thymue, blood, intestine and kidneys can be ascertained by comparison of 
the localisation of dead cells or supernatant with that of live celia. 
Liver 
That localisation in the liver is not immunologically significant is 
suggested by the finding that, thë!e was no difference in the amount of 
].ocaliaation by dead cells or live cells (Table IV.5). It has been 
shown that the removal of lymphocyte glycoprote ins results in a decrease 
in the number of cells that loca]iae to lymphoid tissue with a conconunitant 
increase in the liver (Woodruff & Geaner, 1968, 1969). This suggests 
that cells which do not normally circulate, such as dead, dying, damaged 
or possibly dividing cells, are sequestered by the liver. In vRAwof the 
reported recovery of label from the liver of recipients of heat killed 
5 Cr labelled cells (Bainbridge et al., 1966) and thoracic duct cells 
labelled with high concentrations of Cr (K. Donald, unpublished resulti) 
it vas expected to find that an increase would be observed in the liver 
recovery from recipients of frozen/thawed or allogeneic cells (Tables 
IV.5 and IV.8). The fact that this was not found may be due to the 
rapid destruction by the liver of the dead cells and excretion of the 
label. That the free amino acid, 75Sem can be incorporated by liver 
cells is suggested by the finding that 9.5% of the superuatant counts 
were found in the liver, and the report by Waterlow et aj.. (1969) that 
recycling of 758em occurs in the liver. 
Femur 
A range of 0.4-2.6% of the injected dose was recovered from the femurs 
of animals which had been injected with 75Sem labelled cells, a similar 
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recovery was obtained using 51cr (Fig. IV, 14). The mice had not been 
perfused and therefore a proportion of the radioactivity Pay be duo to 
the blood content of the bones. Experiments to test the functional 
capacity of bone.'marrow coils have demonstrated the presence of T coils 
(Iioenhoff et al., 1970) and although more activity was recovered from the 
femurs of recipients of lymph node lymphocytes and cortisone resistant 
thymocytes than of thynocytos, it seems unlikely a cell-localisation 
technique could detect migration of mature T cells to the bone-marrow. 
(iii) Lungs 
Significantly lower aaounts of radioactivity were recovered from the 
lungs of mice that had been injected with supernatant than from mice 
which had received live lymph node cells (Table IV.4), suggesting that 
recovery in the lungs does represent labelled cells. The present studies 
showed two interesting phenomena regnrding localisation in the lungs; 
the first was the enhanced localisation of dead cells at 24 and 72 hrs 
compared to live cells (Table IV. 5) and the second was the tendency to 
obtain a greater recovery of label at 2 and 6 hrs than at 24 and 72 bre 
(Tables IV.11, 12 and 14). These results suggest that the lungs are the 
first trapping network to be encountered by intravenously injected cells 
and that dead cells, by virtue of their immobility, are probably lesa 
able to escape this trap than live cells. That lymphocytes becomo 
transiently caught in the lungs has been suggested by the results of 
several authors (Weisbergeretal., 1951; Iiius, 1962; Hall, 1967; 
Halotead & Hall, 1972; Hall et si., 1972). Hall et al. (1972) using 
autoradiography, revealed the presence of 3H-thymidine labelled thoracic 
duct cells in the alveoli and capillaries of lungs. 
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Thymus 
Recovery of 75Sem from the thynlue varied from about 0.1-0.7% of the 
injected dose. The amount of activity which was recovered from the 
thymus of mice which had received eupernatant or frozen/thawed cells 
was very variable (Table IV. 4 and Table IV • 5), but the failure to detect 
any difference in apparent thymic localisat ion of syngeneic or allogeneic 
cells (Tables IV.8 and 9) suggests the activity does not einenate from 
cells that entered the thymus. There is little evidence that mature 
lymphocytes enter the thymus (Micklem et al., 1966) although autoradio-
graphic studies have detected some cells in the thymus of rate which 
received 3H-uridine labelled thoracic duct cells (G. Rannie, pers. comm.). 
The major proportion of the radioactivity found in the thymus may be due 
to the blood content, and reutilisation of label disseminated by the blood. 
Virtually no 51,  activity was recovered from the thymus of mice which had 
received 51Cr-labelled spleen cells until 72 hrs after the injection of 
dead cells (Table IV.14). This low level of recovery is supported by 
reporte from other authors using 51Cr (Bainidge et al., 1966; Sprent, 
1973). 
Blood 
The amount of radioactivity recovered in the blood varied from 3-10% in 
1 ml. Evidence precludes the possibility that this repreSents labelled 
cells. The amount of activity recovered in the blood of mice injected 
with super*iatant (Table IV.4) was not less than that recovered from mice 
which had been given live cells. It is difficult to predict the levelS 
of ativity which might be expected from the blood of reoipiente of dead 
cells, for although they would lack recirculating healthy cells, they 
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may have a surplus of dead cells that cannot localige. This may explain 
why there was no difference in the recovery of activity from blood of 
recipients of frozen/thawed or live cells (Table IV.5). In 2 experiments 
(Table IV.].l and IV.5) the blood was centrifuged before counting and the 
plasma was removed. The plasma consistently contained more counts than 
the red cells, sometimes by a factor of 3. Samples of plasma were 
chromatographed on a Sephadex G200 gel filtration column and the major 
part of the activity was found to be associated with the serum protein 
traction as opposed to the free amino-acid • From the point of view of 
reutilisation of eluted radioactivity, it may be more advantageous for 
the isotope to be in the form of serum proteins. The existence of 758em 
in serurn'.proteing may be due to the abi1iy of the liver to metabolige the 
free amino-acid (Waterlow et al., 1969) which possibly elutes from labelled 
cells. 
The recovery of 51Cr from blood was very low (Table IV.14), varying from 
0.1-0.4% of the injected dose. This compares to a recovery of 1.5% in 
1 ml from mice which received 51Cr labelled lymph node colle (Zatz & 
Lance, 1970) and thoracic duct cells (Sprent, 1973). The results in these 
studies (Table IV.14) show that the major part of the activity is found in 
the plasma. It is curious that in experiments which utilised 51Cr-
labelled rat thoracic duct cells, as much as 6% of the injected dose was 
found in the plasma (K. Donald, unpublished results). The discrepancy 
may be due to different labelling conditions. 
NO Intestine 
The recovery of activity from the intestine of mice injected with 
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758em labelled spleen cells was high (11% of the injected dose) but 
probably does not represent labelled cells. Thus there was no 
difference in the recovery of label from the intestine of recipients 
of live and dead cells (Table IV.5) and the propensity for intestinal 
epitheliuia to incorporate 78em  has been deraonstrated (Hnson 
Jacobseon, 196). Preliiiinary experiments indicated that very lo 
levels of activity are recovored from the Poyer's patches. The source 
of label in the intestine was probably elutate. large blast like 
lymphocytes, particularly 3 cells appear to be the major coil typo that 
localise to the Cut (Nail ot al., 1972; Guy-Grand et al. , 1974; 
Parrott & Ferguson, 1974). 
(vii) Kidneys 
Kidneys do not appear to perform any immunological function and when 
hea 	 75lthy only contain lymphocytes present in the blood. 	8en activity 
disappears from tho body quite rapidly as was seen in the total activity 
which was recoverod from mice given thymocytes or supernatant. 
PrefiuRIIably a large proportion of label is eliminated through the kidneys, 
although this is not apparent in terms of activity recoverod from thoso 
organs. 
(',iii) Total rocovory of radioactivity 
Gue of the perplening aspects of these exporiments, and indoed aW 
eporimont utilicing labelled cells, is the depressing rapidity with 
which label disappears from the whole animal. The disappearance is 
apporent from the poor recovery obtained from all the organs counted 
compared with the activity which was injected. A proportion of injected 
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radioactivity may disappear very rapidly, for example Hall et al. (1972) 
recovered 70% of the activity from 125IUdR or 3H-thymidine labelled 
blast cells 30 mini after intravenous injection, this may imply that 
cell death and cataboliem of fragile cells occurs. The loss of activity 
from lymph nodes and spleen over 5 days (Fig. IV.8) represents metabolic 
turnover of proteins containing 75Bern and dying cells • Whole body 
counts were Dot performed on the animals (Fig. IV.8) and it in only 
presumed that the activity was excreted. If the activity was utilised 
by any other tissues, the rapidly inetabolising liver and Intestinal 
epithelium would be obvious locations, and the results from Fig. IV.8 and 
Table IV.5 suggest this does not happen. 
The amount of label recovered from an animal decreases with time after 
the injection of the cells. Lees activity was recovered from the 
selected organs at 24 hi's than at 6 hrs (Tables IV.10, 11 and 12) and at 
72 bra than at 24 bra (Table IV.5). The amount of recoverable activity 
varied with the cell suspension. Low recovery appears to be generally 
associated with an inability of cells to localise in ].ymphoid tissue 
and spleen, and apart from a transient increase in the lung, a concomitant 
increase in activity is not detected in any other organs. 
These results stimulate interest in the role which the liver plays in 
eliminating lymphocytes that do not localise in lyinphoid tissue, spleen 
or intestine. Dead, damaged, allogeneic and possibly some large 
dividing cells are catabolised and a major proportion of the label is  
excreted. Presumably, in the absence of direct evidence from these 
studies, they are catabolised by the liver. Btudie* on the membrane 
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changes that occur to allow sequestration of circulating cells by the 
liver, may contribute to knowledge about the structures of surface 
components necessary for lymphoid localisation. 
Localisation of rat thoracic duct celia 
Only 3% of labelled thoracic duct cells were recovered from the liver of 
syngeneic recipients. This indicates that the fairly high liver 
recovery in the present studies utilising mice was a function of the type 
of cell injected rather than an indication that 75Sem damages cells. 
The results showed a similar distribution to the spleen and lymph nodes 
as were found using mice. The blood contained less activity than was 
found in the blood of mice and may be a consequence of the inoculation of 
an undamaged naturally circulating population of cells. 
General comments 
A summary of the properties of lymphocytes labelled with 78Sein is as 
follows: 
2&Ci/10
7  cells produces an average of 100,000-200,000 cpm. 
Lymph node lymphocytes thymocytes, cortisone resistant thymocytes, 
spleen cells and bone-marrow cells all incorporate the isotope. Evidence 
obtained using 3 H inethionine suggests that there is no difference in 
incôrporat ion between T and B cells, but there is a direct correlation 
between incorporation and cell size. 
75% of the incorporated isotope is found in the TCA precipitable 
fraction of cells. The rate of elution in vitro is about 507, over 
24 hra. 
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Reutilisation studies suggest that about 1% of label released from 
injected dead and dying cells, cells killed in situ and label from live 
cells will remain in lymph nodes or recipients and 2 may be found in 
the spleen. 
758em does not appear to damage the ability of lymphocytes to 
localise and proliferate in response to oxazolone, nor to recognise 
sheep erythrocytes, and cooperate to produce WN and XG antibody. 
Localisation studies suggest that this label is suitable for the 
detection of localisation in lymph nodes. It may be suitable for 
studying localisation in the spleen, but the results are not the same 
as those obtained with 81Cr. Activity recovered in the blood, liver 
and thymus reveals little about the immunological activity of these 
organs. 
The salient point about these studies is that certain features of the 
label (it elutes, does not label cells uniformly and is partially 
reutilised in vivo) impose restrictions on its use and complicate the 
interpretation of the results. The label is most useful for studying 
localisation in situations where large amounts of activity are expected 
to be recovered, for example in the lymph nodes • There are certain 
experimantal situations where results using 75Sem would have to be 
interpreted with great caution and confirmed with autoradiography. 
These are: 
(1) When studying localisation in non-lymphoid tissue. 
(ii) When comparing the localisation of different cell types, because 
of the different incorporation by cells of different sizes. 
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These restrictions apply to every isotope at present used to study cell 
localisation, with the possible exception of 5 IUdR which has other 
disadvantages, and Tc99W about which very little is lcnown. 
Dr. Gordon Rannie kindly compiled a table (Table IV. 15) comparing the 
activities recovered in varioua organs of rats injected with thoracic 
,l,.a..+ rogslla 1hc1Id with 311-uridina 14C-uridlne. 	Sem. 3H-leucine 
14 and C-leucine. The important feature is the occurrence of high 
levels Of activity in the plasma is not restricted to 75Sem labelled 
cells, and that 23.4% of the injected 3H-uridine and 32.14% of the 
injected 3H-leucine was recovered in the perfusate of the recipients. 
These high levels demonstrate the need for caution in interpretating 
quantitative results from tissues where the blood could be contributing 
a major portion of the activity. 
These studies have defined some of the parameters of use of another 
emitting isotope which has the useful features that it labels all 
lymphocytes (as opposed to only dividing cells), does not appear to 
damage inmunocompetence, and could provide a useful comparison with 
reaults obtained with other isotopes. 
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CEAPTER V 
CELL RECEU 11WF DUB ING THE RESPONSE TO OXAZOLONE 
RESULTS 
Experiments were designed to measure the accumulation of labelled 
lymphocytes in the ràgidnal lymph nodes of mice, 1-5 days alter the 
application of oxazolone. The experiments had 2 objective.: 
To investigate the relationship, if any, between the amount of 
proliferation occurring within a lymph node and the ability of that 
lymph node to recruit and retain circulating lymphocytes. 
To investigate the kinetics of cell localisation in antigen-
stimulated lymph nodes from 1-5 days after administration of the antigen. 
Mice which had been lethally irradiated were injected with 10 or ,  
108  thymocytes, or with BSS. On the same day they were painted with 
either oxazolone or alcohol. In this way, 3 groups of mice were 
established, those giving a 'heavy' proliferative response with 108 
thymocytes, those giving a 'moderate' response with 106  thymocytes and 
those giving little response with BSS only. The accumulation of 
labelled lymph node lymphocytes in the draining and contralateral lymph 
nodes of these mice was measured 1,2,3,4 and 5 days alter oxazolone 
was administered. 
Two experiments were performed, one utiliaed 758am and the other utilised 
3 H-leucine. 
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1. Experiment utilising 758em 
The proliferative response of lymph nodes of experimental mice was 
measured by the incorporation of 
125
IUdR and correlated with the 
accumulation of 758em-labelled lymph node lymphocytes 1,2,3,4 and 5 days 
after the administration of oxazolone. The experimental ,protocol is 
shown in Fig. V.I. 
Oxazolone was painted ai the hind foot pad to localise the response to 
the draining popliteal and inguinal nodes and avoid involvement of the 
spleen and distant lymph nodes (Chapter II). The mice were sacrificed 
24 hrs after they received 756em labelled cells and 2 bra after they had 
received 
125
IUdR. Four lymph nodes we' e removed from each animal; 
the draining and contralateral popliteal and inguinal nodes. They were 
counted individually to aaseas4eir content of 758em and 125IUdR. 
The incorporation of 25IUdR by the inguinal nodes of experimental mice 
are shown in Fig. V.2 and V.3 • The amount of 125IUdR incorporated by 
mice which had received 108  thymocytee and oxazolone increased between 
days 2 and 4 and declined between days 4 and 6. (Fig. V.a). The 
response of the mice which had received alcohol and 108 thymocytea 
increased gradually between days 2 and 6 • The incorporation of 125IUdR 
by recipients of 106  thymocytea (Fig. V.3,) shows a contrasting pattern. 
There was little difference between the proliferative response of recip-
ients of oxazolone and of alcohol between days 2 and 5, and only on day 6 
is there an appreciable response to oxazolone. The amount of 125 IUdR 
incorporated by the inguinal nodes of saline-injected mice is shown in 
Fig. V.Z. A low level of incorporation was found between days 2 and 5, and 
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the increase found on clay 6 may have been due to some recovery of the 
host's lymphocytes. 
The objective of this experiment was to compare the accumulation of 
labelled lymphocytes in the lymph nodes of irradiated mice reconstituted 
with 10, 108  thymocytea or saline, and undergoing a 1,2,3,4 or 5 day 
response to oxazolono. The experimental protocol ensured that all 
groups received labelled cells on the same day, from the same cell 
suspension; therefore a direct comparison between the 758em activity 
found in the lymph nodes of the various groups was possible. The 
results are expressed as the log10 of the mean 2-minute counts. 
The localisationa of 758em labelled lymphocytes in the inguinal nodes 
of the various groups is shown in Figs. V.4-'8. Although the popliteal 
nodes were counted, only the results from those mice whteh received 10 8 
thymocytes are presented (Fig. V.?). The variation found in tltio 
pop1itezls of recipients of 106 thymocytes or BOO were too large to 
allow interpretation of the resulto. Essentially there are no obvious 
differences in the pattern of coll-.localioation between groups that 
received different doses of thymocytes. Thus it appears from these 
results that cellular proliferation has not affeóted the magnitude or 
kinetics of col1-1ocaliation in response to oxazolono, over the time 
period studied. There emerges from these figures a pattern of localis-
ation, the major features of which are as follows: 
(a) One day after oxazolono administration the amount of Sem activity 
found in the regional lymph nodes was significantly greater than that 
found in the contralateral nodes (Figs. V., 4, V.5, V.E' and V.) and 
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significantly greater than that found in lymph nodes of mice that 
received alcohol (Figs. V.4, V.6 and V.7). 
The greatest amount of cell-localisation in terms of absolute 
counts was found 1 day after antigen administration. The counts which 
were obtained from the 3 groups at this time were almost identical. 
Two days after oxazolone administration the amount of localisation 
of ilabelled cells in the regional lymph nodes fell significantly below 
the day 1 level (Figs. V.4, V.6 and V.?) to a level eimilar to (Fig. V.5) 
or below (Fig. V.4, V.6 and V.?) that found in the lymph nodee of animals 
treated with alcohol. In Figs. V.4 and V.6 this decrease was not 
confined to the draining lymph nodes and was also found In the contra-
lateral lymph nodes. 
On days 3 and 4 the amount of activity found in the lymph nodes 
draining the site of oxazolone application was greater than that found 
in the contralateral nodes of the same recipients, although this differ -
ence was not significant at day 4 (Fig. V.4 and V.?). By day 3 there 
was no significant difference in the localisation of labelled cells to 
lymph nodes drainizg oxazolone and the respective contralateral lymph 
nodes (Figs. V.4 and V.5). 	In Fig. V.6, however, localisation was still 
apparent in the draining compared to the contralateral nodes at day 5. 
In Fig. V.7 no data for localisation in the ontxã1aterã1nodes - at day5 are 
available. 
The amount of activity found in the lymph nodes draining the 
site of antigen application was on each day (except day 5, Fig. V.5) 
greater than that found in the contralateral nodes of the same animal. 
In contrast, the mice which received alcohol showed similar levels of 
activity in their draining and contralateral lymph nodes. 
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2. Experiment utilising 3H-leucine 
The experimental protocol used was as described for 15Sem, except that 
311.-leucine was used to label lymphocytes and DNA synthesis was not 
estimated. The excised lymph nodes were individually homogenised in 
10% TCA, filtered and the precipitate was counted in a liquid 
scintillation counter. The results are expressed as the log 10 of the 
mean 2-minute counts • The variation found with the results from the 
activity' counted in the inguinal nodes was too large to allow inter-
pretation of the results • The localieation of 3H-leucine labelled 
lymphocytes in the popliteal lymph nodes of the various groups is shown 
in Figs. V..8, V.'.9and V.10, 
There was no significant difference in the amount of localisation which 
was found in the lymph nodes of mice which were undergoing a proliferative 
response to oxazo lone, and the lymph nodes of mice which had received 
BSS only. Thus in accordance with the results obtained using 758em, 
cellular proliferation did not appear to affect cell recruitment. These 
results do not however exhibit all the features of cell localisat ion to 
oxazolone which were found using Thgera.  In particular 2 previously 
observed features were not discerned here: 
Using 758em, maximum localisation in terms of absolute counts was 
found 1 day after oxazolone administration. The present results ehow 
no more activity in the draining popliteala 1 day after oxazolope than 
at 2 and 3 days after oxazolone. 
Using 788am, there was little difference in the amount of 
activity detected between the draining and contralateral nodes of 
recipients of alcohol, 1-3 days after receiving alcohol. The 
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similarity of the counts obtained between these nodes is an important 
control and any deviation from their parity indicates an alteration in 
cell localisation. The interpretation of some of the results using 
3H-leuci.ne is therefore hindered by the knowledge that there was a 
significant difference in the Jocalisation of cells between the 
draining and contralateral nodes of alcohol-stimulated mice at 3 days 
(Fig. V.8 and V.9). This renders equivocal the apparent significant 
difference in localisation found between the draining and contralateral 
nodes of oxazolone-atiinulated mice on day 3. 
There was, however, significantly more activity recovered from the 
draining lymph nodes of oxazolone-stimulated mice than the contra-
lateral nodes, on days 1, 2 and 4 (Fig. V.:9.) and the first 4 days in 
Fig. V.JOartd day 2 in Fig. V.. This was not matched by an equivalent 
difference between the draining and contralateral nodes in the alcohol-
stimulated mice. 
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Localisat ion of 
7
Sem labelled lymph node lymphocytes in the 
inguinal nodes of mice which had been irradiated (900R) and 
Injected with USS, 1-5 days after receiving oxazolone or 
alcohol by foot-pad application. 
• ThSe activity In the draining nodes of recipients of oxazolone 
El 76se activity in the contralateral nodes of recipients of 
oxazolone 
• 	Se activity in the draining nodes of recipients of alcohol 

















Localisation of 75 Sam labelled lymph node lymphocytes in the inguinal 
nodes of tico which had been irradiated (90011) and injected with 
106 thymocytos, 1-5 days a$ter receiving oxazolone or alcohol by foot-
pad application. 
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Fig. V.6 
localisation of 758em lab. ned lymph node lymphocytes in the 
inu1nsl nodes of mice whioh had been irradiated (90011) and 
injected with 108  thymocytee, 1-5 days after receiving 
oxazolone or alcohol by foot.pad application. 
• 75Se activity in draining nodes of recipients of oxazolone 
activity in contralat.ral nodes of recipients of 
oxazolone 
• Be activity in draining nodes of recipients of alcohol 
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Localisation of 7 Sen labelled lymph node lymphocytes in the 
popliteal nodes of mice which had been irradiated (900R) and injected 
with 108  thyzuocytee, 1-5 days after receiving oxazolone or alcohol 
by foot-pad application. 
• ?SSe activity in draining nodes of recipients of o'cazolone 
o 75SO.activlty In contralateral nodes of recipients of 
oxazolone 
• 58e activity in draining nodes of recipients of alcohol 
o 759e activity in contralateral nodes of recipients of 
alcohol. 
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FIC6 V.8 
Looalisation of 311-leuclne labelled lymph node lymphocytes 
in the popliteal nodes of mice which had been irradiated (8001) 
and injected with 828 1-5 days after receiving oxazolono or 
alcohol by foot-pad application. 
•H activity in draining nodes of recipients of oxazolone 
EJ 3 H activity in contralateral nodes of recipients of 
oxazolone 
• 3 H activity in draining nodes of recipients of alcohol 
o 3H activity in contralatoral nodes of recipients of 
alcohol 
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Localisation of 3 I-1eucine labelled lytipb node lymphocytes 
in the popliteal nodes of mice which had been irradiated 
(DOOR) and injected with 106 thymocytea, 1-5 days after 
receiving owzo3one or alcohol by foot-pad application. 
• 3 activity in draining nodes of recipients of oxazolone 
o 	activity in contralateral nodes of recipients of 
oxazolone 
• 3E activity in draining nodes of recipients of alcohol 
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Fig. V.10 
Localiaation of 3H-leucine labelled lymph node lymphocytes 
in the popliteal nodes of mice which had been irradiated 
(900R) and injected with iO8  thymocytea, 1-5 days after 
receiving oxazolone or alcohol by foot-pad application. 
•H activity in draining nodes of recipients of oxazolone 
o 3H activity in contralateral nodes of recipients of 
oxazolone 
o 3H activity in draining nodes of recipients of alcohol 
o 3a activity in contralateral nodes of recipients of 
alcohol 
 











The results of experiments presented in Chapter II suggested the 
existence of a homeostatic mechanism responsible for regulating the 
magnitude of the proliferative response of lymphocytes to oxazolone. 
The mechanism was evidently operative 4-5 days after the administration 
of oxazolone but may well be in force earlier. It is known that one 
of the early events in an immune response consists of an antigen-mediated' 
recruitment of circulating cells (Hall & Morris, 1964; Ford & Gowana, 
1967; Simic & Petrovic, 1971). Any mechanism which could inhibit 
recruitment and retention of lymphocytes may deprive lymph nodes of 
inununocompetent' cells, and so impede the progress of the immune response. 
If this hypothesis is correct, and if it accounts for the pattern of the 
kinetics of the thyiuocyte proliferative response to oxazolone which was 
described in Chapter II, it would be predicted that the antigen-stimulated 
lymph nodes of mice which received only saline would allow the accumul- 
at ion of a greater number of lymphocytes than would the lymph nodes of 
recipients of 108  thymocytea which were undergoing a proliferative 
response to oxazolone. The experiments in this section were deaigned 
to test this prediction. 
In Chapter IV, some of the properties of 75Sein have been described, and 
it was concluded that 75Sem provides a suitable isotopic marker for 
lymphocyte localisation studies • The results of an experiment performed 
with 75Sem were compared to those obtained using 3H-leucine to label 
lymphocytes. The results suggest that 75Sem provides a more sensitive 
eyatem for quantitating cell localisation because; 
lv?. 
There was little difference between the activity recovered from 
the draining and contralateral nodes in alcohol-atiEulated mice 
ing 75Sei, thus providing a 'control' where little locaiisatic 
in the draining nodes is expocted. 
The features that characterised the kinetics of coil accu.ilation 
in response to oxazolone were more consistent using 75Sem than ui.ing 
3 -leuc ins. 
The most likely explanation for the Creator efficacy of 75 OD, in this 
oJ(3tem, is the ease of tissue preparation and consequent reduction of 
experimental errors. Only the experiments which utilisod 75 Zen are 
discussed in the following pages. 
1. The effect of cellular proliferation on cell recruitment 
xporiments measured the DNA synthetic response to oxazolono in the 
draining lymph nodes of mice that had boon irradiated and injected with 
io8 or 106  thymocytes, or saline. Accumulation of labelled cells reached 
a peak one day after the administration of oxazolone and thus preceded 
the peak DNA synthetic response which occurred on day 4 in recipients of 
io8 thymocytee and on day S in recipients of 106  thymocytes. Labelled 
cells accumulated in the lymph nodes of mice which had received BSS only 
and which failed to produce a proliferative response to oxazolono. 
A similar temporal relationship botwe,n cell trapping and DNA synthesis 
was found by Zatz and Gershon (1974), who measured the accumulation of 
51 Cr labelled cells In the spleens of mice undergoing a craft vs host 
response. Despite the vast difference in proliferative activity of the 
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lymph nodes in the groups of mice given different doses of thymocytee, 
there was no discernible difference in the magnitude of accujaulation of 
labelled cells in the lymph nodes • The risulta may tentatively thdicate 
that marginally more cells were recruited by lymph nodes containing 108 
responding cells than lymph nodes containing 106 or not containing ce1i, 
a phenomenon also possibly suggested by the results of Zatz and Gershon 
(1974). Great caution is, however, required in interpreting this issue 
as it is possible that a large number of proliferating cells has a 
greater propensity to reutilise label than a small number of proliferating 
cells. 
It 	not known what mechanism regulates the entry of lymphocytes into 
antigen-stimulated lymph nodes. There is, however, some circumstantial 
evidence that may favour the existence of a type of T cell that directly 
or Indirectly via factors produced during its proliferative activity, 
regulates the entry of cells into lymph nodes. The magnitude of an 
Immune response is dependent on the number of cells that enter the spleen 
(Ford & Gowans, 1967; Simic & Petrovic, 1971), the majority of circulating 
cells are T cells (Raft, 1969.; Raft & Wortia, 1070; Miller & Sprent, 
1911) and T cell proliferation precedes many immune responses (Carter 
At al., 1969). Further evidence is the existence of T cell products 
that cause cellular distension in the paracortical regions of lymph 
node8 (Kelly etal., 1972) and the observation by Parrott and de Souaa 
(1971) that 24 bra after the injection of labelled thymocytes, more were 
found in the lymph nodes of neonatally-thymectomnised mice than in normal 
mice, 
199. 
Nevertheless, the results reported in the present studies must be added 
to an accumulating body of evidence (Frost & Lance, 1974a; Frost, 
1974) that T cells do not have an obvious regulatory effect on cell 
recruitment. They cannot, however, be entirely excluded from such a 
role, because of the possibility that labelled T cells initiate their 
own recruitment. The presence of antigen and its effect on macrophagee 
is probably a more important factor regulating cell traffic through a 
lymph node or spleen (Frost, 1974). 
2. The kinetics of cell localisation to lymph nodes in oxazolone-
stimulated mice 
The effect of antigen which causes the non-specific retardation of cells 
moving through a stimulated organ, can be measured in 2 ways: 
By measuring the deficit in the number of cells leaving the node 
in the efferent lymph (Il1 &. Morris, 1962, 1963, 1965; Ford, 1969). 
By measuring the accumulation of radioactivity in stimulated 
lymph nodes of animals that have received labelled lymphocytes (Zatz & 
Lance, 1971a, 1971b; Emeson & Thursh, 1971; Ford, 1972; Thursh & 
Emeson, 1972; Frost & Lance, 1974a, 1974b). 
The second method was utilised in the present studies. 
Interpretation of the results depends on identifying the control values. 
There are two âOttrols to be considered. The first is the level of 
radioactivity associated with the contralateral lymph nodes in 
recipients of oxazolone, the second is the amount of activity found in 
the lymph nodes of recipients of alcohol. It is important that in the 
mice where no localisat ion is expected, there should be no significant 
200. 
differences in the amount of radioactivity found between the draining 
and contralateral nodes. Indeed, no significant differences were 
detected between these nodes in recipients of alcohol, 1-3 days after 
alcohol administration. 
The most definitive conclusion to be drawn from these results, using 
both controls as criteria, is that labelled cells injected 24 bra after 
the application of oxazolone accumulated preferentially in lymph nodes 
draining the site of antigen application. Therefore oxazolone is yet 
another antigen to be added to the list (Hall & Morris, 1965; Frost & 
Lance, 1974a, 1974b) of those that elicit cell recruitment. By 24 bra 
more than twice as many counts were found in the stimulated nodes than 
were found in the lymph nodes of mice treated with alcohol, demonstrating 
a level of preferential accumulation or localisat ion similar to that 
detected in other systems (Zatz & Lance, 1971a, 1971b). That the peak 
accumulation should be detected within 24 bra of antigen application 
also accords with results from other systems (Zatz & Lance, 1971a; 
Ford, 1968; Thurah & Emeson, 1971; Zatz & Gershon, 1974). Preferential 
accumulation of lymphocytes in oxazolone stimulated nodes appeared to 
have ceased, both in roapect of the deficit in the contralateral nodes, 
and the amount of accumulation in lymph nodes of recipients of alcohol, 
by day 5. On days 3 and 4, more cells accumulated in the lymph nodes 
dragning the application site of oxazolone than in the contralateral nodes, 
but there was little difference between localisation in the nodes draining 
oxazolone and the equivalent lymph nodes of recipients of alcohol. 
Interpretation of this phenomenon depends on determining why consistently 
less cells accumulated in contralatoral lymph nodes of recipients of 
201.. 
oxazolone than in the lymph nodes of mice which had been painted with 
alcohol • Two explanat ions are proposed: 
Antigen non-specifically retards cell movement through a stimulated 
node and also causes the specific retention of antigen reactive cells 
for 24-48 hra (Sprent at a].., 1971; Rowely 	1972). 	If 1-4 
days after oxazolone, cell movement through the stimulated node was 
retarded sufficiently, labelled cells injected during this period might 
be caught in the draining nodes, and their accumulation in contralatoral 
nodes consequently depressed. Similarly the retention of antigen 
reactive cells in the draining nodes might deplete the number of 
circu].at Lug cells available to accumulate in the contra].ateral nodes. 
The latter phenomenon would imply the existence of a large number of 
cells in a lymphocyte population able to recognise oxazolone. 
A highly speculative, proposition is that during the early phase 
of cell-recruitment, a humóral factor is released from the draining 
nodes which inhibita cell entry into the contralateral and possibly more 
distant nodes, for 1-4 days. Such a factor was postulated by Black 
(1974) to account for the immunosuppressive effects of pre-emption. 
A curious feature found in some of the results was the depressed 
accumulation of labelled cells in the lymph nodes draining the site of 
oxAzolone application, 2 days after oxazolone. The results are suspect 
due to the concomitant decrease in localisat ion found in the contra-
lateral nodes of these,mice • It is conceivable that the 'day 2' group 
received deficient injections of labelled cells. This experi't would 
have to be repeated before this decline could be treated cautiously as 
an indication of a regulatory mechanism inhibiting cell recruitment 2 days 
after oxazolone 
202. 
The present experimental findings can be tentatively interpreted in 
terms of cell movements caused by oxazolone in the following manner: 
Within 24 hre of antigen, more cells enter the draining lymph 
nodes, as a possible consequence of increased blood flow, permeability 
or some other meChanism allowing cells to enter the node. This may be 
combined with retardation of cells leaving the lymph node. 
After 24 bra there is no further positive recruitment of cells. 
Lymphocytes enter the draining node at the same rate that they enter 
lymph nodes in unstimulated mice • There is, however, a slower tranait 
time, and this may be accompanied by selection and retention of antigen 
reactive cells. 
The slowing down of cells moving through the lymph nodes described 
in (a) and (b) above may deprive the circulation of cells that would 
normally accumulate in contralatoral nodes. 
Traffic through the draining lymph nodes returns to normal 
probably on days 4 and 5. This is accompanied by localisation of cells 
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